Section H - effective 1 July 2010 (text extract)

This is the text extract for Section H - effective 1 July 2010, browse documents here.

Pharmaceutical Management Agency

Section H

for Hospital Pharmaceuticals

Effective 1 July 2010 New Zealand Pharmaceutical Schedule

Hospital Pharmaceuticals July 2010

Editors Kaye Wilson & Scott Brydon email: schedule@pharmac.govt.nz Telephone +64 4 460 4990 Facsimile +64 4 460 4995 Level 9, 40 Mercer Street PO Box 10 254 Wellington 6143 Freephone Information Line 0800 66 00 50 (9am – 5pm weekdays) Circulation Published each March, July and November. Changes to the contents are published in monthly updates. Annual subscription includes three Section H books. The Pharmaceutical Schedule is a separate publication. The Schedule is distributed free of charge to over 1,000 health professionals, and is also available on an annual subscription. Production Typeset automatically from XML and TEX. See www.pharmac.govt.nz/schedule/archive/ for the XML version of this Schedule. Programmers Anrik Drenth & John Geering email: texschedule@pharmac.govt.nz c Pharmaceutical Management Agency ISSN 1179-3708 pdf ISSN 1172-9694 print This work is licensed under the Creative Commons Attribution 3.0 New Zealand licence. In essence, you are free to copy, distribute and adapt it, as long as you attribute the work to PHARMAC and abide by the other licence terms. To view a copy of this licence, visit: creativecommons.org/licenses/by/3.0/nz/. Attribution to PHARMAC should be in written form and not by reproduction of the PHARMAC logo. While care has been taken in compiling this Schedule, PHARMAC takes no responsibility for any errors or omissions, and shall not be liable for any consequences arising there from.

Contents

Introducing PHARMAC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Members of the PHARMAC Board . . . . . . . . . . . . . . . . . . . . . . . . . 2 Decision Criteria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 PHARMAC and Section H of the Pharmaceutical Schedule . . . . 3 The PHARMAC Hospital Team . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 PHARMAC’s clinical advisors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 Pharmacology and Therapeutics Advisory Committee (PTAC) . . . 4 Hospital Pharmaceuticals Advisory Committee (HPAC) . . . . . . . . . 4 Purpose of the Pharmaceutical Schedule . . . . . . . . . . . . . . . . . . . 5 Finding Information in the Pharmaceutical Schedule . . . . . . . . . . . 5 Community Pharmaceuticals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Hospital Pharmaceuticals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Explaining Hospital Pharmaceutical Entries . . . . . . . . . . . . . . . . . . 6 Glossary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Treatment Costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 PHARMAC website . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Exceptional Circumstances policies . . . . . . . . . . . . . . . . . . . . . . . . 8 Hospital Exceptional Circumstances (HEC) . . . . . . . . . . . . . . . . . . 8 Community Exceptional Circumstances (CEC) . . . . . . . . . . . . . . . 9 Cancer Exceptional Circumstances (CaEC) . . . . . . . . . . . . . . . . . . 9 Part I – General Rules for Hospital Pharmaceuticals . . . . . . . . . 10 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 1. Interpretation and Deﬁnitions . . . . . . . . . . . . . . . . . . . . . . . . . . 10 2. Current Hospital Pharmaceutical Contracts . . . . . . . . . . . . . . . 12 3. National Contract Pharmaceutical Price . . . . . . . . . . . . . . . . . . 12 4. Hospital Supply Status (HSS) . . . . . . . . . . . . . . . . . . . . . . . . . . 12 5. Collection of rebates and payment of ﬁnancial compensation . 13 6. Price and Volume Data. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 7. Discretionary Community Supply Pharmaceuticals . . . . . . . . . 13 8. Pharmaceuticals Cancer Treatment . . . . . . . . . . . . . . . . . . . . . 14 9. Practitioners Prescribing Unapproved Pharmaceuticals . . . . . 14 Part II – Pharmaceuticals Under National Contracts . . . . . . . . . 16 Part III – Discretionary Community Supply Pharmaceuticals . . 58 Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63

Introducing PHARMAC

PHARMAC, the Pharmaceutical Management Agency, is a Crown entity established pursuant to the New Zealand Public Health and Disability Act 2000 (The Act). The primary objective of PHARMAC is to secure for eligible people in need of pharmaceuticals, the best health outcomes that are reasonably achievable from pharmaceutical treatment and from within the amount of funding provided. The PHARMAC Board consists of up to six members appointed by the Minister of Health. All decisions relating to PHARMAC’s operation are made by or under the authority of the Board. In particular, Board members decide on the strategic direction of PHARMAC and may decide which community pharmaceuticals should be subsidised and at what levels, and determine national prices for some pharmaceuticals to be purchased by and used in DHB Hospitals, and whether or not special conditions are to be applied to such purchases. Members of the PHARMAC Board Richard Waddel Kura Denness David Kerr Stuart McLauchlan David Moore Adrienne von Tunzelmann Decisions taken by the PHARMAC Board members, or made under the authority of the Board, incorporate a balanced view of the needs of prescribers and patients. The aim is to achieve long-term gains and efﬁcient ways of making pharmaceuticals available to the community and for DHB Hospitals to purchase them. The functions of PHARMAC are to perform the following, within the amount of funding provided to it in the Pharmaceutical Budget or to DHBs from their own budgets for the use of pharmaceuticals in their hospitals, as applicable, and in accordance with its annual plan and any directions given by the Minister (Section 103 of the Crown Entities Act): a) to maintain and manage a pharmaceutical schedule that applies consistently throughout New Zealand, including determining eligibility and criteria for the provision of subsidies; b) to manage incidental matters arising out of (a), including in exceptional circumstances providing for subsidies for the supply of pharmaceuticals not on the pharmaceutical schedule; c) to engage as it sees ﬁt, but within its operational budget, in research to meet its objectives as set out in Section 47(a) of the Act; d) to promote the responsible use of pharmaceuticals; e) to manage the purchasing of any or all pharmaceuticals, whether used either in a hospital or outside it, on behalf of DHBs; f) any other functions given to PHARMAC by or under any enactment or authorised by the Minister. The policies and criteria set out in the Pharmaceutical Schedule and PHARMAC’s Operating Policies and Procedures arise out of, and are designed to help PHARMAC achieve and perform, PHARMAC’s objective and functions under the Act. However PHARMAC may, having regard to its public law obligations, depart from the strict application of those policies and criteria in certain exceptional cases where it considers this necessary or appropriate in the proper exercise of its statutory discretion and to give effect to its objective and functions, particularly with respect to: G Determining eligibility and criteria for the provision of subsidies; and G In exceptional circumstances providing for subsidies for the supply of pharmaceuticals not on the Pharmaceutical Schedule. Decision Criteria PHARMAC updates the Pharmaceutical Schedule at regular intervals to notify prescribers, pharmacists, hospital managers and patients of changes to Community Pharmaceutical subsidies and the prices for Hospital Pharmaceuticals. In making decisions about amendments to the Pharmaceutical Schedule, PHARMAC is guided by its Operating Policies and Procedures, as amended or supplemented from time to time. PHARMAC takes into account the following criteria when considering proposed amendments to the Schedule: a) the health needs of all eligible people within New Zealand; b) the particular health needs of M¯ ori and Paciﬁc peoples; a c) the availability and suitability of existing medicines, therapeutic medical devices and related products and related things; d) the clinical beneﬁts and risks of pharmaceuticals; e) the cost-effectiveness of meeting health needs by funding pharmaceuticals rather than using other publicly funded health and disability support services; f) the budgetary impact (in terms of the pharmaceutical budget and the Government’s overall health budget) of any changes to the Schedule; g) the direct cost to health service users; h) the Government’s priorities for health funding, as set out in any objectives notiﬁed by the Crown to PHARMAC, or in PHARMAC’s Funding Agreement, or elsewhere; and i) such other criteria as PHARMAC thinks ﬁt. PHARMAC will carry out appropriate consultation when it intends to take any such “other criteria” into account.

The Operating Policies and Procedures, including any supplements, also describe the way in which PHARMAC determines the level of subsidy or purchase price payable for each Community Pharmaceutical or Hospital Pharmaceutical, respectively. Copies of PHARMAC’s Operating Policies and Procedures and of any applicable supplements are available on the PHARMAC website (www.pharmac.govt.nz), or on request.

PHARMAC and Section H of the Pharmaceutical Schedule:

PHARMAC manages the national Pharmaceutical Schedule, which lists: G Pharmaceuticals available in the community and subsidised by the Government with funding from the Pharmaceutical Budget; and G some Pharmaceuticals purchased by DHBs for use in their hospitals, and includes those Hospital Pharmaceuticals for which national prices have been negotiated by PHARMAC. In the community approximately 1848 Pharmaceuticals are subsidised by the Government. Most are available to all eligible people within New Zealand on prescription by a medical doctor. Some are listed with guidelines or conditions such as ‘only if prescribed for a dialysis patient’ or ‘Special Authority - Retail Pharmacy’, to ensure that Pharmaceuticals are used by those people who are most likely to beneﬁt from them. Pharmaceuticals provided to patients for use while in DHB Hospitals are not covered by Sections A to G of the Pharmaceutical Schedule. Section H of the Pharmaceutical Schedule is not a comprehensive list of pharmaceuticals that are used within DHB Hospitals. Section H of the Pharmaceutical Schedule includes Pharmaceuticals that can be purchased at a national price by DHBs for use in their hospitals. These are referred to as National Contract Pharmaceuticals. Section H of the Pharmaceutical Schedule also identiﬁes Pharmaceutical Cancer Treatments that DHBs have been directed to fund for use in their hospitals and/or in association with services provided in their hospitals, as well as new Pharmaceuticals used in hospitals, which have been or are being assessed by PHARMAC, the results of that analysis being available to DHB Hospitals via PHARMAC’s website. A list of Discretionary Community Supply Pharmaceuticals, in Section H of the Pharmaceutical Schedule, identiﬁes those products that currently are not subsidised from the Pharmaceutical Budget as Community Pharmaceuticals in Sections A to G of the Pharmaceutical Schedule but which DHBs can at their discretion fund for use in the community from their own budgets without speciﬁc Hospital Exceptional Circumstances approval.

The PHARMAC Hospital Team Steffan Crausaz Manager, Funding and Procurement Andrew Davies Procurement Initiatives Manager Katie Appleby Hospital Exceptional Circumstances Panel Co-ordinator PHARMAC’s clinical advisors Pharmacology and Therapeutics Advisory Committee (PTAC) PHARMAC works closely with the Pharmacology and Therapeutics Advisory Committee (PTAC), an expert medical committee which provides independent advice to PHARMAC on health needs and the clinical beneﬁts of particular pharmaceuticals for use in the community and/or in DHB Hospitals. The committee members are all senior, practising clinicians. The chair of PTAC sits with the PHARMAC Board in an advisory capacity. PTAC helps decide which community pharmaceuticals are to be subsidised from public monies by making recommendations to PHARMAC. Part of the role of PTAC is to review whether Community Pharmaceuticals already listed on the Schedule should continue to receive Government funds. The resources freed up can be used to subsidise other Community Pharmaceuticals with a greater therapeutic worth. PHARMAC may obtain clinical advice from PTAC in relation to national purchasing strategies for Hospital Pharmaceuticals. There may be additional specialist hospital representatives on PTAC subcommittees, or additional PTAC subcommittees, where PHARMAC considers this necessary. PTAC members are: Carl Burgess Marianne Empson Ian Hosford Sisira Jayathissa George Laking Jim Lello Graham Mills Peter Pillans Mark Weatherall Howard Wilson MBChB, MD, MRCP (UK), FRACP, FRCP, physician/clinical pharmacologist, Chair BHB, MBChB, MMed (ClinEpi) FRACP, FRCPA MBChB, FRANZCP, psychiatrist MMedSc (Clin Epi), MMBS, MD, MRCP (UK), FRCP (Edin), FRACP, FAFPHM, Dip Clin Epi, Dip OHP, Dip HSM, MBS PhD, MB, B.Med.Sci, MD, FRACP BHB, MBChB, DCH, FRNZCGP, general practitioner MBChB, MTropHlth, MD, FRACP, infectious disease specialist and general physician MBBCh, MD, FCP, FRACP, clinical pharmacologist BA, MBChB, MApplStats, FRACP BSc, PhD, MB, BS, Dip Obst, FRNZCGP, FRAGCP Deputy Chair

Contact PTAC C/-Advisory Committee Manager, Pharmaceutical Management Agency, PO Box 10 254, WELLINGTON 6143, Email: PTAC@pharmac.govt.nz Hospital Pharmaceuticals Advisory Committee (HPAC) The Hospital Pharmaceutical Advisory Committee (HPAC) is a committee made up of representatives from DHBs, as nominated by DHBs and appointed by the PHARMAC Board. The PHARMAC Board has appointed the following members to HPAC: Neil Aitcheson Materials Manager MidCentral Paul Barrett Pharmacy Services Manager Canterbury Simon Donlevy Pharmacy Manager Southland Sarah Fitt Pharmacy Manager Auckland Jan Goddard Pharmacy Services Waikato Chris Morgan Materials Manager Auckland David Ryan Pharmacy Operations Manager Waitemata Contact HPAC C/- Manager, Funding and Procurement, Pharmaceutical Management Agency, PO Box 10 254 WELLINGTON 6143

Purpose of the Pharmaceutical Schedule

The purpose of the Schedule is to list: G the Community Pharmaceuticals that are subsidised by the Government and to show the amount of the subsidy paid to contractors, as well as the manufacturer’s price and any access conditions that may apply; and G some Hospital Pharmaceuticals that are purchased and used by DHB Hospitals, including those for which national prices have been negotiated by PHARMAC. The purpose of the Schedule is not to show the ﬁnal cost to Government of subsidising each Community Pharmaceutical or to DHBs in purchasing each Hospital Pharmaceutical since that will depend on any rebate and other arrangements PHARMAC has with the supplier and, for some Hospital Pharmaceuticals, on any logistics arrangements put in place by individual DHB Hospitals. Finding Information in the Pharmaceutical Schedule Community Pharmaceuticals For Community Pharmaceuticals, the Schedule is organised in a way to help the reader ﬁnd Community Pharmaceuticals, which may be used to treat similar conditions. To do this, Community Pharmaceuticals are ﬁrst classiﬁed anatomically, originally based on the Anatomical Therapeutic Chemical (ATC) system, and then further classiﬁed under section headings structured for the New Zealand medical system. G Section A lists the General Rules in relation to Community Pharmaceuticals and related products. G Section B lists Community Pharmaceuticals and related products by anatomical classiﬁcation, which are further divided into one or more therapeutic headings. Community Pharmaceuticals used to treat similar conditions are grouped together. G Section C lists the rules in relation to Extemporaneously Compounded Products (ECPs) and Community Pharmaceuticals that will be subsidised when extemporaneously compounded. G Section D lists the rules in relation to Special Foods and the Special Foods that are subsidised. G Section E Part I lists the Community Pharmaceuticals that are subsidised on a Practitioner’s Supply Order (PSO) and Wholesale Supply Order (WSO). G Section E Part II lists rural areas for the purpose of PSOs. G Section F lists the Community Pharmaceuticals dispensing period exemptions. G Section G lists the Community Pharmaceuticals eligible for reimbursement of safety cap and related rules. The listings are displayed alphabetically (where practical) within each level of the classiﬁcation system. Each anatomical section contains a series of therapeutic headings, some of which may contain a further classiﬁcation level. Where a Community Pharmaceutical is used in more than one therapeutic area, they may be cross-referenced. The therapeutic headings in the Pharmaceutical Schedule do not necessarily correspond to the therapeutic groups and therapeutic subgroups, which PHARMAC establishes for the separate purpose of determining the level of subsidy to be paid for each Community Pharmaceutical. The index located at the back of the book in which Sections A-G of the Pharmaceutical Schedule are published can be used to ﬁnd page numbers for generic chemical entities, or product brand names. Hospital Pharmaceuticals Section H lists Pharmaceuticals that DHBs fund from their own budgets. The Hospital Pharmaceuticals are grouped into the following Parts in Section H: G Part I lists the rules in relation to Hospital Pharmaceuticals. G Part II lists Hospital Pharmaceuticals for which national contracts exist (National Contract Pharmaceuticals). These are listed alphabetically by generic chemical entity name and line item, the relevant Price negotiated by PHARMAC and, if applicable, an indication of whether it has Hospital Supply Status (HSS) and any associated DV Limit. G Part III lists Discretionary Community Supply Pharmaceuticals, which are not Community Pharmaceuticals, but which a DHB Hospital can, in its discretion, fund for use in the community from its own budget. The index located at the back of the Section H can be used to ﬁnd page numbers for generic chemical entities, or product brand names, for Hospital Pharmaceuticals.

Explaining Hospital Pharmaceutical Entries Section H of the Pharmaceutical Schedule lists National Contract Pharmaceuticals and Discretionary Community Supply Pharmaceuticals that are available to be purchased by DHBs. Where applicable, the listing of the Hospital Pharmaceutical may have an indication of whether it has HSS (if the brand name is in bold), its Price and any associated DV Limit. Example

Pharmaceuticals Under National Contracts

Price (ex man. excl GST) $ Brand or Generic Manufacturer

Per

CHEMICAL Presentation A ............................................................10.00 Generic name listed alphabetically From 1 January 2010 to 30 June 2012, at least 99% of the total volume of this item purchased must be Brand C Presentation B - 1% DV Limit Jan-10 to 2012 ...........15.00 Presentation C ............................................................18.00

100

Brand A Brand B Brand C Brand D Brand or manufacturer’s name Product with Hospital Supply Status (HSS)

50 250 ml

CHEMICAL Presentation D ............................................................26 26.53 Form and strength

100

Brand E

Quantity the Price applies to Standard national price excluding GST

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

In the case of presentation B, Brand C is the Pharmaceutical with HSS. While the price indicated applies from the date on which it was listed, it does not have HSS until the date indicated in the DV Limit. The 1% DV Limit means that at least 99% of the total volume of all brands of that presentation purchased by DHB Hospitals from the date HSS effective indicated must be the HSS brand. Subject to clause 4 of the General Rules for Hospital Pharmaceuticals, DHB Hospitals may only purchase up to the DV Limit of other brands. The brand E of Presentation D, does not have HSS or any DV Limit. Accordingly, DHB Hospitals are able to buy that brand at the listed Price if they choose, but may also buy any other brand of the presentation in any quantity required, at whatever price the DHB Hospital negotiates with the relevant supplier.

Glossary

Units of Measure gram ..................................................g kilogram...........................................kg international unit ...............................iu microgram........................................µg milligram .........................................mg millilitre.............................................ml millimole......................................mmol unit.....................................................u

Abbreviations Ampoule ...................................... Amp Granules ......................................Gran Suppository ................................ Supp Capsule ........................................ Cap Infusion............................................Inf Tablet .............................................Tab Cream...........................................Crm Injection ...........................................Inj Tincture.........................................Tinc Device........................................... Dev Linctus .......................................... Linc Trans Dermal Delivery Dispersible................................... Disp Liquid..............................................Liq System.................................. TDDS Effervescent.................................... Eff Long Acting..................................... LA Emulsion..................................... Emul Ointment....................................... Oint Enteric Coated................................EC Sachet ........................................ Sach Gelatinous ..................................... Gel Solution........................................ Soln HSS Hospital Supply Status, the status of being the brand of the relevant Hospital Pharmaceutical listed in Section H Part II as HSS, that DHBs are obliged to purchase subject to any DV Limit for that Hospital Pharmaceutical for the period of hospital supply, as awarded under an agreement between PHARMAC and the relevant pharmaceutical supplier. S29 This medicine is an unapproved medication supplied under Section 29 of the Medicines Act 1981. Practitioners prescribing this medication should: a) be aware of and comply with their obligations under Section 29 of the Medicines Act 1981 and otherwise under that Act and the Medicines Regulations 1984; b) be aware of and comply with their obligations under the Health and disability Commissioner’s Code of Consumer Rights, including the requirement to obtain informed consent from the patient (PHARMAC recommends that Practitioners obtain written consent); and c) exercise their own skill, judgement, expertise and discretions, and make their own prescribing decisions with respect to the use of an unapproved Pharmaceutical or a Pharmaceutical for an indication for which it is not approved. Note: Where medicines supplied under Section 29 that are used for emergency situations, patient details required under Section 29 of the Medicines Act may be retrospectively provided to the supplier.

Hospital Pharmaceutical and Pharmaceutical Cancer Treatment Costs The cost of purchasing Hospital Pharmaceuticals and Pharmaceutical Cancer Treatments (for use in DHB hospitals and/or in association with Outpatient services provided in DHB hospitals) is met by the Funder (in particular, the relevant DHB) from its own budget. As required by section 23(7) of the Act, in performing any of their functions in relation to the supply of Pharmaceuticals, including Pharmaceutical Cancer Treatments, DHBs must not act inconsistently with the Pharmaceutical Schedule. PHARMAC website Information about PHARMAC is available on its website at http://www.pharmac.govt.nz. The website includes copies of the Annual Review, Annual Report and Annual Plan, as well as information such as the Pharmaceutical Schedule, Pharmaceutical Schedule Updates, other publications and recent press releases. Copies of the February 2002 National Hospital Pharmaceutical Strategy can be found on the website. Also, for details about hospital pharmaceuticals that have been assessed by PHARMAC and further information about assessments undertaken by DHB Hospitals, please refer to http://www.pharmac.govt.nz/hpad Exceptional Circumstances policies The purpose of the Exceptional Circumstances policies are to provide: G funding from the Community Exceptional Circumstances budget for medication, to be used in the community, in circumstances where the provision of a funded community medication is appropriate, but funding from the Pharmaceutical Budget is not able to be provided through the Pharmaceutical Schedule (“Community Exceptional Circumstances”); or G an assessment process for DHB Hospitals to determine whether they can fund medication, to be used in the community, in circumstances where the medication is neither a Community Pharmaceutical nor a Discretionary Community Supply Pharmaceutical and where the patient does not meet the criteria for Community Exceptional Circumstances (“Hospital Exceptional Circumstances”); or G an assessment process for DHB Hospitals to determine whether they can fund pharmaceuticals for the treatment of cancer in their DHB Hospital, or in association with Outpatient services provided in their DHB Hospital, in circumstances where the pharmaceutical is not identiﬁed as a Pharmaceutical Cancer Treatment (“Cancer Exceptional Circumstances”) in Sections A-H of the Pharmaceutical Schedule. Upon receipt of an application for approval for Community Exceptional Circumstances or Hospital Exceptional Circumstances, the Exceptional Circumstances Panel ﬁrst decides whether an application will be assessed initially under the Community Exceptional Circumstances criteria or the Hospital Exceptional Circumstances criteria. Cancer Exceptional Circumstances is a separate process. Hospital Exceptional Circumstances (HEC) If the application is ﬁrst assessed but not approved under the Community Exceptional Circumstances criteria, the Exceptional Circumstances Panel may recommend the funding of the pharmaceutical for use in the community by a speciﬁc patient from a DHB Hospital’s own budget under Hospital Exceptional Circumstances. If the application is ﬁrst assessed under the Hospital Exceptional Circumstances criteria, the Exceptional Circumstances Panel may: a) recommend against the funding of the pharmaceutical for use in the community by a speciﬁc patient from a DHB Hospital’s own budget, in which case a DHB Hospital must not fund the pharmaceutical from its own budget; b) recommend the funding of the pharmaceutical for use in the community by a speciﬁc patient from a DHB Hospital’s own budget under Hospital Exceptional Circumstances, in which case a DHB Hospital may, but is not obliged to, fund the pharmaceutical from its own budget; c) defer its decision until further assessment under the Community Exceptional Circumstances criteria can undertaken; or d) recommend interim funding of the pharmaceutical for use in the community by a speciﬁc patient from a DHB Hospital’s own budget under Hospital Exceptional Circumstances until further assessment under the Community Exceptional Circumstances criteria can be undertaken. Permission to fund a pharmaceutical for use in the community by a speciﬁc patient from a DHB Hospital’s own budget under Hospital Exceptional Circumstances will only be granted by PHARMAC where it has been demonstrated that such funding is cost-effective for the relevant DHB in the region in which the patient resides. If the patient being treated with a pharmaceutical under Hospital Exceptional Circumstances usually resides in a district other than that within the jurisdiction of the DHB initiating the treatment, then the DHB initiating the treatment must either agree to fund any on-going treatment required once the patient has returned to his/her usual DHB, or obtain written consent from the DHB or DHBs in which the patient will reside following the commencement of treatment.

Community Exceptional Circumstances (CEC) In order to qualify for Community Exceptional Circumstances approval one of the following entry criteria must be met: a) the condition must be rare; or b) the reaction to alternative funded treatment must be unusual; or c) an unusual combination of circumstances applies. Rare and unusual are considered to be in the order of less than 10 people nationally. Where one of the above Community Exceptional Circumstances entry criteria is met, the application may then be further examined under supplementary criteria, assessing suitability of the pharmaceutical, clinical beneﬁt, the cost effectiveness of the treatment, and the patient’s ability to pay for the treatment. Where these documented criteria are met, a subsidy sufﬁcient to fully fund the pharmaceutical will be made available to the speciﬁc patient on whose behalf the application was made. Community Exceptional Circumstances funding is only available where the criteria are met and is not available for ﬁnancial reasons alone. Cancer Exceptional Circumstances (CaEC) Permission to fund a pharmaceutical for the treatment of cancer from the Hospital’s own budget under Cancer Exceptional Circumstances will only be granted by PHARMAC where it has been demonstated that the proposed use meets the criteria. If the patient being treated with a pharmaceutical under Cancer Exceptional Circumstances usually resides in a district other than that within the jurisdiction of the DHB initiating the treatment, then the DHB initiating the treatment must either agree to fund any on-going treatment required once the patient has returned to his/her usual DHB, or obtain written consent from the DHB or DHBs in which the patient will reside following the commencement of treatment. Applications for Community Exceptional Circumstances, Hospital Exceptional Circumstances and Cancer Exceptional Circumstances should be made on the standard application form available from the PHARMAC website www.pharmac.govt.nz or the address below: The Coordinator, Exceptional Circumstances Panel Phone (04) 916 7553 CEC PHARMAC (04) 916 7521 HEC PO Box 10 254 (09) 916 7561 CaEC Wellington 6143 or fax (09) 523 6870 Email: ecpanel@pharmac.govt.nz

Treatment considered with an unfunded pharmaceutical Yes Is the patient currently being treated at a public hospital (either as an in-patent or out-patient)? No Is the condition for the proposed use of the pharmaceutical rare (prevalence less than 10 in NZ)? No Consider under Hospital EC (HEC) criteria No

Is the pharmaceutical for the treatment of cancer? Yes Consider under Cancer EC (CaEC) criteria; use CaEC form

Yes

Consider under Community EC (CEC) criteria

(needs CEC/HEC form) Meets CaEC Criteria? Yes No HEC panel No review application Yes Yes Is it cost-effective for the hospital to fund for use in the community? No

Approve under CaEC. Recommend hospital funds entire course

Approve under HEC EC panel recommends hospital funds entire course

Has this application previously been declined under HEC criteria? Yes Decline application

No Meets CEC Criteria? Yes Approve under CEC

Part I: General Rules for Hospital Pharmaceuticals

INTRODUCTION

Section H contains general rules that apply, and other information relating, to Hospital Pharmaceuticals. The amounts payable by a DHB to the relevant pharmaceutical supplier are based on the contractual arrangements between PHARMAC and the relevant pharmaceutical supplier for a national price for that National Contract Pharmaceutical. The Pharmaceutical Schedule shows the national price at which the National Contract Pharmaceutical can be purchased by DHBs, providers of logistics services, wholesalers or other such distributors, or Contract Manufacturers directly from the pharmaceutical supplier. As required by section 23(7) of the Act, in performing any of its functions in relation to the supply of Pharmaceuticals, DHBs must not act inconsistently with the Schedule. 1 Interpretation and Deﬁnitions 1.1 In this Schedule, unless the context otherwise requires: “Act” means the New Zealand Public Health and Disability Act 2000. “Cancer Exceptional Circumstances” means the policies and criteria administered by PHARMAC relating to the ability to fund, from a DHB hospital’s own budget, pharmaceuticals for the treatment of cancer that are not identiﬁed as Pharmaceutical Cancer Treatments in Sections A-H of the Pharmaceutical Schedule. “Community Exceptional Circumstances” means the policies and criteria administered by the Exceptional Circumstances Panel relating to funding from the Community Exceptional Circumstances budget for medication, to be used in the community, in circumstances where the provision of a funded community medication is appropriate, but funding from the Pharmaceutical Budget is not able to be provided through the Pharmaceutical Schedule. “Community Pharmaceutical” means a Pharmaceutical listed in Sections A to G of the Pharmaceutical Schedule that is subsidised by the Funder from the Pharmaceutical Budget for use in the community. “Contract Manufacturer” means a manufacturer or a supplier that is a party to a contract with the relevant DHB Hospital to compound Hospital Pharmaceuticals, on request from that DHB Hospital. “Designated Delivery Point” means at a DHB Hospital’s discretion: a) a delivery point agreed between a pharmaceutical supplier and the relevant DHB Hospital, to which delivery point that pharmaceutical supplier must supply the Pharmaceutical directly at the Price; and/or b) any delivery point designated by the relevant DHB Hospital or PHARMAC, such delivery point being within 30 km of the relevant pharmaceutical supplier’s national distribution centre. “DHB” means an organisation established as a District Health Board by or under Section 19 of the Act. “DHB Hospital” means a DHB, including its hospital or associated provider unit that the DHB purchases Hospital Pharmaceuticals for. “Discretionary Community Supply Pharmaceutical” means the list of Pharmaceuticals set out in Section H Part III of the Schedule, which may be funded by a DHB Hospital from its own budget for use in the community. “DV Limit” means, for a particular Hospital Pharmaceutical with HSS, the National DV Limit or the Individual DV Limit. “DV Pharmaceutical” means a discretionary variance Pharmaceutical that does not have HSS but is used in place of one that does. Usually this means it is the same chemical entity, at the same strength, and in the same or a similar presentation or form, as the relevant Hospital Pharmaceutical with HSS. Where this is not the case, a note will be included with the listing of the HSS pharmaceutical. “Exceptional Circumstances Panel” means the panel of clinicians, appointed by the PHARMAC Board, that is responsible for administering policies in relation to Community Exceptional Circumstances and Hospital Exceptional Circumstances. “Funder” means the body or bodies responsible, pursuant to the Act, for the funding of Pharmaceuticals listed on the Schedule (which may be one or more DHBs and/or the Ministry of Health) and their successors. “GST” means goods and services tax under the Goods and Services Tax Act 1985. “Hospital Exceptional Circumstances” means the policies and criteria administered by the Exceptional Circumstances Panel relating to the ability to fund, from a DHB Hospital’s own budget, pharmaceuticals for use in the community by a speciﬁc patient where a subsidy is not available from the Pharmaceutical Budget or under Community Exceptional Circumstances. “Hospital Pharmaceuticals” means National Contract Pharmaceuticals, DV Pharmaceuticals and Discretionary Community Supply Pharmaceuticals. “HSS” means hospital supply status, the status of being the brand of the relevant Hospital Pharmaceutical listed in Section H Part II as HSS, that DHBs are obliged to purchase subject to any DV Limit for that Hospital Pharmaceutical for the period of hospital supply, as awarded under an agreement between PHARMAC and the relevant pharmaceutical supplier. Pharmaceuticals with HSS are listed in Section H Part II in bold text. “Individual DV Limit” means, for a particular Hospital Pharmaceutical with HSS and a particular DHB Hospital, the dis-

Part I: General Rules for Hospital Pharmaceuticals

cretionary variance limit, being the speciﬁed percentage of that DHB Hospital’s Total Market Volume up to which that DHB Hospital may purchase DV Pharmaceuticals of that Hospital Pharmaceutical. “National Contract Pharmaceutical” means a Hospital Pharmaceutical for which PHARMAC has negotiated a national contract and the Price. “National DV Limit” means, for a particular Hospital Pharmaceutical with HSS, the discretionary variance limit, being the speciﬁed percentage of the Total Market Volume up to which all DHB Hospitals may collectively purchase DV Pharmaceuticals of that Hospital Pharmaceutical. “Outpatient” in relation to a Community Pharmaceutical, means a person who, as part of treatment at a hospital or other institution under the control of a DHB, is prescribed the Community Pharmaceutical for consumption or use in the person’s home. “PHARMAC” means the Pharmaceutical Management Agency established by Section 46 of the Act (PHARMAC). “Pharmacode” means the six or seven digit identiﬁer assigned to a Pharmaceutical and notiﬁed to a pharmaceutical supplier by the Pharmacy Guild. “Pharmaceutical” means a medicine, therapeutic medical device, or related product or related thing listed in Sections B to H of the Schedule. “Pharmaceutical Budget” means the pharmaceutical budget set for PHARMAC by the Crown for the subsidised supply of Community Pharmaceuticals. “Pharmaceutical Cancer Treatments” means Pharmaceuticals for the treatment of cancer, listed in Sections A to G of the Schedule and identiﬁed therein as a “PCT” or “PCT only” Pharmaceuticals that DHBs must fund, from their own budgets, for use in their hospitals, and/or in association with Outpatient services provided in their DHB Hospitals, in relation to the treatment of cancers. “Price” means the standard national price, and, unless agreed otherwise between PHARMAC and the pharmaceutical supplier, includes any costs associated with the supply of a National Contract Pharmaceutical listed in Section H Part II of the Pharmaceutical Schedule to, at a DHB Hospital’s discretion, any Designated Delivery Point, or to a Contract Manufacturer (expressly for the purpose of compounding). “Schedule” means this Pharmaceutical Schedule and all its sections and appendices. “Section B” of this Pharmaceutical Schedule means the list of Community Pharmaceuticals eligible for Subsidies included in the Schedule. “Section C” of this Pharmaceutical Schedule means the list of community extemporaneously compounded preparations and galenicals eligible for Subsidies included in the Schedule. “Section D” of this Pharmaceutical Schedule means the list of community special foods eligible for Subsidies included in the Schedule. “Section E Part I” of this Pharmaceutical Schedule means the list of Community Pharmaceuticals eligible for Subsidies and available on a Practitioner’s Supply Order or a Wholesale Supply Order included in the Schedule. “Section E Part II” of this Pharmaceutical Schedule means the list of remote areas for the purpose of community Practitioner’s Supply Orders included in the Schedule. “Section F Part I” of this Pharmaceutical Schedule means the part of Section F relating to the exemption from dispensing in Monthly Lots, and requirement to dispense in 90 Day Lots in respect of the Community Pharmaceuticals referred to in this part of Section F. “Section F Part II” of this Pharmaceutical Schedule means the part of Section F relating to the exemption from dispensing in Monthly Lots in respect of the Community Pharmaceuticals referred to in this part of Section F. “Section G” of this Pharmaceutical Schedule means the list of Community Pharmaceuticals eligible for reimbursement of safety cap. “Section H” of this Pharmaceutical Schedule means the general rules for Hospital Pharmaceuticals and the lists of National Contract Pharmaceuticals and any associated DV Limits and Discretionary Community Supply Pharmaceuticals included in Section H of the Schedule. “Section H Part I” of this Pharmaceutical Schedule means the general rules for Hospital Pharmaceuticals. “Section H Part II” of this Pharmaceutical Schedule means the list of National Contract Pharmaceuticals, the relevant Price, an indication of whether the Pharmaceutical has HSS and any associated DV Limit. “Section H Part III” of this Pharmaceutical Schedule means the list of Discretionary Community Supply Pharmaceuticals. “Total Market Volume” means, for a particular Hospital Pharmaceutical with HSS in any given period, in accordance with the data available to PHARMAC, the sum of: a) the total number of Units of the relevant Hospital Pharmaceutical with HSS purchased by all DHB Hospitals, or by a particular DHB Hospital in the case of the Individual DV Limit; and

Part I: General Rules for Hospital Pharmaceuticals

b) the total number of Units of all the relevant DV Pharmaceuticals purchased by all DHB Hospitals, or by a particular DHB Hospital in the case of the Individual DV Limit. “Unit” means an individual unit of a Pharmaceutical (e.g. tablet, 1 ml of an oral liquid, amp, syringe). “Unapproved Indication” means, for a Pharmaceutical, an indication for which it is not approved under the Medicines Act 1981. Practitioners prescribing Pharmaceuticals for Unapproved Indications should be aware of, and comply with, their obligations under Section 25 and/or Section 29 of the Medicines Act 1981 and as set out in Part I: General Rules for Hospital Pharmaceuticals, rule 9. 1.2 In addition to the above interpretations and deﬁnitions, unless the content requires otherwise, a reference in the Schedule to: a) the singular includes the plural; and b) any legislation includes a modiﬁcation and re-enactment of, legislation enacted in substitution for, and a regulation, Order in Council, and other instrument from time to time issued or made under, that legislation, where that legislation, regulation, Order in Council or other instrument has an effect on the prescribing, dispensing or subsidising of Pharmaceuticals. 2 Current Hospital Pharmaceutical Contracts 2.1 A DHB Hospital may enter into a contract for the purchase of any Pharmaceutical that is not a National Contract Pharmaceutical, provided that such contract: a) does not oblige the relevant DHB Hospital to purchase a volume of that Pharmaceutical, if that Pharmaceutical is a DV Pharmaceutical, that is greater than the relevant DV Limit; b) enables PHARMAC to access and use future price and volume data in respect of that Pharmaceutical; and c) enables the relevant DHB Hospital to terminate the contract or relevant parts of the contract in order to give full effect to the national contract on 3 months’ written notice to the pharmaceutical supplier. 2.2 From the day after a DHB Hospital’s current supply contract for a chemical entity that is a National Contract Pharmaceutical expires, that DHB Hospital is to purchase the relevant National Contract Pharmaceutical listed in Section H Part II at the Price, and is to comply with the DV Limits for the National Contract Pharmaceutical where it has HSS. 2.3 Following written notiﬁcation from PHARMAC that a Pharmaceutical is a National Contract Pharmaceutical, either through Section H updates or otherwise, DHB Hospitals are to take any steps available to them to terminate current contracts, and are not to enter into any new contracts or extend the period of any current contracts, for the supply of that National Contract Pharmaceutical listed in Section H Part II or the relevant chemical entity, unless PHARMAC expressly notiﬁes otherwise. 3 National Contract Pharmaceutical Price 3.1 DHB Hospitals must take all necessary steps to enable any contracts between PHARMAC and a pharmaceutical supplier in relation to National Contract Pharmaceuticals to be given full effect. 3.2 National Contract Pharmaceuticals that can be purchased by DHBs at the relevant Price, as agreed between PHARMAC and the relevant pharmaceutical supplier, are hereby deemed to include every medicine, therapeutic medical device, or related product or related thing listed in Section H Part II of the Schedule except DV Pharmaceuticals. 3.3 A National Contract Pharmaceutical is to be made available by the relevant pharmaceutical supplier for purchase at the relevant Price by any or all of the following: a) DHB Hospitals at Designated Delivery Points; and/or b) Contract Manufacturers (expressly for the purpose of compounding). 4 Hospital Supply Status (HSS) 4.1 The DV Limit for any National Contract Pharmaceutical which has HSS is set out beside the listing of the relevant National Contract Pharmaceutical in Section H Part II of the Schedule and may be amended from time to time. 4.2 If a National Contract Pharmaceutical is listed in Section H Part II as having HSS, DHB Hospitals: a) are expected to use up any existing stocks of DV Pharmaceuticals during the First Transition Period; b) must not purchase DV Pharmaceuticals in volumes exceeding their usual requirements, or in volumes exceeding those which they reasonably expect to use, within the First Transition Period; and c) must purchase the Hospital Pharmaceutical with HSS except: i) to the extent that the DHB Hospital may use its discretion to purchase a DV Pharmaceutical within the DV Limit, provided that (subject to subclause (iii) below) the DV Limit has not been exceeded nationally; ii) if the pharmaceutical supplier fails to supply that Hospital Pharmaceutical, in which case the relevant DHB Hospital does not have to comply with the DV Limit for that Hospital Pharmaceutical during that period of non-supply (and any such month(s) included in a period of non-supply will be excluded in any review of the DV Limit in accordance with clause 4.3 below);

Part I: General Rules for Hospital Pharmaceuticals

iii) that where the DV Limit has been exceeded nationally, the DHB Hospital may negotiate with the pharmaceutical supplier who supplies the National Contract Pharmaceutical with HSS for written permission to vary the application of that DHB Hospital’s Individual DV Limit for any patient whose exceptional needs require a DV Pharmaceutical. 4.3 PHARMAC may, in its discretion, for any period or part period: a) review usage by DHB Hospitals of the National Contract Pharmaceutical and DV Pharmaceuticals to determine whether the DV Limit has been exceeded; and b) audit compliance by DHBs with the DV Limits and related requirements. 4.4 PHARMAC will address any issues of non-compliance by any individual DHB with a DV Limit by: a) obtaining the relevant DHB’s assurance that it will comply with the DV Limit for that National Contract Pharmaceutical with HSS in the remainder of the applicable period and any subsequent periods; and b) informing the relevant supplier of the HSS Pharmaceutical of any individual DHB’s non-compliance with the DV Limit for that HSS Pharmaceutical. 4.5 In addition to the steps taken by PHARMAC under clause 4.4 above to address any issues of non-compliance by any individual DHB with a DV Limit, the relevant pharmaceutical supplier may require, in its discretion, ﬁnancial compensation from the relevant DHB: a) an amount representing its contribution towards exceeding the DV Limit (where PHARMAC is able to quantify this based on the information available to it); or b) the sum of $1,000 or $5,000 (depending on the terms of the applicable national contract applying to the HSS Pharmaceutical), whichever is the greater as between sub-paragraphs (a) and (b) within the number of business days speciﬁed in the notice requiring such payment to be made. 5 Collection of rebates and payment of ﬁnancial compensation 5.1 Following the receipt of any rebates from a pharmaceutical supplier in respect of a particular Hospital Pharmaceutical, PHARMAC will notify each relevant DHB and DHB Hospital of the amount of the rebate owing to it, being a portion of the total rebate determined by PHARMAC on the basis of that DHB Hospital’s usage of that Hospital Pharmaceutical, where this is able to be determined. Where data to determine individual DHB Hospitals’ usage is not available, PHARMAC will apportion rebates on the basis of an alternative method agreed between the relevant DHBs and PHARMAC. 5.2 PHARMAC will pay each DHB Hospital the rebate amounts (if any) owing to it, no less frequently than once each calendar quarter in respect of rebates received quarterly (or more often). 6 Price and Volume Data 6.1 DHB Hospitals are to provide to PHARMAC, on a monthly basis in accordance with PHARMAC’s requirements, any volume data and, unless it would result in a breach of an existing contract, price data held by those DHB Hospitals in respect of any Hospital Pharmaceuticals listed in Section H of the Schedule. 6.2 All price and volume data provided to PHARMAC under clause 6.1 above should identify the relevant Hospital Pharmaceutical by using a Pharmacode or some other unique numerical identiﬁer, and the date (month and year) on which the DHB Hospital incurred a cost for the purchase of that Pharmaceutical. Volume is to be measured in units (that being the smallest possible whole unit – e.g. a capsule, a vial, a millilitre etc). 7 Discretionary Community Supply Pharmaceuticals 7.1 Discretionary Community Supply Pharmaceuticals are deemed to include every medicine, therapeutic medical device, or related product or related thing listed in Section H Part III of the Schedule. 7.2 PHARMAC may, in its discretion, list any pharmaceutical that is not a Community Pharmaceutical as a Discretionary Community Supply Pharmaceutical, including a pharmaceutical that PHARMAC is made aware of by HPAC, the Exceptional Circumstances Panel, a DHB Hospital or relevant hospital personnel. 7.3 A DHB Hospital may use its discretion to purchase Discretionary Community Supply Pharmaceuticals for use in the community, provided that, if the patient being treated with a Discretionary Community Supply Pharmaceutical usually resides in a district other than that within the jurisdiction of the DHB initiating the treatment, then the DHB initiating the treatment must either agree to fund any on-going treatment required once the patient has returned to his/her usual DHB, or obtain written consent from the DHB or DHBs in which the patient will reside following the commencement of treatment. 7.4 The funding of a Discretionary Community Supply Pharmaceutical for use in the community will be sourced from the relevant DHB’s own budget. For the avoidance of doubt, the Discretionary Community Supply Pharmaceutical is not a Community Pharmaceutical and funding is not available for Discretionary Community Supply Pharmaceuticals from

Part I: General Rules for Hospital Pharmaceuticals

the Pharmaceutical Budget. 7.5 Subject to rule 7.6, DHB Hospitals must not fund for use in the community, any pharmaceuticals that are not Discretionary Community Supply Pharmaceuticals unless they have been approved under Hospital Exceptional Circumstances. 7.6 DHB Hospitals may fund from their own budgets, any Pharmaceutical that is listed in Sections A-G of the Pharmaceutical Schedule without Hospital Exceptional Circumstances (HEC) approval provided that: a) i) up to 5 days treatment, or one original pack, (where inappropriate to provide less); or ii) more than 5 days treatment, provided that the relevant DHB Hospital has a dispensing for discharge policy and the quantity supplied is in accordance with that policy; and b) the Pharmaceutical is supplied consistent with any restrictions applying to that Pharmaceutical in Section A-G of the Pharmaceutical Schedule. Note dispensing for discharge as described in rule 7.6 is at the discretion of individual DHBs. 8 Pharmaceutical Cancer Treatments 8.1 DHBs are obliged to fund Pharmaceutical Cancer Treatments in accordance with the October 2001 direction from the Minister of Health. 8.2 The list of Pharmaceutical Cancer Treatments may be amended from time to time. Additions and/or amendments to the list require the approval of the PHARMAC Board. 8.3 Pharmaceutical Cancer Treatments may be used in combination with each other, including where such combinations result in admixtures or dilutions that differ from those speciﬁed. 8.4 DHBs must not fund Pharmaceuticals for the treatment of cancer or Pharmaceutical Cancer Treatments for indications related to the treatment of cancer, if they are not listed in Sections A to G of the Pharmaceutical Schedule, unless the unlisted pharmaceutical: a) has Cancer Exceptional Circumstances approval; or b) has Community Exceptional Circumstances or Hospital Exceptional Circumstances approval; or c) is being used as part of a bona ﬁde clinical trial which has Ethics Committee approval; or d) is being used and funded as part of a paediatric oncology service; or e) was being used to treat the patient in question prior to 1 July 2005. 8.5 Some indications for Pharmaceutical Cancer Treatments listed in the Schedule are Unapproved Indications. Some of these formed part of the October 2001 direction from the Minister of Health as to pharmaceuticals and indications for which DHBs must provide funding. As far as reasonably practicable, these Unapproved Indications are marked in the Schedule. However, PHARMAC makes no representation and gives no guarantee as to the accuracy of this information. Practitioners prescribing Pharmaceutical Cancer Treatments for such Unapproved Indications should: a) be aware of and comply with their obligations under sections 25 and 29 of the Medicines Act 1981, as applicable, and otherwise under that Act and the Medicines Regulations 1984; b) be aware of and comply with their obligations under the Health and Disability Commissioner’s Code of Consumer Rights, including the requirement to obtain informed consent from the patient (PHARMAC recommends that Practitioners obtain written consent); and c) exercise their own skill, judgment, expertise and discretion, and make their own prescribing decisions with respect to the use of an unapproved Pharmaceutical Cancer Treatment or a Pharmaceutical Cancer Treatment for an Unapproved Indication. 8.6 Applications to add pharmaceuticals, and add or amend indications for Pharmaceutical Cancer Treatments, may be made in writing by pharmaceutical suppliers and/or clinicians to PHARMAC. Applications should follow PHARMAC’s Guidelines for Submissions to PTAC for New Chemical Entity Pharmaceuticals and Recommended methods to derive clinical inputs for proposals to PHARMAC, copies of which are available from PHARMAC or PHARMAC’s website. 8.7 Applications made under clause 8.6 must be assessed by HPAC, PHARMAC, PTAC and/or relevant subcommittees of PTAC.

Part I: General Rules for Hospital Pharmaceuticals

9 Practitioners prescribing unapproved Pharmaceuticals Practitioners should, where possible, prescribe Pharmaceuticals that are approved under the Medicines Act 1981. However, the access criteria under which a Pharmaceutical is listed on the Pharmaceutical Schedule may: a) in some case, explicitly permit Government funded access to a Pharmaceutical that is not approved under the Medicines Act 1981 or for an Unapproved Indication; or b) not explicitly preclude Government funded access to a Pharmaceutical when it is used for an Unapproved Indication. Accordingly, if Practitioners are planning on prescribing an unapproved Pharmaceutical or a Pharmaceutical for an Unapproved Indication, Practitioners should: a) be aware of and comply with their obligations under sections 25 and 29 of the Medicines Act 1981, as applicable, and otherwise under that Act and the Medicines Regulations 1984; b) be aware of and comply with their obligations under the Health and Disability Commissioner’s Code of Consumer Rights, including the requirement to obtain informed consent from the patient (PHARMAC recommends that Practitioners obtain written consent); and c) exercise their own skill, judgment, expertise and discretion, and make their own prescribing decisions with respect to the use of an unapproved Pharmaceutical or a Pharmaceutical for an Unapproved Indication. Practitioners should be aware that simply by listing a Pharmaceutical on the Pharmaceutical Schedule PHARMAC makes no representations about whether that Pharmaceutical has any form of approval or consent under, or whether the supply or use of the Pharmaceutical otherwise complies with, the Medicines Act 1981. Further, the Pharmaceutical Schedule does not constitute an advertisement, advertising material or a medical advertisement as deﬁned in the Medicines Act or otherwise.

Part II: Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

ABACAVIR SULPHATE WITH LAMIVUDINE Tab 600 mg with lamivudine 300 mg ............................................................630.00 ABCIXIMAB Inj 10 mg .......................................................................................................579.53 ACARBOSE Tab 50 mg – 1% DV Jul-09 to 2012 ...............................................................16.50 Tab 100 mg – 1% DV Jul-09 to 2012 .............................................................26.70 ACETAZOLAMIDE Tab 250 mg – 1% DV Dec-08 to 2011 ...........................................................10.40 ACETYLCYSTEINE Inj 200 mg per ml, 10 ml ...............................................................................219.75 ACICLOVIR Tab dispersible 200 mg .....................................................................................1.98 Tab dispersible 400 mg .....................................................................................6.64 Tab dispersible 800 mg .....................................................................................7.38 Inj 250 mg – 1% DV Nov-09 to 2012 .............................................................25.50 ACITRETIN Cap 10 mg ......................................................................................................75.80 Cap 25 mg ....................................................................................................162.96 ACTIVATED CHARCOAL Oral liq 50 g per 250 ml ..................................................................................43.50 ADALIMUMAB Inj 40 mg per 0.8 ml preﬁlled pen ..............................................................1,799.92 Inj 40 mg per 0.8 ml preﬁlled syringe ........................................................1,799.92 ADEFOVIR DIPIVOXIL Tab 10 mg .....................................................................................................670.00 ADRENALINE Inj 1 in 1,000, 1 ml ............................................................................................4.98 5.25 Inj 1 in 10,000, 10 ml ......................................................................................27.00 ALENDRONATE SODIUM Tab 40 mg .....................................................................................................133.00 Tab 70 mg .......................................................................................................35.91 ALENDRONATE SODIUM WITH CHOLECALCIFEROL Tab 70 mg with cholecalciferol 5,600 iu ..........................................................35.91 ALFACALCIDOL Cap 0.25 µg ....................................................................................................26.32 Cap 1 µg .........................................................................................................87.98 ALLOPURINOL Tab 100 mg – 1% DV Mar-09 to 2011..............................................................5.44 Tab 300 mg – 1% DV Mar-09 to 2011..............................................................4.03 ALPROSTADIL Inj 0.5 mg per ml, 1 ml – 1% DV Sep-09 to 2012......................................1,417.50 AMANTADINE HYDROCHLORIDE Cap 100 mg – 1% DV Oct-08 to 2011 ...........................................................47.81

30 1 90 90 100 10

Kivexa ReoPro Glucobay Glucobay Diamox Martindale Acetylcysteine Lovir Lovir Lovir Pﬁzer Neotigason Neotigason Carbosorb-X HumiraPen Humira Hepsera Aspen Adrenaline Mayne Mayne Fosamax Fosamax Fosamax Plus One-Alpha One-Alpha Apo-Allopurinol Apo-Allopurinol Prostin VR Symmetrel

25 56 35 5 100 100 250 ml 2 2 30 5 5 30 4 4 100 100 250 100 5 60

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

AMBRISENTAN Tab 5 mg ....................................................................................................4,585.00 Tab 10 mg ..................................................................................................4,585.00 AMIKACIN SULPHATE Inj 5 mg per ml, 5 ml .......................................................................................88.00 AMILORIDE Oral liq 1 mg per ml ........................................................................................26.20 AMILORIDE WITH HYDROCHLOROTHIAZIDE Tab 5 mg with hydrochlorothiazide 50 mg ......................................................13.00 AMINOPHYLLINE Inj 25 mg per ml, 10 ml ...................................................................................12.84 AMISULPRIDE Tab 100 mg .....................................................................................................22.52 Tab 200 mg .....................................................................................................97.03 Tab 400 mg ...................................................................................................185.44 Oral liq 100 mg per ml ....................................................................................55.44 AMITRIPTYLINE Tab 10 mg .........................................................................................................2.77 Tab 25 mg .........................................................................................................3.40 Tab 50 mg .........................................................................................................5.20

30 30 10 25 ml 500 5 30 60 60 60 ml 50 100 100

Volibris Volibris Biomed Biomed Amizide Mayne Solian Solian Solian Solian Amirol Amitrip Amitrip

AMLODIPINE Note: HSS for Apo-Amlodipine tab 5 mg and tab 10 mg has been suspended due to an out-of-stock. Tab 5 mg .........................................................................................................22.82 30 Norvasc 7.33 100 Apo-Amlodipine Tab 10 mg .......................................................................................................34.85 30 Norvasc 11.79 100 Apo-Amlodipine AMOXYCILLIN Cap 250 mg ....................................................................................................17.30 Cap 500 mg ....................................................................................................27.25 Drops 100 mg per ml – 1% DV Jan-09 to 2011 ...............................................4.00 Grans for oral liq 125 mg per 5 ml ....................................................................1.55 Grans for oral liq 250 mg per 5 ml – 1% DV Feb-10 to 2012 ...........................1.10 Inj 250 mg – 1% DV Jan-09 to 2011..............................................................12.42 Inj 500 mg – 1% DV Jan-09 to 2011..............................................................14.24 Inj 1 g – 1% DV Jan-09 to 2011.....................................................................21.62 AMOXYCILLIN CLAVULANATE Tab amoxycillin 500 mg with potassium clavulanate 125 mg – 1% DV May-09 to 2011 ........................................................................................ 25.10 Grans for oral liq 125 mg with potassium clavulanate 31.25 mg per 5 ml – 1% DV Jan-10 to 2012................................................................... 2.20 Grans for oral liq 250 mg with potassium clavulanate 62.5 mg per 5 ml – 1% DV Jan-10 to 2012............................................................................ 3.85 Inj 600 mg – 1% DV Jan-10 to 2012..............................................................12.67 Inj 1.2 g – 1% DV Jan-10 to 2012..................................................................16.50 AMPHOTERICIN B Liposomal inj 50 mg vial – 1% DV Sep-09 to 2012...................................3,450.00 500 500 30 ml 100 ml 100 ml 10 10 10 Apo-Amoxi Apo-Amoxi Ospamox Ospamox Ospamox Ibiamox Ibiamox Ibiamox

100 100 ml 100 ml 10 10 10

Synermox Curam Curam Curam Curam AmBisome

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

ANASTROZOLE Tab 1 mg .........................................................................................................29.50 ANTITHYMOCYTE GLOBULIN (EQUINE) Inj 50 mg per ml, 5 ml ................................................................................2,137.50 APOMORPHINE HYDROCHLORIDE Inj 10 mg per ml, 2 ml ...................................................................................110.00 APREPITANT Cap 2 × 80 mg and 1 × 125 mg ..................................................................116.00 AQUEOUS CREAM Crm 100 g – 1% DV Nov-08 to 2011 ...............................................................1.49 Note: DV Limit applies to pack sizes of 100 g or less. Crm 500 g – 1% DV Jan-09 to 2011................................................................2.28 Note: DV Limit applies to pack sizes of greater than 100 g. ARIPIPRAZOLE Tab 10 mg .....................................................................................................123.54 Tab 15 mg .....................................................................................................175.28 Tab 20 mg .....................................................................................................213.42 Tab 30 mg .....................................................................................................260.07 ARSENIC TRIOXIDE Inj 10 mg ....................................................................................................4,817.00 ATAZANAVIR SULPHATE Cap 150 mg ..................................................................................................568.34 Cap 200 mg ..................................................................................................757.79

30 5 5 3 100 g 500 g

DP-Anastrozole ATGAM Apomine Emend Tri-Pack AFT AFT

30 30 30 30 10 60 60

Abilify Abilify Abilify Abilify AFT Reyataz Reyataz

ATENOLOL Note: HSS Status has been transferred to Atenolol Tablet USP tab 50 mg and 100 mg from Paciﬁc Atenolol. Paciﬁc Atenolol remains listed. Tab 50 mg – 1% DV May-10 to 2012 ...............................................................6.18 500 Paciﬁc Atenolol 12.36 1,000 Atenolol Tablet USP Tab 100 mg – 1% DV May-10 to 2012 ...........................................................10.73 500 Paciﬁc Atenolol 21.46 1,000 Atenolol Tablet USP ATOMOXETINE HYDROCHLORIDE Cap 10 mg ....................................................................................................107.03 Cap 18 mg ....................................................................................................107.03 Cap 25 mg ....................................................................................................107.03 Cap 40 mg ....................................................................................................107.03 Cap 60 mg ....................................................................................................107.03 Cap 80 mg ....................................................................................................139.11 Cap 100 mg ..................................................................................................139.11 ATRACURIUM BESYLATE Inj 10 mg per ml, 2.5 ml – 1% DV Sep-09 to 2012.........................................12.55 Inj 10 mg per ml, 5 ml – 1% DV Sep-09 to 2012............................................26.04 ATROPINE SULPHATE Eye drops 1% .................................................................................................17.36 Inj 600 µg, 1 ml – 1% DV Dec-09 to 2012......................................................52.00 AZITHROMYCIN Tab 500 mg – 1% DV Sep-09 to 2012 .............................................................5.95 28 28 28 28 28 28 28 5 5 15 ml 50 2 Strattera Strattera Strattera Strattera Strattera Strattera Strattera Tracrium Tracrium Atropt AstraZeneca Arrow-Azithromycin

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

BACLOFEN Tab 10 mg – 1% DV Dec-09 to 2012 ...............................................................4.75 Inj 10 mg – 1% DV Nov-09 to 2012 .............................................................190.08 BASILIXIMAB Inj 20 mg amp ............................................................................................3,200.00 BECLOMETHASONE DIPROPIONATE Aerosol inhaler, 50 µg per dose CFC-free ........................................................8.54 Metered aqueous nasal spray, 50 µg per dose .................................................4.00 Aerosol inhaler, 100 µg per dose CFC-free ....................................................12.50 Metered aqueous nasal spray, 100 µg per dose ...............................................4.81 Aerosol inhaler, 250 µg per dose CFC-free ....................................................22.67 BENDROFLUAZIDE Tab 2.5 mg – 1% DV Jul-10 to 2011 ................................................................7.58 Tab 5 mg – 1% DV Jul-10 to 2011 .................................................................11.75 BENZATHINE BENZYLPENICILLIN inj 1.2 mega u per 2.3 ml ..............................................................................315.00 BENZTROPINE MESYLATE Tab 2 mg ...........................................................................................................7.99 BENZYLPENICILLIN SODIUM Inj 1 mega u – 1% DV Dec-08 to 2011 ..........................................................10.49 BERACTANT Inj 25 mg per ml, 8 ml intratracheal ..............................................................550.00 BETAHISTINE DIHYDROCHLORIDE Tab 16 mg .........................................................................................................9.26 BETAMETHASONE VALERATE Scalp app 0.1% – 1% DV Dec-09 to 2012 .......................................................7.22 BEZAFIBRATE Tab 200 mg – 1% DV Dec-08 to 2011 .............................................................9.75 Tab long-acting 400 mg ....................................................................................5.70 BICALUTAMIDE Tab 50 mg – 1% DV Jan-09 to 2011..............................................................27.10 BISACODYL Tab 5 mg – 1% DV Sep-10 to 2013 .................................................................4.99 Suppos 5 mg ....................................................................................................3.00 Suppos 10 mg ..................................................................................................3.00 BLOOD GLUCOSE DIAGNOSTIC TEST METER Meter ................................................................................................................6.00 9.00

100 1 1 200 dose 200 dose 200 dose 200 dose 200 dose 500 500 10 60 10 1 84 100 ml 90 30 30 200 6 6 1

Pacifen Lioresal Intrathecal Simulect Beclazone 50 Alanase Beclazone 100 Alanase Beclazone 250 Arrow-Bendroﬂuazide Arrow-Bendroﬂuazide Bicillin LA Benztrop Sandoz Survanta Vergo 16 Beta Scalp Fibalip Bezalip Retard Bicalox Lax-Tabs Dulcolax Dulcolax CareSens POP CareSens II FreeStyle Lite On Call Advanced Optium Xceed Accu-Chek Performa

19.00

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

BLOOD GLUCOSE DIAGNOSTIC TEST STRIP Blood glucose test strips × 50 and lancets × 5 .............................................19.10 19.60 Blood glucose test strips ................................................................................21.65 10.82 21.65 BOSENTAN Tab 62.5 mg ...............................................................................................4,585.00 Tab 125 mg ................................................................................................4,585.00 BRIMONIDINE TARTRATE Eye drops 0.2% – 1% DV Sep-08 to 2011 .......................................................7.93 BUDESONIDE Metered aqueous nasal spray, 50 µg per dose .................................................4.00 Metered aqueous nasal spray, 100 µg per dose ...............................................4.81 BUMETANIDE Tab 1 mg .........................................................................................................16.36 BUPIVACAINE HYDROCHLORIDE Inf 0.125%, 100 ml theatre pack ...................................................................109.39 Inf 0.125%, 200 ml theatre pack ...................................................................146.23 Inf 0.25%, 100 ml theatre pack .....................................................................132.42 Inj 0.5%, 4 ml ..................................................................................................29.35 Inj 0.5%, 8% glucose, 4 ml .............................................................................24.50 Inj 0.25%, 20 ml – 1% DV Sep-09 to 2012 ....................................................35.00 Inj 0.5%, 10 ml – 1% DV Sep-09 to 2012 ......................................................35.00 Inj 0.5%, 10 ml theatre pack – 1% DV Sep-09 to 2012..................................28.00 Inj 0.375%, 20 ml theatre pack .......................................................................56.20 Inj 0.5%, 20 ml theatre pack – 1% DV Sep-09 to 2012..................................25.00 BUPIVACAINE HYDROCHLORIDE WITH ADRENALINE Inj 0.25% with 1:400,000 adrenaline, 10 ml – 1% DV Sep-09 to 2011 .........134.76 Inj 0.5% with 1:200,000 adrenaline, 20 ml – 1% DV Sep-09 to 2011 ..........115.40 BUPIVACAINE HYDROCHLORIDE WITH FENTANYL Inf 0.125% with 2 µg fentanyl per ml, 100 ml bag – 1% DV Jan-09 to 2011 ................................................................................................... 200.00 Inf 0.125% with 2 µg fentanyl per ml, 200 ml bag – 1% DV Jan-09 to 2011 ................................................................................................... 200.00 Inj 0.125% with 2 µg fentanyl per ml, 15 ml preﬁlled syringe – 1% DV Jan-09 to 2011......................................................................................... 61.50 Inj 0.125% with 2 µg fentanyl per ml, 20 ml preﬁlled syringe – 1% DV Jan-09 to 2011......................................................................................... 78.00 BUPROPION HYDROCHLORIDE Tab modiﬁed-release 150 mg .........................................................................65.00 BUSPIRONE HYDROCHLORIDE Tab 5 mg .........................................................................................................28.00 Tab 10 mg .......................................................................................................17.00

1 50 test 25 test 50 test 60 60 5 ml 200 dose 200 dose 100 5 5 5 5 5 5 50 5 5 5 5 5

On Call Advanced CareSens Accu-Chek Performa FreeStyle Lite Optium 5 second test Optium 5 second test Tracleer Tracleer AFT Butacort Aqueous Butacort Aqueous Burinex Marcain Marcain Marcain Marcain Isobaric Marcain Heavy Marcain Marcain Marcain Marcain Marcain Marcain with Adrenaline Marcain with Adrenaline

10 10 10 10 30 100 100

Bupafen Bupafen Biomed Biomed Zyban Paciﬁc Buspirone Paciﬁc Buspirone

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

CAFFEINE CITRATE Oral liq 10 mg per ml ......................................................................................13.50 Inj 10 mg per ml, 2.5 ml ..................................................................................50.70 CALCIPOTRIOL Crm 50 µg per g .............................................................................................20.20 56.32 Oint 50 µg per g ..............................................................................................20.20 56.32 Soln 50 µg per ml ...........................................................................................20.22 33.79 CALCITONIN Inj 100 u per ml, 1 ml – 1% DV Dec-08 to 2011...........................................110.00 CALCITRIOL Cap 0.25 µg – 1% DV Feb-10 to 2012.............................................................3.03 Cap 0.5 µg – 1% DV Feb-10 to 2012...............................................................5.62 Oral liq 1 µg per ml .........................................................................................39.40 CALCIUM CARBONATE Tab eff 1.75 g (1 g elemental) – 1% DV Sep-08 to 2011 .................................6.54 CALCIUM FOLINATE Tab 15 mg .......................................................................................................63.89 Inj 50 mg – 1% DV Sep-08 to 2011 ...............................................................24.50 Inj 100 mg – 1% DV Sep-08 to 2011 ...............................................................9.75 Inj 300 mg – 1% DV Sep-08 to 2011 .............................................................30.00 Inj 1 g – 1% DV Sep-08 to 2011 ..................................................................100.00 CALCIUM GLUCONATE Inj 10%, 10 ml .................................................................................................21.40 CALCIUM POLYSTYRENE SULPHONATE Powder ..........................................................................................................169.85 CANDESARTAN Tab 4 mg .........................................................................................................16.22 Tab 8 mg .........................................................................................................19.30 Tab 16 mg .......................................................................................................23.54 Tab 32 mg .......................................................................................................38.50 CAPECITABINE Tab 150 mg ...................................................................................................115.00 Tab 500 mg ...................................................................................................705.00 CAPSAICIN Crm 0.075% ...................................................................................................12.50 CAPTOPRIL Tab 12.5 mg ....................................................................................................10.40 Tab 25 mg .......................................................................................................13.40 Tab 50 mg .......................................................................................................19.00

25 ml 5 30 g 100 g 30 g 100 g 30 ml 60 ml 5 30 30 10 ml 30 10 5 1 1 1

Biomed Biomed Daivonex Daivonex Daivonex Daivonex Daivonex Daivonex Miacalcic Airﬂow Airﬂow Rocaltrol Calsource Mayne Calcium Folinate Ebewe Calcium Folinate Ebewe Calcium Folinate Ebewe Calcium Folinate Ebewe Mayne Calcium Resonium Atacand Atacand Atacand Atacand Xeloda Xeloda Zostrix HP Apo-Captopril Apo-Captopril Apo-Captopril

10 300 g 30 30 30 30 60 120 45 g 500 500 500

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

CARBOPLATIN Inj 10 mg per ml, 5 ml – 1% DV Dec-09 to 2012............................................20.00 Inj 10 mg per ml, 15 ml – 1% DV Dec-09 to 2012..........................................22.50 Inj 10 mg per ml, 45 ml – 1% DV Dec-09 to 2012..........................................55.00 Inj 10 mg per ml, 100 ml – 1% DV Dec-09 to 2012......................................120.00 CARVEDILOL Tab 6.25 mg ....................................................................................................21.00 Tab 12.5 mg ....................................................................................................27.00 Tab 25 mg .......................................................................................................33.75 CASPOFUNGIN Inj 50 mg – 1% DV Nov-09 to 2012 .............................................................667.50 Inj 70 mg – 1% DV Nov-09 to 2012 .............................................................862.50 CEFACLOR MONOHYDRATE Cap 250 mg ....................................................................................................28.90 Grans for oral liq 125 mg per 5 ml – 1% DV Sep-10 to 2013...........................3.53 CEFAZOLIN SODIUM Inj 500 mg – 1% DV Dec-08 to 2011 ...............................................................5.00 Inj 1 g – 1% DV Dec-08 to 2011 ......................................................................8.00 CEFEPIME HYDROCHLORIDE Inj 1 g, 15 ml – 1% DV Apr-10 to 2011 ..........................................................19.55 Inj 2 g, 77 ml – 1% DV Apr-10 to 2011 ..........................................................39.10 CEFOTAXIME Inj 500 mg – 1% DV Oct-08 to 2011 ................................................................1.69 Inj 1 g – 1% DV Oct-08 to 2011 .......................................................................1.90 Inj 2 g – 1% DV Oct-08 to 2011 .......................................................................2.60 CEFOXITIN SODIUM Powder for inj 1 g ............................................................................................55.00 CEFTAZIDIME Inj 500 mg – 1% DV Sep-08 to 2011 ...............................................................2.84 Inj 1 g – 1% DV Sep-08 to 2011 ......................................................................5.63 Inj 2 g – 1% DV Sep-08 to 2011 ....................................................................11.25 CEFTRIAXONE SODIUM Inf 2 g .............................................................................................................10.50 Inj 500 mg .........................................................................................................3.99 Inj 1 g ................................................................................................................5.40 CEFUROXIME AXETIL Tab 250 mg .....................................................................................................29.40 CEFUROXIME SODIUM Inj 750 mg – 1% DV Aug-08 to 2011 .............................................................10.71 Inj 1.5 g – 1% DV Aug-08 to 2011 ...................................................................4.04 CELIPROLOL Tab 200 mg .....................................................................................................19.00 CEPHALEXIN MONOHYDRATE Grans for oral liq 125 mg per 5 ml – 1% DV Feb-10 to 2012 ...........................8.50 Grans for oral liq 250 mg per 5 ml – 1% DV Feb-10 to 2012 .........................11.50

1 1 1 1 30 30 30 1 1 100 100 ml 5 5 1 1 1 1 1 5 1 1 1 1 1 1 50 5 1 180 100 ml 100 ml

Carboplatin Ebewe Carboplatin Ebewe Carboplatin Ebewe Carboplatin Ebewe Dilatrend Dilatrend Dilatrend Cancidas Cancidas Ranbaxy-Cefaclor Ranbaxy-Cefaclor Hospira Hospira Maxipime Maxipime Cefotaxime Sandoz Cefotaxime Sandoz Cefotaxime Sandoz Mayne Fortum Fortum Fortum AFT AFT AFT Zinnat Zinacef Zinacef Celol Cefalexin Sandoz Cefalexin Sandoz

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

CETIRIZINE HYDROCHLORIDE Tab 10 mg – 1% DV Feb-09 to 2011................................................................2.21 Oral liq 1 mg per ml – 1% DV Feb-09 to 2011 .................................................3.50 CHLORAMPHENICOL Eye oint 1% – 1% DV Sep-09 to 2012 .............................................................2.37 Eye drops 0.5% ................................................................................................2.40 CHLORHEXIDINE Crm 1% obstetric – 1% DV Nov-09 to 2012 ....................................................1.36 Soln 0.02% for irrigation ...................................................................................2.92 Soln 0.05% for irrigation ...................................................................................3.02 3.63 Soln 0.1% for irrigation .....................................................................................3.10 Soln 0.5% for irrigation .....................................................................................4.69 Soln 5%, 500 ml ...........................................................................................186.00 CHLORHEXIDINE GLUCONATE Obstetric lotion 1%, 200 ml ............................................................................81.00 CHLORHEXIDINE IN ALCOHOL Soln 0.5% with 70% alcohol, 100 ml (tinted pink) ...........................................31.80 Soln 0.5% with 70% alcohol, 100 ml (tinted red) ............................................34.80 Soln 0.5% with 70% alcohol, 500 ml (tinted pink) ...........................................65.40 Soln 0.5% with 70% alcohol, 500 ml (tinted red) ............................................70.80 Soln 2% with 70% alcohol, 100 ml (tinted pink) ..............................................42.48 Soln 2% with 70% alcohol, 100 ml (tinted red) ...............................................46.32 CHLORHEXIDINE WITH CETRIMIDE Soln 0.015% with 0.15% cetrimide for irrigation ...............................................3.21 3.47 4.17 Soln 0.05% with 0.5% cetrimide for irrigation ...................................................4.20 3.87 Soln 0.1% with 1% cetrimide for irrigation ........................................................4.38 5.81 CHLOROTHIAZIDE Oral liq 50 mg per ml ......................................................................................22.60 CHLORTHALIDONE Tab 25 mg .........................................................................................................8.00 CHOLECALCIFEROL Tab 50,000 iu ....................................................................................................7.76 CILAZAPRIL Tab 0.5 mg ........................................................................................................2.20 Tab 2.5 mg ........................................................................................................4.10 Tab 5 mg ...........................................................................................................6.01 CILAZAPRIL WITH HYDROCHLOROTHIAZIDE Tab 5 mg with 12.5 mg .....................................................................................6.30 CIPROFLOXACIN Tab 250 mg – 1% DV Jan-09 to 2011..............................................................3.35 Tab 500 mg – 1% DV Jan-09 to 2011..............................................................4.90 Tab 750 mg – 1% DV Jan-09 to 2011..............................................................7.54 Inj 2 mg per ml, 100 ml – 1% DV Jun-10 to 2013 ..........................................41.00

100 200 ml 4g 10 ml 50 g 100 ml 100 ml 500 ml 100 ml 500 ml 12 12 12 12 12 12 12 12 100 ml 500 ml 1,000 ml 100 ml 500 ml 100 ml 500 ml 25 ml 50 12 30 28 28 28 30 30 30 10

Zetop Cetirizine-AFT Chlorsig Chlorsig healthE Baxter Baxter Baxter Baxter Baxter healthE healthE healthE healthE healthE healthE healthE healthE Baxter Baxter Baxter Baxter Baxter Baxter Baxter Biomed Hygroton Cal-d-Forte Inhibace Inhibace Inhibace Inhibace Plus Rex Medical Rex Medical Rex Medical Aspen Ciproﬂoxacin

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

CISPLATIN Inj 1 mg per ml, 50 ml – 1% DV Jul-10 to 2013 .............................................15.00 Inj 1 mg per ml, 100 ml – 1% DV Jul-10 to 2013 ...........................................21.00 CITALOPRAM HYDROBROMIDE Tab 20 mg – 1% DV Jan-09 to 2011................................................................3.78 CLADRIBINE Inj 1 mg per ml, 10 ml ................................................................................5,249.72 CLARITHROMYCIN Tab 250 mg .......................................................................................................7.75 Grans for oral liq 125 mg per 5 ml ..................................................................23.12 CLINDAMYCIN Cap 150 mg ....................................................................................................11.39 Inj phosphate 150 mg per ml, 4 ml – 1% DV Jul-10 to 2013 .........................16.00 CLOBETASOL PROPIONATE Crm 0.05% – 1% DV Dec-09 to 2012 ..............................................................3.48 Oint 0.05% – 1% DV Dec-09 to 2012 ..............................................................3.48 Scalp app 0.05% – 1% DV Dec-09 to 2012 .....................................................6.36 CLOMIPHENE CITRATE Tab 50 mg .........................................................................................................2.50 29.84 CLONAZEPAM Tab 500 µg – 1% DV Dec-08 to 2011 ..............................................................6.26 Tab 2 mg – 1% DV Dec-08 to 2011 ...............................................................11.15 Inj 1 mg per ml, 1 ml .......................................................................................19.00 CLONIDINE TDDS 2.5 mg, 100 µg per day – 1% DV Dec-09 to 2012...............................23.30 TDDS 5 mg, 200 µg per day – 1% DV Dec-09 to 2012..................................32.80 TDDS 7.5 mg, 300 µg per day – 1% DV Dec-09 to 2012...............................41.20 CLONIDINE HYDROCHLORIDE Tab 25 µg – 1% DV Dec-09 to 2012 ..............................................................19.25 Tab 150 µg – 1% DV Dec-09 to 2012 ............................................................33.00 Inj 150 µg per ml, 1 ml – 1% DV Dec-09 to 2012...........................................15.45 CLOPIDOGREL Tab 75 mg .......................................................................................................25.00 73.38 CLOSTRIDUM BOTULINUM Inj 100 u ........................................................................................................467.50 Inj 500 u .....................................................................................................1,295.00 CLOTRIMAZOLE Crm 1% – 1% DV Sep-08 to 2011 ...................................................................0.50 Vaginal crm 1% with applicators – 1% DV Sep-10 to 2013 .............................1.30 Vaginal crm 2% with applicators – 1% DV Sep-10 to 2013 .............................2.50

1 1 84 7 14 70 ml 16 1 30 g 30 g 30 ml 5 10 100 100 5 4 4 4 100 100 5 28

Cisplatin Ebewe Cisplatin Ebewe Arrow-Citalopram Leustatin Klamycin Klacid Dalacin C Dalacin C Dermol Dermol Dermol Phenate Serophene Paxam Paxam Rivotril Catapres-TTS-1 Catapres-TTS-2 Catapres-TTS-3 Dixarit Catapres Catapres Apo-Clopidogrel Arrow-Clopidogrel Plavix Botox Dysport Clomazol Clomazol Clomazol

1 2 20 g 35 g 20 g

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

CLOZAPINE Tab 25 mg .........................................................................................................6.69 13.37 26.74 Tab 50 mg .........................................................................................................8.67 17.33 Tab 100 mg .....................................................................................................34.65 69.30 17.33 34.65 Tab 200 mg .....................................................................................................34.65 69.30 Oral liq 50 mg per ml ......................................................................................17.33 CO-TRIMOXAZOLE Oral liq 240 mg per 5 ml ...................................................................................2.15 COCAINE Soln 4%, 2 ml .................................................................................................25.46 CODEINE PHOSPHATE Tab 15 mg .........................................................................................................5.39 Tab 30 mg .........................................................................................................8.25 Tab 60 mg .......................................................................................................17.76 COLASPASE (L-ASPARAGINASE) Inj 10,000 iu ..................................................................................................102.32 COLCHICINE Tab 500 µg – 1% DV Sep-10 to 2013 ..............................................................9.60 COLISTIN SULPHOMETHATE Inj 150 mg .......................................................................................................65.00 CROTAMITON Crm 10% – 1% DV May-10 to 2012.................................................................3.79 CYCLIZINE HYDROCHLORIDE Tab 50 mg – 1% DV Sep-09 to 2012 ...............................................................1.59 CYCLIZINE LACTATE Inj 50 mg per ml, 1 ml .....................................................................................14.95 CYCLOPHOSPHAMIDE Tab 50 mg – 1% DV Sep-10 to 2013 .............................................................25.71 Inj 1 g ..............................................................................................................23.65 Inj 2 g ..............................................................................................................47.30 CYCLOSPORIN Cap 25 mg ......................................................................................................59.50 Cap 50 mg ....................................................................................................118.54 Cap 100 mg ..................................................................................................237.08 Oral liq 100 mg per ml ..................................................................................264.17 Inf 50 mg per ml, 5 ml – 1% DV Sep-09 to 2012 .........................................276.30 CYPROTERONE ACETATE Tab 50 mg – 1% DV Sep-09 to 2012 .............................................................21.10 Tab 100 mg – 1% DV Sep-09 to 2012 ...........................................................41.50

50 100 50 100 50 100 50 100 50 100 50 100 100 ml 100 ml 1 100 100 100 1 100 1 20 g 10 5 50 1 1 50 50 50 50 ml 10 50 50

Clopine Clopine Clozaril Clozaril Clopine Clopine Clozaril Clozaril Clopine Clopine Clopine Clopine Clopine Deprim Biomed PSM PSM PSM Leunase Colgout Colistin-Link Itch-Soothe Nausicalm Valoid (AFT) Cycloblastin Endoxan Endoxan Neoral Neoral Neoral Neoral Sandimmun Siterone Siterone

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

CYTARABINE Inj 100 mg – 1% DV Aug-10 to 2013 .............................................................76.00 Inj 500 mg – 1% DV Aug-10 to 2013 .............................................................18.15 95.36 Inj 1 g – 1% DV Aug-10 to 2013 ....................................................................37.00 42.65 Inj 2 g – 1% DV Aug-10 to 2013 ....................................................................31.00 34.47 (Mayne Inj 500 mg to be delisted 1 August 2010) (Mayne Inj 1 g to be delisted 1 August 2010) (Mayne Inj 2 g to be delisted 1 August 2010) DACARBAZINE Inj 200 mg .......................................................................................................43.86 DALTEPARIN SODIUM Inj 2,500 iu per 0.2 ml preﬁlled syringe ...........................................................49.00 Inj 5,000 iu per 0.2 ml preﬁlled syringe ...........................................................52.30 Inj 7,500 iu per 0.75 ml graduated syringe .....................................................78.85 Inj 10,000 iu per 1 ml graduated syringe ......................................................105.12 Inj 12,500 iu per 0.5 ml preﬁlled syringe .........................................................84.50 Inj 15,000 iu per 0.6 ml preﬁlled syringe .......................................................105.00 Inj 18,000 iu per 0.72 ml preﬁlled syringe .....................................................125.00 DANAZOL Cap 100 mg ....................................................................................................68.33 Cap 200 mg ...................................................................................................29.35 97.83 (D-Zol Cap 200 mg to be delisted 1 November 2010) DANTHRON WITH POLAXAMER Oral liq 25 mg with poloxamer 200 mg per 5 ml ...............................................9.50 DANTROLENE SODIUM Cap 25 mg ......................................................................................................32.96 Cap 50 mg ......................................................................................................51.70 Inj 1 mg per ml, 20 ml ...................................................................................800.00 DASATINIB Tab 20 mg ..................................................................................................3,774.06 Tab 50 mg ..................................................................................................6,214.20 Tab 70 mg ..................................................................................................7,692.58 Tab 100 mg ................................................................................................6,214.20 DAUNORUBICIN Inj 2 mg per ml, 10 ml .....................................................................................99.00 Inj 5 mg per ml, 4 ml .......................................................................................99.00 DESFERRIOXAMINE MESYLATE Inj 500 mg .......................................................................................................99.00 DESFLURANE Liq 240 ml bottle – 1% DV Nov-09 to 2012...............................................1,230.00 DESMOPRESSIN Tab 100 µg ......................................................................................................36.40 Nasal spray 10 µg per dose – 1% DV Sep-08 to 2011 ..................................29.94

5 1 5 1 1

Pﬁzer Pﬁzer Mayne Pﬁzer Mayne Pﬁzer Mayne

1 10 10 10 10 5 5 5 100 30 100

Mayne Fragmin Fragmin Fragmin Fragmin Fragmin Fragmin Fragmin Azol D-Zol Azol

300 ml 100 100 6 60 60 60 30 1 1 10 6 30 6 ml

Pinorax Dantrium Dantrium Dantrium IV Sprycel Sprycel Sprycel Sprycel Pﬁzer Mayne Mayne Suprane Minirin Desmopressin-PH&T

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

DEXAMETHASONE Eye drops 0.1% – 1% DV Sep-10 to 2013 .......................................................4.50 Oral liq 1 mg per ml ........................................................................................39.90 DEXAMETHASONE SODIUM PHOSPHATE Inj 4 mg per ml, 1 ml – 1% DV Aug-10 to 2013 .............................................21.50 Inj 4 mg per ml, 2 ml – 1% DV Aug-10 to 2013 .............................................31.00 DEXAMPHETAMINE SULPHATE Tab 5 mg .........................................................................................................16.50 DEXTRAN 70 WITH SODIUM CHLORIDE Inf 6% with 0.9% sodium chloride ..................................................................16.59 DEXTROSE Inj 50%, 10 ml – 1% DV Jul-08 to 2011 .........................................................22.75 Inj 50%, 90 ml .................................................................................................11.25 DIAZEPAM Tab 2 mg .........................................................................................................11.44 Tab 5 mg .........................................................................................................13.71 Inj 5 mg per ml, 2 ml .........................................................................................9.24 Rectal tubes 5 mg ...........................................................................................25.05 Rectal tubes 10 mg .........................................................................................30.50 DICLOFENAC SODIUM Tab long-acting 75 mg ......................................................................................3.10 Eye drops 1 mg per ml – 1% DV Sep-08 to 2011 ..........................................13.80 Inj 25 mg per ml, 3 ml – 1% DV Sep-08 to 2011............................................12.00 Suppos 12.5 mg – 1% DV Sep-08 to 2011 ......................................................1.85 Suppos 25 mg – 1% DV Sep-08 to 2011 .........................................................2.22 Suppos 50 mg – 1% DV Sep-08 to 2011 .........................................................3.84 Suppos 100 mg – 1% DV Sep-08 to 2011 .......................................................6.36 DIHYDROCODEINE TARTRATE Tab long-acting 60 mg – 1% DV Jun-10 to 2013 ...........................................27.27 DILTIAZEM HYDROCHLORIDE Tab 30 mg – 5% DV Jun-09 to 31 Dec 2011 ...................................................4.60 Tab 60 mg – 5% DV Jun-09 to 31 Dec 2011 ...................................................8.50 Cap long-acting 120 mg – 5% DV Jun-09 to 31 Dec 2011..............................4.34 Cap long-acting 180 mg – 5% DV Jun-09 to 31 Dec 2011..............................6.50 Cap long-acting 240 mg – 5% DV Jun-09 to 31 Dec 2011..............................8.67 DINOPROSTONE Gel 1 mg, 2.5 ml .............................................................................................52.65 Gel 2 mg, 2.5 ml .............................................................................................64.60 DIPYRIDAMOLE Tab long-acting 150 mg – 1% DV Oct-08 to 2011 .........................................11.52 DISULFIRAM Tab 200 mg .....................................................................................................24.30 DOCETAXEL Inj 20 mg – 1% DV Jul-10 to 2011...............................................................325.00 Inj 80 mg – 1% DV Jul-10 to 2011............................................................1,300.00

5 ml 25 ml 5 5 100 500 ml 5 1 500 500 5 5 5 30 5 ml 5 10 10 10 10 60 100 100 30 30 30 1 1 60 100 1 1

Maxidex Biomed Hospira Hospira PSM Baxter Biomed Biomed Arrow-Diazepam Arrow-Diazepam Mayne Stesolid Stesolid Diclax Voltaren Ophtha Voltaren Voltaren Voltaren Voltaren Voltaren DHC Continus Dilzem Dilzem Cardizem CD Cardizem CD Cardizem CD Prostin E2 Prostin E2 Pytazen SR Antabuse Docetaxel Ebewe Docetaxel Ebewe

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

DOCUSATE SODIUM Cap 50 mg – 1% DV Jun-10 to 2011 ...............................................................3.95 Cap 120 mg – 1% DV Jun-10 to 2011 .............................................................5.49 DOCUSATE SODIUM WITH SENNOSIDES Tab 50 mg with total sennosides 8 mg – 1% DV Jun-10 to 2012 ....................6.38 DOPAMINE HYDROCHLORIDE Inj 40 mg per ml, 5 ml .....................................................................................54.00 DORZOLAMIDE HYDROCHLORIDE WITH TIMOLOL MALEATE Eye drops 2% with timolol maleate 0.5% .......................................................15.50 DOTHIEPIN HYDROCHLORIDE Tab 75 mg .........................................................................................................8.75 Cap 25 mg ........................................................................................................4.75 DOXAZOSIN MESYLATE Tab 2 mg .........................................................................................................22.85 Tab 4 mg .........................................................................................................30.26 DOXORUBICIN Inj 10 mg ...........................................................................................................8.80 Inj 50 mg .........................................................................................................39.40 Inj 100 mg .......................................................................................................81.00 Inj 200 mg .....................................................................................................162.00 DOXYCYCLINE HYDROCHLORIDE Tab 100 mg .......................................................................................................8.10 EMTRICITABINE Cap 200 mg ..................................................................................................307.20 EMULSIFYING OINTMENT Oint BP 100 g – 1% DV Nov-08 to 2011..........................................................2.50 Note: DV Limit applies to pack sizes of 100 g or less. Oint BP 500 g – 1% DV Sep-08 to 2011..........................................................3.69 Note: DV Limit applies to pack sizes of greater than 100 g ENALAPRIL Tab 5 mg – 1% DV Aug-10 to 2012 .................................................................1.98 Tab 10 mg – 1% DV Aug-10 to 2012 ...............................................................2.44 Tab 20 mg – 1% DV Aug-10 to 2012 ...............................................................3.24 ENFUVIRTIDE Powder for inj 90 mg per ml × 60 ..............................................................2,380.00 ENOXAPARIN SODIUM Inj 20 mg – 1% DV Aug-09 to 2012 ...............................................................39.20 Inj 40 mg – 1% DV Aug-09 to 2012 ...............................................................52.30 Inj 60 mg – 1% DV Aug-09 to 2012 ...............................................................78.85 Inj 80 mg – 1% DV Aug-09 to 2012 .............................................................105.12 Inj 100 mg – 1% DV Aug-09 to 2012 ...........................................................135.20 Inj 120 mg – 1% DV Aug-09 to 2012 ...........................................................168.00 Inj 150 mg – 1% DV Aug-09 to 2012 ...........................................................192.00 ENTACAPONE Tab 200 mg – 1% DV Jul-09 to 2012 ...........................................................116.00 ENTECAVIR Tab 0.5 mg ....................................................................................................400.00

100 100 200 5 5 ml 100 100 500 500 1 1 1 1 250 30 100 g 500 g

Laxofast 50 Laxofast 120 Laxsol Mayne Cosopt Dopress Dopress Apo-Doxazosin Apo-Doxazosin Doxorubicin Ebewe Doxorubicin Ebewe Doxorubicin Ebewe Doxorubicin Ebewe Doxine Emtriva AFT AFT

90 90 90 1 10 10 10 10 10 10 10 100 30

Arrow-Enalapril Arrow-Enalapril Arrow-Enalapril Fuzeon Clexane Clexane Clexane Clexane Clexane Clexane Clexane Comtan Baraclude

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

EPHEDRINE SULPHATE Inj 30 mg per ml, 1 ml .....................................................................................44.00 EPIRUBICIN Inj 2 mg per ml, 5 ml – 1% DV Oct-09 to 2012 ..............................................25.00 Inj 2 mg per ml, 25 ml – 1% DV Oct-09 to 2012 ............................................87.50 Inj 2 mg per ml, 50 ml – 1% DV Oct-09 to 2012 ..........................................155.00 Inj 2 mg per ml, 100 ml – 1% DV Oct-09 to 2012 ........................................310.00 EPTIFIBATIDE Inj 2 mg per ml, 10 ml ...................................................................................111.00 Inj 0.75 mg per ml, 100 ml ............................................................................324.00 ERGOMETRINE MALEATE Inj 500 µg per ml, 1 ml ....................................................................................11.60 ERTAPENEM SODIUM Inj 1 g ..............................................................................................................70.00 ERYTHROMYCIN ETHYL SUCCINATE Tab 400 mg – 1% DV Jul-09 to 2012 .............................................................16.95 Grans for oral liq 200 mg per 5 ml – 1% DV Dec-08 to 2011...........................4.35 Grans for oral liq 400 mg per 5 ml – 1% DV Dec-08 to 2011...........................5.85 ERYTHROMYCIN LACTOBIONATE Inj 300 mg .......................................................................................................70.97 Inj 1 g ..............................................................................................................10.93 ERYTHROPOIETIN ALPHA Inj human recombinant 1,000 iu, preﬁlled syringe ..........................................48.68 Inj human recombinant 2,000 iu, preﬁlled syringe ........................................120.18 Inj human recombinant 3,000 iu, preﬁlled syringe ........................................166.87 Inj human recombinant 4,000 iu, preﬁlled syringe ........................................193.13 Inj human recombinant 5,000 iu, preﬁlled syringe ........................................243.26 Inj human recombinant 6,000 iu, preﬁlled syringe ........................................291.92 Inj human recombinant 10,000 iu, preﬁlled syringe ......................................395.18 ERYTHROPOIETIN BETA Inj 2,000 iu, preﬁlled syringe .........................................................................120.18 Inj 3,000 iu, preﬁlled syringe .........................................................................166.87 Inj 4,000 iu, preﬁlled syringe .........................................................................193.13 Inj 5,000 iu, preﬁlled syringe .........................................................................243.26 Inj 6,000 iu, preﬁlled syringe .........................................................................291.92 Inj 10,000 iu, preﬁlled syringe .......................................................................395.18 ETANERCEPT Inj 25 mg .......................................................................................................949.96 ETHAMBUTOL HYDROCHLORIDE Tab 100 mg .....................................................................................................57.81 Tab 400 mg .....................................................................................................56.84 ETIDRONATE DISODIUM Tab 200 mg – 1% DV Jan-10 to 2012............................................................23.95 ETOPOSIDE Cap 50 mg ....................................................................................................340.73 Cap 100 mg ..................................................................................................340.73 Inj 20 mg per ml, 5 ml .....................................................................................25.00

5 1 1 1 1 1 1 5 1 100 100 ml 100 ml 5 1 6 6 6 6 6 6 6 6 6 6 6 6 6 4 56 56 100 20 10 1

Mayne Epirubicin Ebewe Epirubicin Ebewe Epirubicin Ebewe Epirubicin Ebewe Integrilin Integrilin Mayne Invanz E-Mycin E-Mycin E-Mycin Mayne Erythrocin IV Eprex Eprex Eprex Eprex Eprex Eprex Eprex NeoRecormon NeoRecormon NeoRecormon NeoRecormon NeoRecormon NeoRecormon Enbrel Myambutol Myambutol Arrow-Etidronate Vepesid Vepesid Mayne

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

EXEMESTANE Tab 25 mg .....................................................................................................175.00 FELODIPINE Tab long-acting 5 mg – 1% DV Sep-09 to 2012.............................................10.73 Tab long-acting 10 mg – 1% DV Sep-09 to 2012...........................................15.60 FENTANYL CITRATE Inj 50 µg per ml, 2 ml ........................................................................................6.10 Inj 50 µg per ml, 10 ml ....................................................................................15.65 FERROUS FUMARATE Tab 200 mg (65 mg elemental) .........................................................................4.35 FERROUS FUMARATE WITH FOLIC ACID Tab 310 mg (100 mg elemental) with folic acid 350 µg ....................................4.75 FERROUS SULPHATE Oral liq 30 mg per 1 ml (6 mg elemental per 1 ml) – 1% DV Sep-10 to 2013 ..................................................................................................... 10.30 FILGRASTIM Inj 300 µg per 0.5 ml preﬁlled syringe – 1% DV Jun-09 to 31 Dec 2011 .........135.00 Inj 300 µg per 1 ml vial – 1% DV Jun-09 to 31 Dec 2011............................650.00 Inj 480 µg per 0.5 ml preﬂled syringe – 1% DV Jun-09 to 31 Dec 2011 .........216.00 FINASTERIDE Tab 5 mg – 1% DV Dec-08 to 2011 ...............................................................19.20 FLECAINIDE ACETATE Tab 50 mg .......................................................................................................45.82 Tab 100 mg .....................................................................................................80.92 Cap long-acting 100 mg .................................................................................45.82 Cap long-acting 200 mg .................................................................................80.92 Inj 10 mg per ml, 15 ml ...................................................................................52.45 FLUCLOXACILLIN SODIUM Cap 250 mg – 1% DV Mar-10 to 2012 ...........................................................32.00 Cap 500 mg – 1% DV Mar-10 to 2012 .........................................................110.00 Grans for oral liq 125 mg per 5 ml – 1% DV Dec-09 to 2012...........................3.12 Grans for oral liq 250 mg per 5 ml – 1% DV Dec-09 to 2012...........................3.55 Inj 250 mg – 1% DV Feb-09 to 2011................................................................9.00 Inj 500 mg – 1% DV Feb-09 to 2011..............................................................10.40 Inj 1 g – 1% DV Feb-09 to 2011.....................................................................14.00 FLUCONAZOLE Cap 50 mg – 1% DV Sep-08 to 2011...............................................................6.82 Cap 150 mg – 1% DV Sep-08 to 2011.............................................................1.30 Cap 200 mg – 1% DV Sep-08 to 2011...........................................................19.05 Oral liq 10 mg per ml ......................................................................................34.56 Inj 2 mg per ml, 50 ml .......................................................................................7.10 FLUDARABINE PHOSPHATE Tab 10 mg – 1% DV Nov-08 to 2011 ...........................................................867.00 Inj 50 mg – 1% DV Nov-08 to 2011 ..........................................................1,430.00 FLUDROCORTISONE ACETATE Tab 100 µg ........................................................................................................7.62

30 90 90 5 5 100 60

Aromasin Felo 5 ER Felo 10 ER Hospira Hospira Ferro-tab Ferro-F-Tabs

500 ml 1 5 1 30 60 60 30 30 5 250 500 100 ml 100 ml 10 10 10 28 1 28 35 ml 1 20 5 100

Ferodan Neupogen Neupogen Neupogen Fintral Tambocor Tambocor Tambocor CR Tambocor CR Tambocor AFT AFT AFT AFT Flucloxin Flucloxin Flucloxin Paciﬁc Paciﬁc Paciﬁc Diﬂucan POS m-Fluconazole Fludara Oral Fludara Florinef

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

FLUMAZENIL Inj 0.5 mg per 5 ml amp ................................................................................170.10

Anexate

FLUOCORTOLONE CAPROATE WITH FLUOCORTOLONE PIVALATE AND CINCHOCAINE Oint 950 µg, with ﬂuocortolone pivalate 920 µg, and cinchocaine hydrochloride 5 mg per g .............................................................................. 6.35 30 g Suppos 630 µg, with ﬂuocortolone pivalate 610 µg, and cinchocaine hydrochloride 1 mg .................................................................................... 2.66 12 FLUOROMETHOLONE Eye drops 0.1% – 1% DV Sep-09 to 2012 .......................................................4.05 FLUOROURACIL SODIUM Crm 5% ..........................................................................................................26.49 Inj 25 mg per ml, 20 ml ...................................................................................55.60 Inj 25 mg per ml, 100 ml .................................................................................13.55 Inj 50 mg per ml, 10 ml ...................................................................................24.75 Inj 50 mg per ml, 20 ml .....................................................................................8.60 Inj 50 mg per ml, 50 ml ...................................................................................21.50 Inj 50 mg per ml, 100 ml .................................................................................43.00 FLUOXETINE HYDROCHLORIDE Tab dispersible 20 mg, scored – 1% DV Sep-10 to 2013.................................2.50 Cap 20 mg – 1% DV Sep-10 to 2013...............................................................2.70 FLUPENTHIXOL DECANOATE Inj 20 mg per ml, 1 ml .....................................................................................13.14 Inj 20 mg per ml, 2 ml .....................................................................................20.90 Inj 100 mg per ml, 1 ml ...................................................................................40.87 FLUPHENAZINE DECANOATE Inj 12.5 mg per 0.5 ml, 0.5 ml .........................................................................17.60 Inj 25 mg per ml, 1 ml .....................................................................................27.90 Inj 100 mg per ml, 1 ml .................................................................................154.50 FLUTAMIDE Tab 250 mg .....................................................................................................48.30 FLUTICASONE Aerosol inhaler, 50 µg per dose CFC-free ........................................................7.50 Powder for inhalation, 50 µg per dose ..............................................................8.67 Powder for inhalation, 100 µg per dose ..........................................................13.87 Aerosol inhaler, 125 µg per dose CFC-free ....................................................13.60 Aerosol inhaler, 250 µg per dose CFC-free ....................................................27.20 Powder for inhalation, 250 µg per dose ..........................................................24.51 FLUTICASONE WITH SALMETEROL Aerosol inhaler 50 µg with salmeterol 25 µg ...................................................37.48 Powder for inhalation 100 µg with salmeterol 50 µg .......................................37.48 Aerosol inhaler 125 µg with salmeterol 25 µg .................................................49.69 Powder for inhalation 250 µg with salmeterol 50 µg .......................................49.69 FOLIC ACID Oral liq 50 µg per ml .......................................................................................21.05 5 ml 20 g 10 1 5 1 1 1 30 84 5 5 5 5 5 5 100 120 dose 60 dose 60 dose 120 dose 120 dose 60 dose 120 dose 60 dose 120 dose 60 dose 25 ml

Ultraproct Ultraproct FML Efudix Mayne Mayne Fluorouracil Ebewe Fluorouracil Ebewe Fluorouracil Ebewe Fluorouracil Ebewe Fluox Fluox Fluanxol Fluanxol Fluanxol Modecate Modecate Modecate Flutamin Flixotide Flixotide Accuhaler Flixotide Accuhaler Flixotide Flixotide Flixotide Accuhaler Seretide Seretide Accuhaler Seretide Seretide Accuhaler Biomed

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

FUROSEMIDE Tab 40 mg – 1% DV Jul-09 to 2012 ...............................................................10.75 Tab 500 mg .....................................................................................................50.00 Inj 10 mg per ml, 2 ml .....................................................................................29.50 FUSIDIC ACID Tab 250 mg .....................................................................................................34.50 Crm 2% – 1% DV Sep-10 to 2013 ...................................................................3.25 Eye drops 1% ...................................................................................................9.83 Oint 2% – 1% DV Sep-10 to 2013 ...................................................................3.25

1,000 50 50 12 15 g 5g 15 g

Diurin 40 Urex Forte Mayne Fucidin Foban Fucithalmic Foban

GABAPENTIN Note: DV limit of 5% applies to gabapentin chemical rather than each individual line item. Cap 100 mg – 5% DV Aug-09 to 31 Jul 2012 .................................................7.16 100 Cap 300 mg – 5% DV Aug-09 to 31 Jul 2012 ...............................................11.50 100 Cap 400 mg – 5% DV Aug-09 to 31 Jul 2012 ...............................................14.75 100 GADOBENDATE DIMEGLUMINE Inj 0.5 g per litre, 10 ml .................................................................................324.74 Inj 0.5 g per litre, 20 ml .................................................................................636.28 GADOBUTROL Inj 604.72 mg per ml (equivalent to 1 mmol per ml), 7.5 ml preﬁlled syringe ................................................................................................... 253.10 GADODIAMIDE Inj 287 mg per ml, 10 ml ...............................................................................180.00 Inj 287 mg per ml, 10 ml preﬁlled syringe .....................................................220.00 Inj 287 mg per ml, 15 ml ...............................................................................270.00 Inj 287 mg per ml, 15 ml preﬁlled syringe .....................................................330.00 Inj 287 mg per ml, 20 ml preﬁlled syringe .....................................................440.00 GANCICLOVIR Inj 500 mg vial ..............................................................................................380.00 GELATIN PLASMA REPLACER Inf 3.5%, 500 ml bag .........................................................................................9.75 Inf 4% per 500 ml bag ..................................................................................108.00 GEMCITABINE HYDROCHLORIDE Inj 200 mg – 1% DV Sep-10 to 2013 .............................................................12.50 Inj 1 g – 1% DV Sep-10 to 2013 ....................................................................62.50 GENTAMICIN SULPHATE Eye drops 0.3% ..............................................................................................11.40 Inj 10 mg per ml, 1 ml .......................................................................................8.56 Inj 40 mg per ml, 2 ml – 1% DV Dec-09 to 2012..............................................9.00 GLICLAZIDE Tab 80 mg – 1% DV Sep-08 to 2011 .............................................................22.24 GLIPIZIDE Tab 5 mg – 1% DV Sep-08 to 2011 .................................................................3.50 10 10

Nupentin Nupentin Nupentin Multihance Multihance

5 10 10 10 10 10 5 500 ml 10 1 1 5 ml 5 10 500 100

Gadovist Omniscan Omniscan Omniscan Omniscan Omniscan Cymevene Haemaccel Gelofusine Gemcitabine Ebewe Gemcitabine Ebewe Genoptic Mayne Pﬁzer Apo-Gliclazide Minidiab

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

GLUCOSE Inf 5% ...............................................................................................................2.87 2.84 3.87 1.77 1.80 Inf 10% .............................................................................................................3.70 5.29 Inf 50% .............................................................................................................6.84 GLUCOSE WITH SODIUM, POTASSIUM, MAGNESIUM, CHLORIDE AND ACETATE Inf 50 g with 40 mmol/L sodium, 13 mmol/L potassium, 1.5 mmol/L magnesium, 40 mmol/L chloride, and 16 mmol/L acetate ......................... 4.50

50 ml 100 ml 250 ml 500 ml 1,000 ml 500 ml 1,000 ml 500 ml

Baxter Baxter Baxter Baxter Baxter Baxter Baxter Baxter

500 ml

Baxter

GLUCOSE WITH SODIUM, POTASSIUM, MAGNESIUM, CHLORIDE, ACETATE AND GLUCONATE Inf 50 g with 140 mmol/L sodium, 5 mmol/L potassium, 1.5 mmol/L magnesium, 98 mmol/L chloride, 27 mmol/L acetate and 23 mmol/L gluconate ................................................................................. 7.00 1,000 ml GLYCEROL Liquid ..............................................................................................................19.80 Suppos 3.6 g ....................................................................................................6.00 GLYCERYL TRINITRATE Tab 600 µg – 1% DV Mar-09 to 2011...............................................................8.00 Inj 1 mg per ml, 5 ml – 1% DV Dec-09 to 2012..............................................22.70 Inj 1 mg per ml, 50 ml – 1% DV Dec-09 to 2012............................................86.60 Inj 5 mg per ml, 10 ml .....................................................................................40.00 Aerosol spray 400 µg per dose – 1% DV Sep-08 to 2011 ...............................5.16 TDDS 5 mg – 1% DV Jul-08 to 2011 .............................................................16.56 TDDS 10 mg – 1% DV Jul-08 to 2011 ...........................................................19.60 GLYCINE Soln 1.5% for irrigation ...................................................................................11.38 14.44 GOSERELIN ACETATE Inj 3.6 mg ......................................................................................................200.00 Inj 10.8 mg ....................................................................................................500.00 HALOPERIDOL Tab 500 µg ........................................................................................................4.93 Tab 1.5 mg ........................................................................................................7.45 Tab 5 mg .........................................................................................................23.49 Oral liq 2 mg per ml ........................................................................................18.06 Inj 5 mg per ml, 1 ml .......................................................................................17.04 HALOPERIDOL DECANOATE Inj 50 mg per ml, 1 ml .....................................................................................28.39 Inj 100 mg per ml, 1 ml ...................................................................................55.90 HEPARIN SODIUM Inj 1,000 iu per ml, 1 ml ..................................................................................66.80 Inj 1,000 iu per ml, 5 ml ..................................................................................11.44 46.30 Inj 5,000 iu per ml, 1 ml ..................................................................................14.20 Inj 5,000 iu per ml, 5 ml ................................................................................118.50 2,000 ml 20 100 10 10 5 250 dose 30 30 2,000 ml 3,000 ml 1 1 100 100 100 100 ml 10 5 5 50 10 50 5 50

Baxter ABM PSM Lycinate Nitronal Nitronal Mayne Nitrolingual Pumpspray Nitroderm TTS 5 Nitroderm TTS 10 Baxter Baxter Zoladex Zoladex Serenace Serenace Serenace Serenace Serenace Haldol Haldol Concentrate Mayne Pﬁzer Pﬁzer Mayne Pﬁzer

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

HEPARIN WITH SODIUM CHLORIDE Inf 25,000 iu with 0.9% sodium chloride ...........................................................7.25 7.67 HEPARINISED SALINE Inj 10 iu per ml, 5 ml .......................................................................................32.50 HYDRALAZINE Inj 20 mg per ml, 1 ml .....................................................................................25.90 HYDROCORTISONE Tab 5 mg – 1% DV Dec-09 to 2012 .................................................................8.35 Tab 20 mg – 1% DV Dec-09 to 2012 .............................................................20.95 Crm 1%, 14.2 g ................................................................................................2.48 Powder – 1% DV Aug-09 to 2011 ..................................................................33.00 Crm 1%, 100 g .................................................................................................3.75 Crm 1%, 500 g – 1% DV Sep-08 to 2011 ......................................................12.20 Note: DV Limit applies to pack sizes of greater than 100 g. HYDROCORTISONE ACETATE Rectal foam 10%, CFC-Free (14 applications) – 1% DV Dec-09 to 2012 .........23.00 HYDROCORTISONE BUTYRATE Lipocream 0.1% ................................................................................................2.30 6.85 Oint 0.1% ..........................................................................................................6.85 Milky emul 0.1% ...............................................................................................6.85 Scalp lotn 0.1% .................................................................................................3.65 HYDROCORTISONE WITH MICONAZOLE Crm 1% with miconazole nitrate 2% .................................................................2.20 HYDROCORTISONE WITH NATAMYCIN AND NEOMYCIN Crm 1% with natamycin 1% and neomycin sulphate 0.5% ..............................2.79 Oint 1% with natamycin 1% and neomycin sulphate 0.5% ...............................2.79 HYDROGEN PEROXIDE Crm 1% ............................................................................................................8.56 HYDROXOCOBALAMIN Inj 1 mg per ml, 1 ml – 1% DV Apr-10 to 2012 ................................................6.15 HYDROXYCHLOROQUINE SULPHATE Tab 200 mg – 1% DV Jul-09 to 2012 .............................................................22.50 HYDROXYETHYL STARCH 130/0.4 Inj 6% – 1% DV Nov-09 to 2012 ..................................................................198.00 HYDROXYETHYL STARCH 200/0.5 Inj 6%, 500 ml bag – 1% DV Dec-09 to 2012 ..............................................296.00 Inj 10% – 1% DV Sep-08 to 2011 ..................................................................13.50 HYDROXYUREA Cap 500 mg ....................................................................................................31.76 HYOSCINE (SCOPOLAMINE) Patches 1.5 mg ...............................................................................................11.95 HYOSCINE HYDROBROMIDE Inj 400 µg per ml, 1 ml ......................................................................................6.66

250 ml 500 ml 50 5 100 100 14.2 g 25 g 100 g 500 g

Baxter Baxter Pﬁzer Apresoline Douglas Douglas AFT ABM Pharmacy Health PSM

21.1 g 30 g 100 g 100 g 100 ml 100 ml 15 g 15 g 15 g 10 g 3 100 20 16 1 100 2 5

Colifoam Locoid Lipocream Locoid Lipocream Locoid Locoid Crelo Locoid Micreme H Pimafucort Pimafucort Crystacide ABM Plaquenil Voluven Starquin 200 6% StarQuin 10% Hydrea Scopoderm TTS Mayne

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

HYOSCINE N-BUTYLBROMIDE Tab 10 mg – 1% DV Dec-08 to 2011 ...............................................................1.62 Inj 20 mg per ml, 1 ml – 1% DV Dec-08 to 2011..............................................8.04 HYPROMELLOSE Eye drops 0.5% – 1% DV Mar-09 to 2011 .......................................................2.00 IBUPROFEN Oral liq 100 mg per 5 ml – 1% DV Sep-10 to 2013..........................................2.69 IDARUBICIN HYDROCHLORIDE Cap 5 mg – 1% DV Jan-10 to 2012 .............................................................115.00 Cap 10 mg – 1% DV Jan-10 to 2012 ...........................................................144.50 Inj 5 mg – 1% DV Jan-10 to 2012................................................................170.00 Inj 10 mg – 1% DV Jan-10 to 2012..............................................................340.00 IFOSFAMIDE Inj 1 g ..............................................................................................................96.00 Inj 2 g ............................................................................................................180.00 ILOPROST Inf 100 µg per ml, 0.5 ml ...............................................................................925.00 Nebuliser soln 10 µg per ml, 2 ml ..............................................................1,185.00 IMATINIB MESYLATE Tab 100 mg ................................................................................................2,400.00 IMIPENEM WITH CILASTATIN Inj 500 mg with cilastatin 500 mg ...................................................................21.61 IMIPRAMINE HYDROCHLORIDE Tab 10 mg .........................................................................................................5.48 Tab 25 mg .........................................................................................................8.80 IMIQUIMOD Crm 5%, sachet ............................................................................................110.40 INDAPAMIDE Tab 2.5 mg ........................................................................................................4.00 INFLIXIMAB Powder for inj 100 mg ................................................................................1,227.00 INSULIN GLARGINE Inj 100 u per ml, 3 ml ......................................................................................94.50 Inj 100 u per ml, 10 ml ....................................................................................63.00 INSULIN LISPRO WITH INSULIN LISPRO PROTAMINE Inj lispro 25% with insulin lispro protamine 75%, 100 u per ml, 3 ml ..............52.15 Inj lispro 50% with insulin lispro protamine 50%, 100 u per ml, 3 ml ..............52.15 INSULIN PEN NEEDLES 29 g × 12.7 mm ..............................................................................................10.50 11.75 31 g × 5 mm ...................................................................................................11.75 31 g × 6 mm ...................................................................................................10.50 31 g × 8 mm ...................................................................................................10.50 11.75

20 5 15 ml 200 ml 1 1 1 1 1 1 5 30 60 1 50 50 12 100 1 5 1 5 5 100 100 100 100

Gastrosoothe Buscopan Methopt Fenpaed Zavedos Zavedos Zavedos Zavedos Holoxan Holoxan Ilomedin Ventavis Glivec Primaxin Tofranil Tofranil Aldara Napamide Remicade Lantus Lantus SoloStar Lantus Humalog Mix 25 Humalog Mix 50 ABM SC Proﬁ-Fine SC Proﬁ-Fine ABM ABM SC Proﬁ-Fine

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

INSULIN SYRINGES, DISPOSABLE WITH ATTACHED NEEDLE Syringe 0.3 ml with 29 g × 12.7 mm needle ..................................................13.00 Syringe 0.3 ml with 31 g × 8 mm needle .......................................................13.00 Syringe 0.5 ml with 29 g × 12.7 mm needle ..................................................13.00 Syringe 0.5 ml with 31 g × 8 mm needle .......................................................13.00 Syringe 1 ml with 29 g × 12.7 mm needle .....................................................13.00 Syringe 1 ml with 31 g × 8 mm needle ..........................................................13.00 IODINE WITH ALCOHOL Soln 1% with 70% alcohol, 100 ml ...............................................................111.60 IODIXANOL Inj 270 mg per ml (iodine equivalent), 50 ml – 5% DV Apr-10 to 2012 .........223.50 Inj 270 mg per ml (iodine equivalent), 100 ml – 5% DV Apr-10 to 2012 .........447.00 Inj 320 mg per ml (iodine equivalent), 50 ml – 5% DV Apr-10 to 2012 .........223.50 Inj 320 mg per ml (iodine equivalent), 100 ml – 5% DV Apr-10 to 2012 .........447.00 Inj 320 mg per ml (iodine equivalent), 150 ml – 5% DV Apr-10 to 2012 .........670.50 Inj 320 mg per ml (iodine equivalent), 200 ml – 5% DV Apr-10 to 2012 .........565.56 894.00 IOHEXOL Note: Iomeron, Isovue, Optiray, Ultraject and Ultravist are DV Pharmaceuticals. Inj 240 mg per ml (iodine equivalent), 50 ml – 5% DV Apr-10 to 2012..........77.80 Inj 300 mg per ml (iodine equivalent), 20 ml – 5% DV Apr-10 to 2012..........24.00 Inj 300 mg per ml (iodine equivalent), 50 ml – 5% DV Apr-10 to 2012..........77.80 Inj 300 mg per ml (iodine equivalent), 100 ml – 5% DV Apr-10 to 2012 .........155.60 Inj 300 mg per ml (iodine equivalent), 500 ml – 5% DV Apr-10 to 2012 .........468.00 Inj 350 mg per ml (iodine equivalent), 20 ml – 5% DV Apr-10 to 2012..........24.00 Inj 350 mg per ml (iodine equivalent), 50 ml – 5% DV Apr-10 to 2012..........77.80 Inj 350 mg per ml (iodine equivalent), 75 ml – 5% DV Apr-10 to 2012 .........116.70 Inj 350 mg per ml (iodine equivalent), 100 ml – 5% DV Apr-10 to 2012 .........155.60 Inj 350 mg per ml (iodine equivalent), 200 ml – 5% DV Apr-10 to 2012 .........186.70 Inj 350 mg per ml (iodine equivalent), 500 ml – 5% DV Apr-10 to 2012 .........780.00 IPRATROPIUM BROMIDE Nebuliser soln, 250 µg per ml, 1 ml ..................................................................4.30 Nebuliser soln, 250 µg per ml, 2 ml ..................................................................5.25 IRINOTECAN Inj 20 mg per ml, 2 ml – 1% DV Aug-10 to 2012 ...........................................41.00 124.00 Inj 20 mg per ml, 5 ml – 1% DV Aug-10 to 2012 .........................................100.00 310.00 (Camptosar Inj 20 mg per ml, 2 ml to be delisted 1 August 2010) (Camptosar Inj 20 mg per ml, 5 ml to be delisted 1 August 2010) IRON POLYMALTOSE Inj 50 mg per ml, 2 ml – 1% DV Sep-08 to 2011............................................20.95

100 100 100 100 100 100

ABM DM Ject ABM DM Ject ABM DM Ject ABM DM Ject ABM DM Ject ABM DM Ject healthE Visipaque Visipaque Visipaque Visipaque Visipaque Visipaque Visipaque

12 10 10 10 10 10 6 10

10 6 10 10 6 6 10 10 10 6 10 20 20 1 1

Omnipaque Omnipaque Omnipaque Omnipaque Omnipaque Omnipaque Omnipaque Omnipaque Omnipaque Omnipaque Omnipaque Ipratropium Steri-Neb Ipratropium Steri-Neb Irinotecan-Rex Camptosar Irinotecan-Rex Camptosar

Ferrum H

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

IRON SUCROSE Inj 20 mg per ml, 5 ml – 1% DV Apr-10 to 2011 ..........................................100.00 ISOFLURANE Liq 250 ml bottle – 1% DV Nov-09 to 2012..................................................540.00 ISONIAZID Tab 100 mg .....................................................................................................20.00 ISOPROPYL ALCOHOL Soln 70%, 500 ml ...........................................................................................67.80 ISOSORBIDE MONONITRATE Tab 20 mg .......................................................................................................18.00 Tab long-acting 60 mg ......................................................................................4.15 ISOTRETINOIN Cap 10 mg – 1% DV Nov-09 to 2012.............................................................48.48 Cap 20 mg – 1% DV Nov-09 to 2012.............................................................69.70 ITRACONAZOLE Cap 100 mg ....................................................................................................23.70 IVERMECTIN Tab 3 mg – 1% DV Oct-08 to 2011 ................................................................25.96 KETOCONAZOLE Shampoo 2% – 1% DV Oct-08 to 2011 ...........................................................3.48 KETONE BLOOD BETA-KETONE ELECTRODES Test strips .........................................................................................................8.50 LABETALOL Tab 50 mg .........................................................................................................8.66 Tab 100 mg .....................................................................................................10.59 Tab 200 mg .....................................................................................................18.47 Tab 400 mg .....................................................................................................34.44 LACTULOSE Oral liq 10 g per 15 ml ......................................................................................6.65 LAMOTRIGINE Tab dispersible 2 mg .........................................................................................6.74 Tab dispersible 5 mg .........................................................................................9.64 15.00 Tab dispersible 25 mg .....................................................................................19.38 20.40 29.09 Tab dispersible 50 mg .....................................................................................32.97 34.70 47.89 Tab dispersible 100 mg ...................................................................................56.91 59.90 79.16

5 6 100 12 100 90 180 180 15 4 100 ml 10 strip

Venofer Aerrane PSM healthE Ismo-20 Duride Oratane Oratane Sporanox Stromectol Sebizole Optium Blood Ketone Test Strips Hybloc Hybloc Hybloc Hybloc Duphalac Lamictal Lamictal Arrow-Lamotrigine Logem Arrow-Lamotrigine Mogine Lamictal Logem Arrow-Lamotrigine Mogine Lamictal Logem Arrow-Lamotrigine Mogine Lamictal

100 100 100 100 1,000 ml 30 30 56 56

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

LANSOPRAZOLE Cap 15 mg ........................................................................................................3.50 Cap 30 mg ........................................................................................................4.65 LEFLUNOMIDE Tab 10 mg .......................................................................................................55.00 79.27 Tab 20 mg .......................................................................................................76.00 108.60 Tab 100 mg .....................................................................................................54.44 LETROZOLE Tab 2.5 mg – 1% DV Apr-10 to 2012 .............................................................26.55 LEUPRORELIN Inj 3.75 mg ....................................................................................................221.60 Inj 3.75 mg preﬁlled syringe .........................................................................221.60 Inj 7.5 mg ......................................................................................................166.20 Inj 11.25 mg ..................................................................................................591.68 Inj 11.25 mg preﬁlled syringe .......................................................................591.68 Inj 22.5 mg ....................................................................................................443.76 Inj 30 mg .......................................................................................................591.68 Inj 30 mg preﬁlled syringe .........................................................................1,109.40 Inj 45 mg .......................................................................................................832.05 LEVOBUNOLOL Eye drops 0.25% ..............................................................................................7.00 Eye drops 0.5% ................................................................................................7.00 LEVODOPA WITH BENSERAZIDE Tab dispersible 50 mg with benserazide 12.5 mg ...........................................10.00 Cap 50 mg with benserazide 12.5 mg ..............................................................8.00 Cap 100 mg with benserazide 25 mg .............................................................12.50 Cap long-acting 100 mg with benserazide 25 mg ..........................................17.00 Cap 200 mg with benserazide 50 mg .............................................................25.00 LEVODOPA WITH CARBIDOPA Tab 100 mg with carbidopa 25 mg ..................................................................20.00 Tab long-acting 200 mg with carbidopa 50 mg ...............................................47.50 Tab 250 mg with carbidopa 25 mg ..................................................................40.00 LIGNOCAINE Gel 2% – 1% DV Nov-09 to 2012 ....................................................................6.00 Gel 2%, 10 ml urethral syringe .......................................................................43.26 LIGNOCAINE HYDROCHLORIDE Pump spray 10%, 50 ml CFC-free ..................................................................60.00 Inj 0.5%, 5 ml ..................................................................................................44.10 Inj 1%, 2 ml – 1% DV Sep-09 to 2012 ...........................................................57.60 Inj 1%, 5 ml – 1% DV Sep-09 to 2012 ...........................................................35.00 Inj 1%, 20 ml – 1% DV Sep-09 to 2012 .........................................................20.00 Inj 2%, 2 ml – 1% DV Sep-09 to 2012 ...........................................................62.40 Inj 2%, 5 ml – 1% DV Sep-09 to 2012 ...........................................................23.00 Inj 2%, 20 ml – 1% DV Sep-09 to 2012 .........................................................15.00

28 28 30 30 3 30 1 1 1 1 1 1 1 1 1 5 ml 5 ml 100 100 100 100 100 100 100 100 30 ml 10 50 ml 50 50 50 5 50 50 5

Solox Solox AFT-Leﬂunomide Arava AFT-Leﬂunomide Arava Arava Letara Lucrin Depot Lucrin Depot PDS Eligard Lucrin Depot Lucrin Depot PDS Eligard Eligard Lucrin Depot PDS Eligard Betagan Betagan Madopar Dispersible Madopar 62.5 Madopar 125 Madopar HBS Madopar 250 Sinemet Sinemet CR Sinemet Xylocaine Jelly Pﬁzer Xylocaine Xylocaine Xylocaine Xylocaine Xylocaine Xylocaine Xylocaine Xylocaine

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

LIGNOCAINE HYDROCHLORIDE WITH ADRENALINE Inj 1% with 1:100,000 of adrenaline 5 ml ........................................................18.00 Inj 1% with 1:200,000 of adrenaline 20 ml ......................................................44.00 Inj 2% with 1:200,000 of adrenaline 20 ml ......................................................49.50 LIGNOCAINE WITH CHLORHEXIDINE Gel 2% with 0.05% chlorhexidine ...................................................................43.26 LIGNOCAINE WITH PRILOCAINE Crm 2.5% with prilocaine 2.5%, 30 g .............................................................41.00 Patch 2.5% with prilocaine 2.5% ..................................................................104.00 Crm 2.5% with prilocaine 2.5%, 5 g ...............................................................41.00 LISINOPRIL Tab 5 mg – 1% DV Sep-09 to 2012 .................................................................2.06 Tab 10 mg – 1% DV Sep-09 to 2012 ...............................................................2.36 Tab 20 mg – 1% DV Sep-09 to 2012 ...............................................................2.87 LOPINAVIR WITH RITONAVIR Tab 100 mg with ritonavir 25 mg ...................................................................183.75 Tab 200 mg with ritonavir 50 mg ...................................................................735.00 Oral liq 80 mg with ritonavir 20 mg per ml ....................................................735.00 LORATADINE Tab 10 mg – 1% DV Sep-10 to 2013 ...............................................................2.09 Oral liq 1 mg per ml – 1% DV Sep-10 to 2013.................................................3.10 LORAZEPAM Tab 1 mg .........................................................................................................16.42 Tab 2.5 mg ......................................................................................................11.17 MACROGOL 3350 Powder 13.125 g, sachets ..............................................................................18.14 MAGNESIUM SULPHATE Inj 49.3%, 5 ml ................................................................................................26.60 MANNITOL Inf 10% ...........................................................................................................14.21 Inf 15% .............................................................................................................9.84 Inf 20% ...........................................................................................................10.80 MEBENDAZOLE Tab 100 mg – 1% DV May-09 to 2011 ...........................................................17.28 MEBEVERINE HYDROCHLORIDE Tab 135 mg – 1% DV Dec-08 to 2011 ...........................................................18.00 MEDROXYPROGESTERONE ACETATE Tab 2.5 mg – 1% DV Jul-10 to 2013 ................................................................3.09 Tab 5 mg – 1% DV Jul-10 to 2013 .................................................................13.06 Tab 10 mg – 1% DV Jul-10 to 2013 .................................................................6.85 Tab 100 mg – 1% DV Jul-10 to 2013 .............................................................96.50 Tab 200 mg – 1% DV Jul-10 to 2013 .............................................................70.50 Inj 150 mg per ml, 1 ml syringe – 1% DV Jul-10 to 2013 ................................7.15 MEGESTROL ACETATE Tab 160 mg – 1% DV May-10 to 2012 ...........................................................57.92

10 5 5 10 30 g 20 5 30 30 30 60 120 300 ml 100 100 ml 250 100 30 10 1,000 ml 500 ml 500 ml 24 90 30 100 30 100 30 1 30

Xylocaine Xylocaine Xylocaine Pﬁzer EMLA EMLA EMLA Arrow-Lisinopril Arrow-Lisinopril Arrow-Lisinopril Kaletra Kaletra Kaletra Loraclear Hayfever Relief Lorapaed Ativan Ativan Movicol Mayne Baxter Baxter Baxter De-Worm Colofac Provera Provera Provera Provera Provera Depo-Provera Apo-Megestrol

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

MEGLUMINE DIATRIZOATE WITH SODIUM AMIDOTRIZOATE Oral soln 660 mg per ml with sodium amidotrizoate 100 mg per ml ...............21.00 Oral soln 660 mg per ml, with sodium amidotrizoate 100 mg per ml, 100 ml .................................................................................................... 210.00 MEGLUMINE GADOPENTETATE Inj 469 mg per ml (equivalent to 0.5 mmol per ml), 10 ml preﬁlled syringe ........................................................................................................ 92.00 Inj 469 mg per ml (equivalent to 0.5 mmol per ml), 10 ml vial ......................184.00 MEROPENEM Inj 500 mg – 1% DV Sep-08 to 2011 ...........................................................255.00 Inj 1 g – 1% DV Sep-08 to 2011 ..................................................................505.00 MESALAZINE Tab 400 mg .....................................................................................................49.50 Tab EC 500 mg ...............................................................................................49.50 Tab long-acting 500 mg ..................................................................................59.05 Enema 1 g per 100 ml – 1% DV Sep-09 to 2012...........................................45.96 Suppos 500 mg ..............................................................................................25.20 Suppos 1 g .....................................................................................................50.96 MESNA Tab 400 mg ...................................................................................................168.30 Tab 600 mg ...................................................................................................251.35 Inj 100 mg per ml, 4 ml .................................................................................109.63 Inj 100 mg per ml, 10 ml ...............................................................................251.73 METFORMIN HYDROCHLORIDE Tab immediate-release 500 mg – 1% DV Jan-10 to 2012 ...............................8.09 Tab immediate-release 850 mg – 1% DV Jan-10 to 2012 ...............................6.67 METHADONE HYDROCHLORIDE Tab 5 mg ...........................................................................................................2.10 Oral liq 2 mg per ml – 1% DV Jul-09 to 2012 ..................................................5.95 Oral liq 5 mg per ml – 1% DV Jul-09 to 2012 ..................................................5.55 Oral liq 10 mg per ml – 1% DV Jul-09 to 2012 ................................................8.95 Inj 10 mg per ml, 1 ml .....................................................................................61.00 METHOTREXATE Tab 2.5 mg – 1% DV Sep-09 to 2012 ..............................................................5.22 Tab 10 mg – 1% DV Sep-09 to 2012 .............................................................40.93 Inj 100 mg per ml, 10 ml – 1% DV Nov-08 to 2011........................................27.50 Inj 100 mg per ml, 50 ml – 1% DV Nov-08 to 2011......................................135.00 METHYL HYDROXYBENZOATE Powder ............................................................................................................10.00 METHYLCELLULOSE Powder ............................................................................................................14.00 METHYLDOPA Tab 125 mg – 1% DV Dec-08 to 2011 ...........................................................12.00 Tab 250 mg – 1% DV Dec-08 to 2011 ...........................................................13.10 Tab 500 mg – 1% DV Dec-08 to 2011 ...........................................................20.85

100 ml 10

Gastrograﬁn Gastrograﬁn

5 10 10 10 100 100 100 7 20 28 50 50 15 15 500 250 10 200 ml 200 ml 200 ml 10 30 50 1 1 25 g 100 g 100 100 100

Magnevist Magnevist Merrem Merrem Asacol Asamax Pentasa Pentasa Asacol Pentasa Uromitexan Uromitexan Uromitexan Uromitexan Apotex Apotex Methatabs Biodone Biodone Forte Biodone Extra Forte AFT Methoblastin Methoblastin Methotrexate Ebewe Methotrexate Ebewe ABM ABM Prodopa Prodopa Prodopa

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

METHYLPHENIDATE HYDROCHLORIDE Tab 5 mg ...........................................................................................................3.20 Tab 10 mg .........................................................................................................3.00 Tab immediate-release 10 mg ..........................................................................3.00 Tab 20 mg .........................................................................................................7.85 Tab immediate-release 20 mg ........................................................................50.00 Tab long-acting 20 mg ....................................................................................10.95 METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE Tab extended-release 18 mg ..........................................................................58.96 Tab extended-release 27 mg ..........................................................................65.44 Tab extended-release 36 mg ..........................................................................71.93 Tab extended-release 54 mg ..........................................................................86.24 Cap modiﬁed-release 10 mg ..........................................................................19.50 Cap modiﬁed-release 20 mg ..........................................................................25.50 Cap modiﬁed-release 30 mg ..........................................................................31.90 Cap modiﬁed-release 40 mg ..........................................................................38.25 METHYLPREDNISOLONE Tab 4 mg – 1% DV Sep-09 to 2012 ...............................................................48.57 Tab 100 mg – 1% DV Sep-09 to 2012 .........................................................166.52 METHYLPREDNISOLONE ACEPONATE Crm 0.1% .........................................................................................................4.95 Oint 0.1% ..........................................................................................................4.95 METHYLPREDNISOLONE ACETATE Inj 40 mg per ml, 1 ml – 1% DV Sep-08 to 2011..............................................6.03 METHYLPREDNISOLONE ACETATE WITH LIGNOCAINE Inj 40 mg per ml with lignocaine 10 mg per ml, 1 ml – 1% DV Sep-08 to 2011 ....................................................................................................... 6.03 METHYLPREDNISOLONE SODIUM SUCCINATE Inj 40 mg per ml, 1 ml – 1% DV Dec-09 to 2012..........................................151.40 Inj 62.5 mg per ml, 2 ml – 1% DV Dec-09 to 2012.......................................412.59 Inj 500 mg – 1% DV Dec-09 to 2012 .............................................................20.80 Inj 1 g – 1% DV Dec-09 to 2012 ....................................................................42.57 METOCLOPRAMIDE HYDROCHLORIDE Tab 10 mg .........................................................................................................5.15 Inj 5 mg per ml, 2 ml – 1% DV Sep-08 to 2011................................................4.50 METOPROLOL SUCCINATE Tab long-acting 23.75 mg .................................................................................2.18 Tab long-acting 47.5 mg ...................................................................................2.74 Tab long-acting 95 mg ......................................................................................4.71 Tab long-acting 190 mg ....................................................................................8.51 METOPROLOL TARTRATE Tab long-acting 200 mg ..................................................................................18.40

30 30 30 30 100 30 30 30 30 30 30 30 30 30 100 20 15 g 15 g 1

Rubifen Rubifen Ritalin Rubifen Ritalin SR Rubifen SR Concerta Concerta Concerta Concerta Ritalin LA Ritalin LA Ritalin LA Ritalin LA Medrol Medrol Advantan Advantan Depo-Medrol

Depo-Medrol with Lidocaine Solu-Medrol Solu-Medrol Solu-Medrol Solu-Medrol Metamide Pﬁzer Betaloc CR Metoprolol - AFT CR Betaloc CR Metoprolol - AFT CR Betaloc CR Metoprolol - AFT CR Betaloc CR Metoprolol - AFT CR Slow-Lopresor

25 25 1 1 100 10 30 30 30 30

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

METRONIDAZOLE Tab 200 mg .......................................................................................................9.50 Tab 400 mg .....................................................................................................17.50 Oral liq 200 mg per 5 ml .................................................................................25.00 Inj 500 mg, 100 ml – 1% DV Sep-08 to 2011.................................................12.30 Suppos 500 mg ..............................................................................................24.48 MICONAZOLE NITRATE Crm 2% – 1% DV Sep-08 to 2011 ...................................................................0.42 Powder 2% .......................................................................................................8.50 MIDAZOLAM Inj 1 mg per ml, 5 ml .......................................................................................10.75 Inj 5 mg per ml, 3 ml .......................................................................................11.90 MIRTAZAPINE Tab 30 mg .......................................................................................................22.00 Tab 45 mg .......................................................................................................35.00 MITOZANTRONE Inj 2 mg per ml, 5 ml .....................................................................................110.00 Inj 2 mg per ml, 10 ml – 1% DV Sep-10 to 2013..........................................100.00 Inj 2 mg per ml, 12.5 ml ................................................................................407.50 MIVACURIUM Inj 10 mg per 5 ml ...........................................................................................33.92 Inj 20 mg per 10 ml .........................................................................................67.17 MOCLOBEMIDE Tab 150 mg – 1% DV May-10 to 2012 ...........................................................69.23 Tab 300 mg – 1% DV May-10 to 2012 ...........................................................31.33 MOMETASONE FUROATE Crm 0.1% – 1% DV Jan-10 to 2012.................................................................2.38 4.55 Oint 0.1% – 1% DV Jan-10 to 2012.................................................................2.38 4.55 Lotn 0.1% .........................................................................................................4.80 MORPHINE HYDROCHLORIDE Oral liq 1 mg per ml – 1% DV Dec-09 to 2012.................................................8.84 Oral liq 2 mg per ml – 1% DV Dec-09 to 2012...............................................11.62 Oral liq 5 mg per ml – 1% DV Dec-09 to 2012...............................................14.65 Oral liq 10 mg per ml – 1% DV Dec-09 to 2012.............................................21.55

100 100 100 ml 5 10 15 g 30 g 10 5 30 30 1 1 1 5 5 500 100 15 g 45 g 15 g 45 g 30 ml 200 ml 200 ml 200 ml 200 ml

Trichozole Trichozole Flagyl-S AFT Flagyl Multichem Daktarin Hypnovel Hypnovel Avanza Avanza Mitozantrone Ebewe Mitozantrone Ebewe Onkotrone Mivacron Mivacron Apo-Moclobemide Apo-Moclobemide m-Mometasone m-Mometasone m-Mometasone m-Mometasone Elocon RA-Morph RA-Morph RA-Morph RA-Morph

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

MORPHINE SULPHATE Tab immediate-release 10 mg – 1% DV Dec-09 to 2012.................................2.80 Tab immediate-release 20 mg – 1% DV Dec-09 to 2012.................................5.52 Cap long-acting 10 mg .....................................................................................1.80 Cap long-acting 30 mg .....................................................................................2.64 Cap long-acting 60 mg .....................................................................................7.20 Cap long-acting 100 mg ...................................................................................7.85 Cap long-acting 200 mg .................................................................................17.00 Inj 1 mg per ml, 10 ml preﬁlled syringe – 1% DV Jan-09 to 2011..................34.50 Inj 1 mg per ml, 30 ml preﬁlled syringe – 1% DV Jan-09 to 2011..................75.00 Inj 1 mg per ml, 50 ml preﬁlled syringe – 1% DV Jan-09 to 2011..................59.50 Inj 2 mg per ml, 30 ml preﬁlled syringe – 1% DV Jan-09 to 2011..................95.00 Inj 5 mg per ml, 1 ml .........................................................................................5.17 Inj 10 mg per ml, 1 ml – 1% DV Aug-08 to 2011 .............................................4.50 Inj 15 mg per ml, 1 ml .......................................................................................4.70 Inj 30 mg per ml, 1 ml – 1% DV Aug-08 to 2011 .............................................4.98 MORPHINE TARTRATE Inj 80 mg per ml, 1.5 ml ..................................................................................20.20 Inj 80 mg per ml, 5 ml .....................................................................................67.37 MUCILAGINOUS LAXATIVES Dry ....................................................................................................................5.72 MYCOPHENOLATE MOFETIL Tab 500 mg ...................................................................................................206.66 Cap 250 mg ..................................................................................................206.66 Pwd for oral liq 1 g per 5 ml ..........................................................................285.00 Inj 500 mg vial ..............................................................................................133.33 NADOLOL Tab 40 mg .......................................................................................................14.97 Tab 80 mg .......................................................................................................22.19 NALOXONE HYDROCHLORIDE Inj 400 µg per ml, 1 ml ....................................................................................33.00 NALTREXONE HYDROCHLORIDE Tab 50 mg .....................................................................................................180.00 NAPROXEN Tab 250 mg – 1% DV Dec-09 to 2012 ...........................................................23.70 Tab 500 mg – 1% DV Dec-09 to 2012 ...........................................................24.88 NAPROXEN SODIUM Tab 275 mg .......................................................................................................6.00 NEOSTIGMINE METHYLSULPHATE Inj 2.5 mg per ml, 1 ml ....................................................................................20.30 NEVIRAPINE Tab 200 mg – 1% DV Oct-09 to 2012 ..........................................................319.80 Oral suspension 10 mg per ml – 1% DV Oct-09 to 2012.............................134.55

10 10 10 10 10 10 10 10 10 10 10 5 5 5 5 5 5 325 g 50 100 165 ml 4 100 100 5 30 500 250 120 50 60 240 ml

Sevredol Sevredol m-Eslon m-Eslon m-Eslon m-Eslon m-Eslon Biomed Biomed Biomed Biomed Mayne Mayne Mayne Mayne Mayne Mayne Konsyl-D CellCept CellCept CellCept CellCept Apo-Nadolol Apo-Nadolol Mayne ReVia Noﬂam 250 Noﬂam 500 Sonaﬂam AstraZeneca Viramune Viramune Suspension

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

NICOTINE Note: Nicotrol and Nicorette patches are DV Pharmacueticals. Patch 7 mg – 10% DV Apr-08 to 31 Dec 2010 ..............................................10.53 Patch 14 mg – 10% DV Apr-08 to 31 Dec 2010 ............................................11.63 Patch 21 mg – 10% DV Apr-08 to 31 Dec 2010 ............................................12.32 Lozenge 1 mg – 10% DV Apr-08 to 31 Dec 2010 .........................................11.08 Lozenge 2 mg – 10% DV Apr-08 to 31 Dec 2010 .........................................11.08 Gum 2 mg (fruit) – 10% DV Apr-08 to 31 Dec 2010......................................14.97 Gum 2 mg (mint) – 10% DV Apr-08 to 31 Dec 2010 .....................................14.97 Gum 4 mg (fruit) – 10% DV Apr-08 to 31 Dec 2010......................................20.02 Gum 4 mg (mint) – 10% DV Apr-08 to 31 Dec 2010 .....................................20.02 NIFEDIPINE Tab long-acting 20 mg ......................................................................................7.30 Tab long-acting 30 mg ....................................................................................10.70 Tab long-acting 60 mg ....................................................................................15.35 NORADRENALINE ACID TARTRATE Inj 1:1,000 per 2 ml .........................................................................................42.00 NORETHISTERONE Tab 5 mg – 1% DV Sep-08 to 2011 ...............................................................25.00 NORFLOXACIN Tab 400 mg .....................................................................................................22.50 NORTRIPTYLINE HYDROCHLORIDE Tab 10 mg – 1% DV Dec-08 to 2011 ...............................................................5.94 Tab 25 mg – 1% DV Dec-08 to 2011 .............................................................20.06 NYSTATIN Tab 500,000 u ...................................................................................................9.60 Cap 500,000 u ................................................................................................11.64 Oral liq 100,000 u per ml – 1% DV Dec-08 to 2011.........................................3.19 OCTREOTIDE Inj LAR, 10 mg preﬁlled syringe ................................................................1,772.50 Inj LAR, 20 mg preﬁlled syringe ................................................................2,358.75 Inj LAR, 30 mg preﬁlled syringe ................................................................2,951.25 Inj 50 µg per ml, 1 ml ......................................................................................25.65 39.15 Inj 100 µg per ml, 1 ml ....................................................................................48.50 72.90 Inj 500 µg per ml, 1 ml ..................................................................................175.00 359.10 OIL IN WATER EMULSION Crm ...................................................................................................................2.80 OLANZAPINE Tab 2.5 mg ......................................................................................................51.07 Tab 5 mg .......................................................................................................101.21 Tab 10 mg .....................................................................................................204.49 Wafer 5 mg ...................................................................................................102.19 Wafer 10 mg .................................................................................................204.37

7 7 7 36 36 96 96 96 96 100 30 30

Habitrol Habitrol Habitrol Habitrol Habitrol Habitrol Habitrol Habitrol Habitrol Nyefax Retard Adeﬁn XL Arrow-Nifedipine XR Adeﬁn XL Arrow-Nifedipine XR Levophed Primolut N Arrow-Norﬂoxacin Norpress Norpress Nilstat Nilstat Nilstat Sandostatin LAR Sandostatin LAR Sandostatin LAR Hospira Sandostatin Hospira Sandostatin Hospira Sandostatin healthE Fatty Cream Zyprexa Zyprexa Zyprexa Zyprexa Zydis Zyprexa Zydis

6 100 100 100 250 50 50 24 ml 1 1 1 5 5 5

500 g 28 28 28 28 28

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

OMEPRAZOLE Cap 10 mg – 1% DV May-09 to 2011 ..............................................................2.14 Cap 20 mg – 1% DV May-09 to 2011 ..............................................................3.05 Cap 40 mg – 1% DV May-09 to 2011 ..............................................................3.59 Inf 40 mg – 1% DV May-09 to 2011...............................................................38.65 Inj 40 mg – 1% DV May-09 to 2011 ...............................................................38.20 ONDANSETRON HYDROCHLORIDE Tab 4 mg .........................................................................................................17.18 Tab disp 4 mg .................................................................................................17.18 Tab 8 mg .........................................................................................................33.89 Tab disp 8 mg .................................................................................................20.43 Inj 2 mg per ml, 2 ml – 1% DV Nov-09 to 2012..............................................14.40 Inj 2 mg per ml, 4 ml – 1% DV Nov-09 to 2012..............................................23.20 OXALIPLATIN Inj 50 mg – 1% DV Jan-10 to 2012................................................................65.00 Inj 100 mg – 1% DV Jan-10 to 2012............................................................130.00 OXYBUTYNIN Tab 5 mg .........................................................................................................44.79 Oral liq 5 mg per 5 ml .....................................................................................50.40 OXYCODONE HYDROCHLORIDE Tab controlled-release 5 mg .............................................................................7.51 Tab controlled-release 10 mg .........................................................................11.14 Tab controlled-release 20 mg .........................................................................18.93 Tab controlled-release 40 mg .........................................................................33.29 Tab controlled-release 80 mg .........................................................................58.03 Cap 5 mg ..........................................................................................................2.83 Cap 10 mg ........................................................................................................5.58 Cap 20 mg ........................................................................................................9.77 Oral liq 5 mg per 5 ml .....................................................................................11.20 Inj 10 mg per ml, 1 ml .....................................................................................14.40 Inj 10 mg per ml, 2 ml .....................................................................................28.80 OXYTOCIN Inj 5 iu per ml, 1 ml – 1% DV Dec-09 to 2012..................................................5.94 Inj 10 iu per ml, 1 ml – 1% DV Dec-09 to 2012................................................7.48 OXYTOCIN WITH ERGOMETRINE MALEATE Inj 5 iu with ergometrine maleate 500 µg per ml, 1 ml – 1% DV Dec-09 to 2012 ..................................................................................................... 10.12 PACLITAXEL Inj 30 mg – 1% DV Oct-08 to 2011 ..............................................................189.75 Inj 100 mg – 1% DV Oct-08 to 2011 ............................................................125.35 Inj 150 mg – 1% DV Oct-08 to 2011 ............................................................188.03 Inj 300 mg – 1% DV Oct-08 to 2011 ............................................................376.05 Inj 600 mg – 1% DV Oct-08 to 2011 ............................................................724.50 PAMIDRONATE DISODIUM Inj 3 mg per ml, 5 ml – 1% DV Sep-08 to 2011..............................................18.75 Inj 3 mg per ml, 10 ml – 1% DV Sep-08 to 2011............................................37.50 Inj 6 mg per ml, 10 ml – 1% DV Sep-08 to 2011............................................75.00 Inj 9 mg per ml, 10 ml – 1% DV Sep-08 to 2011..........................................112.50

30 30 30 5 5 10 10 20 10 5 5 1 1 500 473 ml 20 20 20 20 20 20 20 20 250 ml 5 5 5 5

Dr Reddy’s Omeprazole Dr Reddy’s Omeprazole Dr Reddy’s Omeprazole Dr Reddy’s Omeprazole Dr Reddy’s Omeprazole Zofran Zofran Zydis Zofran Zofran Zydis Zofran Zofran Oxaliplatin Ebewe Oxaliplatin Ebewe Apo-Oxybutynin Apo-Oxybutynin OxyContin OxyContin OxyContin OxyContin OxyContin OxyNorm OxyNorm OxyNorm OxyNorm OxyNorm OxyNorm Syntocinon Syntocinon

5 5 1 1 1 1 1 1 1 1

Syntometrine Paclitaxel Ebewe Paclitaxel Ebewe Paclitaxel Ebewe Paclitaxel Ebewe Paclitaxel Ebewe Pamisol Pamisol Pamisol Pamisol

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

PANCURONIUM BROMIDE Inj 2 mg per ml, 2 ml – 1% DV Dec-09 to 2012............................................128.00 PANTOPRAZOLE Tab 20 mg – 1% DV Sep-10 to 2013 ...............................................................1.23 Tab 40 mg – 1% DV Sep-10 to 2013 ...............................................................1.54 Inj 40 mg ...........................................................................................................8.75 PAPAVERINE HYDROCHLORIDE Inj 12 mg per ml, 10 ml ...................................................................................73.12 PARACETAMOL Oral liq 120 mg per 5 ml – 20% DV Sep-08 to 2011........................................6.80 Oral liq 250 mg per 5 ml – 20% DV Sep-08 to 2011........................................7.00 Suppos 25 mg ................................................................................................56.35 Suppos 50 mg ................................................................................................56.35 Suppos 125 mg ................................................................................................7.49 Suppos 250 mg ..............................................................................................14.40 Suppos 500 mg ..............................................................................................20.50 PARAFFIN Yellow soft – 1% DV Oct-09 to 2012 ................................................................1.04 PAROXETINE HYDROCHLORIDE Tab 20 mg – 1% DV Sep-10 to 2013 ...............................................................2.38 PEGFILGRASTIM Inj 6 mg per 0.6 ml preﬁlled syringe ..........................................................1,395.00 PENICILLAMINE Tab 125 mg .....................................................................................................61.93 Tab 250 mg .....................................................................................................98.98 PERGOLIDE Tab 0.25 mg – 1% DV Sep-08 to 2011 ..........................................................48.00 Tab 1 mg – 1% DV Sep-08 to 2011 .............................................................170.00 PERHEXILINE MALEATE Tab 100 mg .....................................................................................................62.90 PERMETHRIN Lotn 5% – 1% DV Feb-10 to 2011 ...................................................................3.65 PETHIDINE HYDROCHLORIDE Tab 50 mg .........................................................................................................3.20 Tab 100 mg .......................................................................................................4.20 Inj 50 mg per ml, 1 ml .......................................................................................5.20 Inj 50 mg per ml, 2 ml .......................................................................................5.50 PHENOBARBITONE Tab 15 mg .......................................................................................................25.00 Tab 30 mg .......................................................................................................26.00

50 28 28 1 5 1,000 ml 1,000 ml 20 20 20 20 50 10 g 30 1 100 100 100 100 100 30 ml 10 10 5 5 500 500

AstraZeneca Dr Reddy’s Pantoprazole Dr Reddy’s Pantoprazole Pantocid Mayne Paracare Junior Paracare Double Strength Biomed Biomed Panadol Panadol Paracare API Loxamine Neulastim D-Penamine D-Penamine Permax Permax Pexsig A-Scabies PSM PSM Mayne Mayne PSM PSM

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

PHENOXYMETHYLPENICILLIN (PENICILLIN V) Cap potassium salt 250 mg ..............................................................................4.29 Cap potassium salt 500 mg ..............................................................................8.15 Grans for oral liq 125 mg per 5 ml – 1% DV Sep-10 to 2013...........................1.68 Grans for oral liq 250 mg per 5 ml – 1% DV Sep-10 to 2013...........................1.78 PHENTOLAMINE MESYLATE Inj 10 mg per ml, 1 ml .....................................................................................27.50 PHENYLEPHRINE HYDROCHLORIDE Inj 1%, 1 ml ...................................................................................................115.50 PHYTOMENADIONE Inj 2 mg per 0.2 ml ............................................................................................8.00 Inj 10 mg per ml, 1 ml .......................................................................................9.21 PINDOLOL Tab 5 mg – 1% DV Mar-10 to 2012..................................................................5.40 Tab 10 mg – 1% DV Mar-10 to 2012................................................................9.19 Tab 15 mg – 1% DV Mar-10 to 2012..............................................................13.80 PIOGLITAZONE Tab 15 mg – 1% DV Dec-09 to 2012 ...............................................................2.61 Tab 30 mg – 1% DV Dec-09 to 2012 ...............................................................5.23 Tab 45 mg – 1% DV Dec-09 to 2012 ...............................................................7.80 PIPERACILLIN SODIUM WITH TAZOBACTAM SODIUM Inj 4 g with tazobactam sodium 500 mg – 1% DV Jun-10 to 2013 ................12.00 PIROXICAM Tab dispersible 10 mg .......................................................................................3.25 Tab dispersible 20 mg .......................................................................................5.50 PIZOTIFEN Tab 500 µg – 1% DV Apr-10 to 2012 .............................................................21.10 PODOPHYLLOTOXIN Soln 0.5% .......................................................................................................33.60 POLOXAMER Oral drops 10% – 1% DV Dec-08 to 2011 .......................................................3.78 POLYETHYLENE GLYCOL WITH SODIUM SULPHATE Powder, sachets .............................................................................................16.46 POLYVINYL ALCOHOL Eye drops 1.4% ................................................................................................2.95 3.62 Eye drops 3% ...................................................................................................3.80 3.88 PORACTANT ALFA Inj 80 mg per ml, 1.5 ml ................................................................................425.00 Inj 80 mg per ml, 3 ml ...................................................................................695.00 POTASSIUM CHLORIDE Tab long-acting 600 mg – 1% DV Dec-09 to 2012...........................................7.00 POTASSIUM CHLORIDE WITH GLUCOSE Inf 20 mmol/L with 5% glucose .........................................................................7.36

50 50 100 ml 100 ml 5 25 5 5 100 100 100 28 28 28 1 50 100 100 3.5 ml 30 ml 4 15 ml 15 ml

Cilicaine VK Cilicaine VK AFT AFT Regitine Neosynephrine HCL Konakion MM Konakion MM Apo-Pindolol Apo-Pindolol Apo-Pindolol Pizaccord Pizaccord Pizaccord Tazocin EF Piram-D Piram-D Sandomigran Condyline Coloxyl Klean Prep Vistil Liquiﬁlm Tears Vistil Forte Liquiﬁlm Forte Curosurf Curosurf Span-K Baxter

1 1 200 1,000 ml

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

POTASSIUM CHLORIDE WITH GLUCOSE AND SODIUM CHLORIDE Inf 20 mmol/L with 2.5% glucose and 0.45% sodium chloride .........................4.95 Inf 20 mmol/L with 4% glucose and 0.18% sodium chloride ............................3.45 4.30 Inf 30 mmol/L with 4% glucose and 0.18% sodium chloride ............................3.62 POTASSIUM CHLORIDE WITH SODIUM CHLORIDE Inf 20 mmol/L with 0.9% sodium chloride .........................................................3.85 Inf 30 mmol/L with 0.9% sodium chloride .........................................................2.59 Inf 40 mmol/L with 0.9% sodium chloride .........................................................6.62 POVIDONE IODINE Oint 10% ...........................................................................................................3.27 Alcohol skin preparation 10% with 30% alcohol .............................................10.00 Antiseptic soln 10% ..........................................................................................6.20 2.95 6.20 PRAZOSIN HYDROCHLORIDE Tab 1 mg ...........................................................................................................5.53 Tab 2 mg ...........................................................................................................7.00 Tab 5 mg .........................................................................................................11.70 PREDNISOLONE SODIUM PHOSPHATE Oral liq 5 mg per ml – 1% DV Sep-09 to 2012.................................................9.95 PREDNISONE Tab 1 mg – 1% DV Dec-08 to 2011 ...............................................................10.68 Tab 2.5 mg – 1% DV Dec-08 to 2011 ............................................................12.09 Tab 5 mg – 1% DV Dec-08 to 2011 ...............................................................11.09 Tab 20 mg – 1% DV Dec-08 to 2011 .............................................................29.03 PREGNANCY TEST – HCG URINE Cassette – 1% DV May-10 to 2012................................................................22.80

500 ml 500 ml 1,000 ml 1,000 ml 1,000 ml 1,000 ml 1,000 ml 25 g 500 ml 500 ml 100 ml 500 ml 100 100 100 30 ml 500 500 500 500 40 test

Baxter Baxter Baxter Baxter Baxter Baxter Baxter Betadine Betadine Skin Prep Betadine Riodine Riodine Apo-Prazo Apo-Prazo Apo-Prazo Redipred Apo-Prednisone Apo-Prednisone Apo-Prednisone Apo-Prednisone Innovacon hCG One Step Pregnancy Test Citanest Citanest Cilicaine Natulan Antinaus Allersoothe Allersoothe Promethazine Winthrop Elixir Mayne

PRILOCAINE HYDROCHLORIDE Inj 0.5%, 50 ml ................................................................................................80.00 Inj 2%, 5 ml .....................................................................................................30.90 PROCAINE PENICILLIN Inj 1.5 mega u – 1% DV Dec-08 to 2011 .......................................................50.86 PROCARBAZINE HYDROCHLORIDE Cap 50 mg ....................................................................................................225.00 PROCHLORPERAZINE Tab 5 mg .........................................................................................................16.85 PROMETHAZINE HYDROCHLORIDE Tab 10 mg – 1% DV Jan-09 to 2011................................................................2.72 Tab 25 mg – 1% DV Jan-09 to 2011................................................................4.44 Oral liq 5 mg per 5 ml – 1% DV Apr-10 to 2012 ..............................................3.10 Inj 25 mg per ml, 2 ml .....................................................................................11.00

5 10 5 50 500 50 50 100 ml 5

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

PROPOFOL Inj 1%, 20 ml ...................................................................................................10.21 Inj 1%, 50 ml .....................................................................................................5.56 Inj 1%, 50 ml preﬁlled syringe ........................................................................14.19 Inj 1%, 100 ml ...................................................................................................9.28 Inj 2%, 50 ml preﬁlled syringe ........................................................................15.43 PROPRANOLOL Cap long-acting 160 mg .................................................................................16.90 PROPYLENE GLYCOL Liq ...................................................................................................................12.00 QUETIAPINE Tab 25 mg .......................................................................................................46.20 16.78 Tab 100 mg .....................................................................................................92.40 32.59 Tab 200 mg ...................................................................................................158.76 56.70 Tab 300 mg ...................................................................................................267.12 95.40 QUINAPRIL Tab 5 mg ...........................................................................................................1.60 Tab 10 mg .........................................................................................................1.75 Tab 20 mg .........................................................................................................2.35 QUINAPRIL WITH HYDROCHLOROTHIAZIDE Tab 10 mg with hydrochlorothiazide 12.5 mg ...................................................3.37 Tab 20 mg with hydrochlorothiazide 12.5 mg ...................................................4.57 QUININE SULPHATE Tab 200 mg .....................................................................................................17.20 Tab 300 mg – 1% DV Dec-09 to 2012 ...........................................................54.06 RALTEGRAVIR POTASSIUM Tab 400 mg ................................................................................................1,350.00 RANITIDINE HYDROCHLORIDE Tab 150 mg .......................................................................................................7.99 Tab 300 mg .....................................................................................................10.94 Oral liq 150 mg per 10 ml .................................................................................7.95 Inj 25 mg per ml, 2 ml .......................................................................................8.75

5 1 1 1 1 100 500 ml 60 90 60 90 60 90 60 90 30 30 30 30 30 250 500 60 250 250 300 ml 5

Diprivan Provive 1% Diprivan Provive 1% Diprivan Diprivan Provive 1% Diprivan Cardinol LA ABM Seroquel Quetapel Seroquel Quetapel Seroquel Quetapel Seroquel Quetapel Accupril Accupril Accupril Accuretic 10 Accuretic 20 Q 200 Q 300 Isentress Arrow-Ranitidine Arrow-Ranitidine Peptisoothe Zantac

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

RECOMBINANT FACTOR VIII Inj 250 IU ......................................................................................................225.00 237.50 250.00 Inj 500 IU ......................................................................................................450.00 475.00 500.00 Inj 1,000 IU ...................................................................................................900.00 950.00 1,000.00 Inj 1,500 IU ................................................................................................1,425.00 Inj 2,000 IU ................................................................................................1,800.00 2,000.00 REMIFENTANIL HYDROCHLORIDE Inj 1 mg vial ....................................................................................................50.75 Inj 2 mg vial ..................................................................................................101.50 RETEPLASE Inj 10 iu vial ................................................................................................1,850.00 RIFABUTIN Cap 150 mg – 1% DV Sep-10 to 2013.........................................................213.19 RISPERIDONE Orally-disintergrating tab 0.5 mg ....................................................................21.42 Tab 0.5 mg ........................................................................................................1.17 3.51 5.20 3.51 Orally-disintergrating tab 1 mg .......................................................................42.84 Tab 1 mg ...........................................................................................................6.00

1 1

Xyntha Advate Kogenate FS Xyntha Advate Kogenate FS Xyntha Advate Kogenate FS Advate Xyntha Kogenate FS Ultiva Ultiva Rapilysin Mycobutin Risperdal Quicklet Ridal Ridal Risperdal Apo-Risperidone Risperdal Quicklet Apo-Risperidone Dr Reddy’s Risperidone Ridal Risperdal Risperdal Quicklet Apo-Risperidone Dr Reddy’s Risperidone Ridal Risperdal Apo-Risperidone Dr Reddy’s Risperidone Ridal Risperdal Apo-Risperidone Dr Reddy’s Risperidone Ridal Risperdal Apo-Risperidone Risperon Risperdal Risperdal Consta Risperdal Consta Risperdal Consta

5 5 2 30 28 20 60 20 60 28 60

30.77 Orally-disingergrating tab 2 mg ......................................................................85.71 Tab 2 mg .........................................................................................................11.00

28 60

61.53 Tab 3 mg .........................................................................................................15.00

92.32 Tab 4 mg .........................................................................................................20.00

123.05 Oral liq 1 mg per ml ........................................................................................18.35 45.92 Microspheres for inj 25 mg ...........................................................................175.00 Microspheres for inj 37.5 mg ........................................................................230.00 Microspheres for inj 50 mg ...........................................................................280.00

30 ml

1 1 1

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

RITONAVIR Cap 100 mg ..................................................................................................121.27 RITUXIMAB Inj 100 mg per 10 ml vial ...........................................................................1,195.00 Inj 500 mg per 50 ml vial ...........................................................................2,987.00 RIZATRIPTAN BENZOATE Wafer 10 mg ...................................................................................................25.32 ROPINIROLE HYDROCHLORIDE Tab 0.25 mg – 1% DV Sep-10 to 2013 ............................................................6.20 Tab 1 mg – 1% DV Sep-10 to 2013 ...............................................................15.95 Tab 2 mg – 1% DV Sep-10 to 2013 ...............................................................24.95 Tab 5 mg – 1% DV Sep-10 to 2013 ...............................................................38.00 ROPIVACAINE HYDROCHLORIDE Inj 2 mg per ml, 10 ml .....................................................................................19.75 Inj 2 mg per ml, 20 ml .....................................................................................33.20 Inf 2 mg per ml, 100 ml .................................................................................104.00 Inf 2 mg per ml, 200 ml .................................................................................184.00 Inj 7.5 mg per ml, 10 ml ..................................................................................35.00 Inj 7.5 mg per ml, 20 ml ..................................................................................62.45 Inj 10 mg per ml, 10 ml ...................................................................................41.10 Inj 10 mg per ml, 20 ml ...................................................................................74.20 ROPIVACAINE HYDROCHLORIDE WITH FENTANYL Inf 2 mg per ml with 2 µg of fentanyl per ml, 100 ml .....................................145.20 Inf 2 mg per ml with 2 µg of fentanyl per ml, 200 ml .....................................262.60 ROXITHROMYCIN Tab 150 mg – 1% DV Sep-09 to 2012 .............................................................8.98 Tab 300 mg – 1% DV Sep-09 to 2012 ...........................................................16.48 SALBUTAMOL Oral liq 2 mg per 5 ml – 1% DV Sep-10 to 2013..............................................1.99 Aerosol inhaler 100 µg per dose, CFC-free ......................................................4.00 Inhaler 100 µg dose, 200 doses .......................................................................6.00 Nebuliser soln, 1 mg per ml, 2.5 ml – 1% DV Sep-09 to 2012.........................3.52 Nebuliser soln, 2 mg per ml, 2.5 ml – 1% DV Sep-09 to 2012.........................3.70 SALBUTAMOL WITH IPRATROPIUM BROMIDE Aerosol inhaler, 100 µg with ipratropium bromide, 20 µg per dose ................13.50 Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per vial, 2.5 ml – 1% DV Sep-09 to 2012 ........................................................................... 4.29 SALICYLIC ACID Powder ............................................................................................................15.00 SALMETEROL Aerosol inhaler CFC-free, 25 µg per dose ......................................................26.46 Powder for inhalation, breath activated 50 µg per dose ..................................26.46 SEVOFLURANE Liq 250 ml bottle – 1% DV Nov-09 to 2012...............................................1,230.00 SILVER SULPHADIAZINE Crm 1% ..........................................................................................................12.30

84 2 1 3 84 84 84 84 5 5 5 5 5 5 5 5 5 5 50 50 150 ml 200 dose 200 dose 20 20 200 dose 20 500 g 120 dose 60 dose 6 50 g

Norvir Mabthera Mabthera Maxalt Melt Ropin Ropin Ropin Ropin Naropin Naropin Naropin Naropin Naropin Naropin Naropin Naropin Naropin Naropin Arrow-Roxithromycin Arrow-Roxithromycin Salapin Salamol Ventolin Asthalin Asthalin Combivent Duolin ABM Serevent Serevent Accuhaler Baxter Flamazine

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

SIMVASTATIN Tab 10 mg Tab 20 mg Tab 40 mg Tab 80 mg

– 1% DV May-09 to 2011 ...............................................................2.05 – 1% DV May-09 to 2011 ...............................................................3.00 – 1% DV May-09 to 2011 ...............................................................5.35 – 1% DV May-09 to 2011 .............................................................11.65

90 90 90 90 100 100 60 ml 1

Arrow-Simva Arrow-Simva Arrow-Simva Arrow-Simva Rapamune Rapamune Rapamune Fleet Phosphate Enema

SIROLIMUS Tab 1 mg .......................................................................................................813.00 Tab 2 mg ....................................................................................................1,626.00 Oral liq 1 mg per ml ......................................................................................487.80 SODIUM ACID PHOSPHATE Enema 16% with sodium phosphate 8% ..........................................................2.50 SODIUM ALGINATE Oral liq 500 mg with sodium bicarbonate 267 mg and calcium carbonate 160 mg per 10 ml ................................................................................. 4.95 SODIUM BICARBONATE Powder BP ........................................................................................................9.80 11.99 Inf 5% .............................................................................................................19.06 Inj 8.4%, 50 ml ................................................................................................19.95 Inj 8.4%, 100 ml ..............................................................................................20.50 SODIUM CHLORIDE Soln 0.9% for irrigation .....................................................................................2.49 2.88 2.96 10.00 12.67 Inf 0.45% ..........................................................................................................5.50 Inf 0.9% ............................................................................................................3.01 2.28 3.60 1.77 1.80 Inf 3% ...............................................................................................................5.69 Soln 0.9% for irrigation, 30 ml – 1% DV Nov-08 to 2011 ...............................20.00 Inj 0.9%, 5 ml ....................................................................................................8.77 Inj 0.9%, 10 ml ..................................................................................................8.77 Inj 0.9%, 20 ml ..................................................................................................7.86 Inj 23.4%, 20 ml ..............................................................................................26.50 SODIUM CHLORIDE WITH GLUCOSE Inf 0.18% with glucose 4% ...............................................................................1.77 1.80 Inf 0.45% with glucose 2.5% ............................................................................4.95 Inf 0.45% with glucose 5% ...............................................................................9.87 5.80 Inf 0.9%, with glucose 5% ................................................................................4.54 SODIUM CITRATE WITH SODIUM LAURYL SULPHOACETATE Enema 90 mg with sodium lauryl sulphoacetate 9 mg per ml, 5 ml .................7.30 SODIUM CITRO-TARTRATE Gran eff 4 g sachets .........................................................................................2.75

500 ml 500 g 500 ml 1 1 100 ml 500 ml 1,000 ml 2,000 ml 3,000 ml 500 ml 50 ml 100 ml 250 ml 500 ml 1,000 ml 1,000 ml 30 50 50 20 5 500 ml 1,000 ml 500 ml 500 ml 1,000 ml 1,000 ml 12 28

Acidex ABM Biomed Baxter Biomed Biomed Baxter Baxter Baxter Baxter Baxter Baxter Baxter Baxter Baxter Baxter Baxter Baxter Pﬁzer AstraZeneca AstraZeneca Multichem Biomed Baxter Baxter Baxter Baxter Baxter Baxter Microlax Ural

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

SODIUM DIOTRIZOATE Powder for oral soln 3.705 g, 10 ml sachet ..................................................149.50 SODIUM HYALURONATE Ophthalmic inj 14 mg per ml – 1% DV Oct-09 to 2012 ..................................50.00 Opthalmic solution 10 mg per ml, 0.85 ml – 1% DV Oct-09 to 2012 .............35.00 Inj 10 ml per ml, 0.35 ml; and inj 30 mg per ml with chondroitin sulphate 40 mg per ml, 0.4 ml ................................................................................ 64.00 Inj 10 ml per ml, 0.5 ml; and inj 30 mg per ml with chondroitin sulphte 40 mg per ml, 0.55 ml .............................................................................. 74.00 SOLIFENACIN SUCCINATE Tab 5 mg .........................................................................................................56.50 Tab 10 mg .......................................................................................................56.50 SORBOLENE WITH GLYCERIN Crm with 10% glycerine, 500 ml .....................................................................87.60 SOTALOL Tab 80 mg – 1% DV Sep-09 to 2012 .............................................................27.50 Tab 160 mg – 1% DV Sep-09 to 2012 ...........................................................10.50 SPACER DEVICE 800 ml ...............................................................................................................8.50 SPECIAL FOOD SUPPLEMENT Amino acid based elemental formula, powder (unﬂavoured) ............................6.00 Fat free arginine supplement, powder (orange) ................................................2.15 Oral elemental feed 1 kcal/ml, powder (unﬂavoured) .......................................4.50 Oral supplement 1 kcal/ml, powder (chocolate) .............................................10.22 Oral supplement 1 kcal/ml, powder (vanilla) ...................................................10.22 Protein supplement powder ..............................................................................8.95 Liquid (chocolate) .............................................................................................4.00 Liquid (vanilla) ..................................................................................................4.00 Oral elemental feed 1 kcal/ml liquid (vanilla) ....................................................4.95 Oral feed 1 kcal/ml, liquid (vanilla) ....................................................................2.10 Renal oral feed 2 kcal/ml, liquid (vanilla) ..........................................................3.31 SPIRONOLACTONE Tab 25 mg – 1% DV Sep-10 to 2013 ...............................................................4.60 Tab 100 mg – 1% DV Sep-10 to 2013 ...........................................................15.15 Oral liq 5 mg per ml ........................................................................................26.80 STREPTOKINASE Inj 250,000 IU – 1% DV Dec-08 to 2011......................................................117.70 Inj 1,500,000 IU – 1% DV Dec-08 to 2011...................................................188.10 SULPHASALAZINE Tab 500 mg .....................................................................................................11.68 Tab EC 500 mg ...............................................................................................12.89 SULPHUR Precipitated .......................................................................................................6.50

50 1 1 1 1 30 30 12 500 100 1 48.5 g 9.2 g 80.4 g 900 g 900 g 227 g 237 ml 237 ml 237 ml 237 ml 237 ml 100 100 25 ml 1 1 100 100 100 g

Ioscan Healon GV Healon Duovisc Duovisc Vesicare Vesicare healthE Mylan Mylan Volumatic Vivonex Paediatric Resource Arginaid Vivonex TEN Sustagen Hospital Formula Sustagen Hospital Formula Resource Beneprotein Impact Advanced Recovery Impact Advanced Recovery Peptamen OS 1.0 Resource Diabetic Novasource Renal Spirotone Spirotone Biomed Streptase Streptase Salazopyrin Salazopyrin EN ABM

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

SUMATRIPTAN Tab 50 mg – 1% DV Apr-10 to 2013 ..............................................................38.83 Tab 100 mg – 1% DV Apr-10 to 2013 ............................................................77.66 SUNSCREENS, PROPRIETARY Lotn ..................................................................................................................2.55 5.10 SUXAMETHONIUM CHLORIDE Inj 50 mg per ml, 2 ml .....................................................................................95.00 SYRUP (PHARMACEUTICAL GRADE) Liq ...................................................................................................................21.75 TACROLIMUS Cap 0.5 mg ...................................................................................................214.00 Cap 1 mg ......................................................................................................428.00 Cap 5 mg ...................................................................................................1,070.00 TAMOXIFEN CITRATE Tab 10 mg .......................................................................................................10.80 Tab 20 mg .........................................................................................................6.66 11.10 TAR WITH TRIETHANOLAMINE LAURYL SULPHATE AND FLUORESCEIN Soln 2.3% with triethanolamine lauryl sulphate and ﬂuorescein sodium – 1% DV Dec-08 to 2011 ........................................................................... 2.90 5.45 TEMAZEPAM Tab 10 mg – 1% DV Dec-08 to 2011 ...............................................................0.83 TEMOZOLOMIDE Cap 5 mg ........................................................................................................50.00 Cap 20 mg ....................................................................................................170.00 Cap 100 mg ..................................................................................................840.00 Cap 250 mg ...............................................................................................2,100.00 TENOFOVIR DISOPROXIL FUMARATE Tab 300 mg ...................................................................................................531.00 TENOXICAM Inj 20 mg – 1% DV Jul-10 to 2013...................................................................9.95 TERBINAFINE Tab 250 mg – 1% DV Sep-08 to 2011 ...........................................................25.50 TERLIPRESSIN Inj 1 mg – 1% DV Dec-08 to 2011 ...............................................................450.00 TESTOSTERONE Transdermal patch, 2.5 mg per day ................................................................80.00 TESTOSTERONE CYPIONATE Inj long-acting 100 mg per ml, 10 ml – 1% DV Sep-08 to 2011 .....................61.41 TESTOSTERONE UNDECANOATE Cap 40 mg – 1% DV Jul-10 to 2012 ..............................................................79.92

100 100 100 g 200 g

Arrow-Sumatriptan Arrow-Sumatriptan Marine Blue Lotion SPF 30+ Marine Blue Lotion SPF 30+ AstraZeneca Midwest Prograf Prograf Prograf Genox Tamoxifen Sandoz Genox

50 2,000 ml 100 100 50 100 60 100

500 ml 1,000 ml 25 5 5 5 5 30 1 100 5 60 1 100

Pinetarsol Pinetarsol Normison Temodal Temodal Temodal Temodal Viread AFT Apo-Terbinaﬁne Glypressin Androderm Depo-Testosterone Arrow-Testosterone

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

TETRACOSACTRIN Inj 1 mg per ml, 1 ml – 1% DV Sep-08 to 2011..............................................26.88 Inj 250 µg – 1% DV Sep-08 to 2011 ............................................................177.18 TIMOLOL MALEATE Eye drops 0.25%, gel forming ..........................................................................3.30 Eye drops 0.5%, gel forming ............................................................................3.78 TIOTROPIUM BROMIDE Powder for inhalation 18 µg per dose .............................................................70.00 TIROFIBAN HYDROCHLORIDE Inj 0.25 mg per ml, 50 ml ..............................................................................370.00 TOBRAMYCIN Inj 40 mg per ml, 2 ml .....................................................................................34.50 TOLBUTAMIDE Tab 500 mg .....................................................................................................12.00 TOPIRAMATE Tab 25 mg .......................................................................................................11.07 26.04 Tab 50 mg .......................................................................................................18.81 44.26 Tab 100 mg .....................................................................................................31.99 75.25 Tab 200 mg .....................................................................................................55.19 129.85 Sprinkle cap 15 mg .........................................................................................20.84 Sprinkle cap 25 mg .........................................................................................26.04 TRAMADOL HYDROCHLORIDE Tab sustained release 100mg ...........................................................................5.60 Tab sustained release 150 mg ..........................................................................8.40 Tab sustained release 200 mg ........................................................................11.20 Cap 50 mg – 1% DV Aug-10 to 2011 .............................................................2.80 6.95 Inj 50 mg per ml, 1 ml .......................................................................................4.50 Inj 50 mg per ml, 2 ml .......................................................................................4.50 (Tramal Cap 50 mg to be delisted 1 August 2010) TRANEXAMIC ACID Tab 500 mg – 1% DV Jun-10 to 2013............................................................32.92 Inj 100 mg per ml, 5 ml – 1% DV Sep-09 to 2012........................................124.73 TRASTUZUMAB Inj 150 mg vial ...........................................................................................1,350.00 Inj 440 mg vial ...........................................................................................3,875.00 TRETINOIN Cap 10 mg ....................................................................................................435.90

1 10 2.5 ml 2.5 ml 30 dose 1 5 100 60 60 60 60 60 60 20 20 20 20 100 5 5

Synacthen Depot Synacthen Timoptol XE Timoptol XE Spiriva Aggrastat Mayne Diatol Arrow-Topiramate Topamax Arrow-Topiramate Topamax Arrow-Topiramate Topamax Arrow-Topiramate Topamax Topamax Topamax Tramal Retard Tramal Retard Tramal Retard Tramal Arrow-Tramadol Tramal 50 Tramal 100

100 10 1 1 100

Cyklokapron Cyklokapron Herceptin Herceptin Vesanoid

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

TRIAMCINOLONE ACETONIDE 0.1% in dental paste USP – 1% DV Sep-08 to 2011 .......................................4.38 Crm 0.02% – 1% DV Dec-08 to 2011 ..............................................................6.63 Oint 0.02% – 1% DV Dec-08 to 2011 ..............................................................6.69 Inj 10 mg per ml, 1 ml .....................................................................................11.11 Inj 10 mg per ml, 5 ml .....................................................................................10.31 Inj 40 mg per ml, 1 ml – 1% DV Dec-08 to 2011............................................29.09 Inj 40 mg per ml, 5 ml .....................................................................................23.44 TRIAMCINOLONE ACETONIDE WITH GRAMICIDIN, NEOMYCIN AND NYSTATIN Ear drops 1 mg with nystatin 100,000 u, neomycin sulphate 2.5 mg and gramicidin 250 µg per g ...................................................................... 3.35 TRIAMTERENE WITH HYDROCHLOROTHIAZIDE Tab 50 mg with hydrochlorothiazide 25 mg ......................................................5.00 TRIMETHOPRIM Tab 300 mg – 1% DV Dec-08 to 2011 .............................................................8.69 TROPISETRON Cap 5 mg – 1% DV Mar-10 to 2012 ...............................................................77.41 Inj 1 mg per ml, 2 ml .......................................................................................19.20 Inj 1 mg per ml, 5 ml .......................................................................................38.40 URSODEOXYCHOLIC ACID Cap 300 mg – 1% DV Sep-08 to 2011.........................................................179.00 VALACICLOVIR Tab 500 mg ...................................................................................................102.72 VANCOMYCIN HYDROCHLORIDE Inj 50 mg per ml, 10 ml – 1% DV Dec-08 to 2011............................................5.04 VENLAFAXINE Cap 37.5 mg ...................................................................................................18.64 Cap 75 mg ......................................................................................................37.27 Cap 150 mg ....................................................................................................45.68 VERAPAMIL HYDROCHLORIDE Tab 40 mg .........................................................................................................7.01 Tab 80 mg .......................................................................................................11.74 Tab long-acting 240 mg ..................................................................................25.00 Inj 2.5 mg per ml, 2 ml ......................................................................................7.54 VINBLASTINE SULPHATE Inj 10 mg .......................................................................................................137.50 VINCRISTINE SULPHATE Inj 1 mg per ml, 1 ml – 1% DV Aug-10 to 2013 ...........................................108.00 Inj 1 mg per ml, 2 ml – 1% DV Aug-10 to 2013 ...........................................116.00 VINORELBINE Inj 10 mg per ml, 1 ml – 1% DV Sep-09 to 2012............................................24.00 Inj 10 mg per ml, 5 ml – 1% DV Sep-09 to 2012..........................................120.00

5g 100 g 100 g 5 1 5 1

Oracort Aristocort Aristocort Kenacort-A Kenacort-A Kenacort-A40 Kenacort-A40

7.5 ml 100 50 5 1 1 100 30 1 28 28 28 100 100 250 5 5 5 5 1 1

Kenacomb Triamizide TMP Navoban Navoban Navoban Actigall Valtrex Paciﬁc Efexor XR Efexor XR Efexor XR Isoptin Isoptin Verpamil SR Isoptin Mayne Hospira Hospira Navelbine Navelbine

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Pharmaceuticals Under National Contracts

Price (ex man. excl. GST) $ Brand or Generic Manufacturer

Per

WATER Inf .....................................................................................................................4.50 Soln for irrigation ..............................................................................................2.68 2.61 2.75 9.71 15.80 Puriﬁed for inj 5 ml ............................................................................................9.31 10.51 Puriﬁed for inj 10 ml ........................................................................................10.38 11.32 Puriﬁed for inj 20 ml ..........................................................................................5.04 WATER WITH SODIUM, POTASSIUM, CALCIUM AND CHLORIDE Inf 147 mmol/L sodium, 4 mmol/L potassium, 2.2 mmol/L calcium and 156 mmol/L chloride .................................................................................. 5.13 WATER WITH SODIUM, POTASSIUM, CALCIUM, BICARBONATE AND CHLORIDE Inf 131 mmol/L sodium, 5 mmol/L potassium, 2 mmol/L calcium, 29 mmol/L bicarbonate and 111 mmol/L chloride ..................................... 1.77 1.80

1,000 ml 100 ml 500 ml 1,000 ml 2,000 ml 3,000 ml 50 50 20

Baxter Baxter Baxter Baxter Baxter Baxter Multichem AstraZeneca Multichem AstraZeneca Multichem

1,000 ml

Baxter

500 ml 1,000 ml

Baxter Baxter

WATER WITH SODIUM, POTASSIUM, CALCIUM, BICARBONATE, CHLORIDE AND GLUCOSE Inf 131 mmol/L sodium, 5 mmol/L potassium, 2 mmol/L calcium, 29 mmol/L bicarbonate, 111 mmol/L chloride and glucose 5% ................. 5.38 1,000 ml WATER WITH SODIUM, POTASSIUM, MAGNESIUM, CHLORIDE, ACETATE AND GLUCONATE Inf 140 mmol/L sodium, 5 mmol/L potassium, 1.5 mmol/L magnesium, 98 mmol/L chloride, 27 mmol/L acetate and 23 mmol/L gluconate ........... 5.00 500 ml 3.10 1,000 ml ZIDOVUDINE (AZT) Cap 100 mg – 1% DV Jun-10 to 2013 .........................................................145.00 Oral liq 10 mg per ml – 1% DV Jun-10 to 2013 .............................................29.00 ZINC AND CASTOR OIL Ointment ...........................................................................................................1.20 ZINC SULPHATE Cap 137.4 mg (50 mg elemental) – 1% DV Dec-08 to 2011..........................10.00 ZIPRASIDONE Cap 20 mg Cap 40 mg Cap 60 mg Cap 80 mg ......................................................................................................87.88 ....................................................................................................164.78 ....................................................................................................247.17 ....................................................................................................329.56 100 200 ml 20 g 100 60 60 60 60 1 500 5 100

Baxter

Baxter Baxter Retrovir Retrovir Orion Zincaps Zeldox Zeldox Zeldox Zeldox Zometa Apo-Zopiclone Clopixol Clopixol

ZOLEDRONIC ACID Soln for Inf 4 mg, 5 ml ..................................................................................550.00 ZOPICLONE Tab 7.5 mg – 1% DV Feb-09 to 2011.............................................................21.02 ZUCLOPENTHIXOL DECANOATE Depot inj 200 mg per ml, 1 ml .........................................................................19.80 ZUCLOPENTHIXOL HYDROCHLORIDE Tab 10 mg .......................................................................................................31.45

Products with Hospital Supply Status (HSS) are in bold Expiry date of HSS period is 30 June of the year indicated unless otherwise stated.

Part III: Discretionary Community Supply Pharmaceuticals

ALBENDAZOLE Tab 200 mg CEFOTAXIME SODIUM Inj 500 mg Inj 1 g For any indication approved by the hospital service, with review at 6 weeks. CEFOXITIN SODIUM Powder for injection 1 g For any indication approved by the hospital service, with review at 6 weeks. CEFTAZIDIME Inj 500 mg Inj 1 g Inj 2 g For any indication approved by the hospital service, with review at 6 weeks. CEFTRIAXONE SODIUM Inj 1 g For any indication approved by the hospital service, with review at 6 weeks. CEFUROXIME AXETIL Tab 250 mg Oral liq 125 mg per 5 ml Up to 2 weeks supply for any appropriate indication CEFUROXIME SODIUM Inj 250 mg Inj 750 mg Inj 1.5 g For any indication approved by the hospital service, with review at 6 weeks. CHLORHEXIDINE Eye drops 0.02% For a period of 3 months for treatment of acanthamoeba keratitis. CIPROFLOXACIN Oral liq 5% Oral liq 10% Up to 6 weeks supply for any appropriate indication CLOPIDOGREL Tab 75 mg Up to 4 weeks supply post stenting. Not to be funded for acute coronary syndrome or transient ischaemic attacks

Albenza Zentel Indeﬁnite supply to cover treatment of hydatid disease, strongyloidiasis, toxocariasis, ancylostomiasis, neurocysticerosis and schistosomiasis (where ﬁrst line treatment has failed) until EC funding is approved (Section 29) AMIKACIN SULPHATE Inj 250 mg per ml, 2 ml For any indication approved by the hospital service, with review at 6 weeks AMOXYCILLIN CLAVULANATE Inj 600 mg Inj 1.2 g For any indication approved by the hospital service, with review at 6 weeks AMPHOTERICIN B Inj 50 mg Oral liq 100 mg per ml (non-liposomal only) Up to 6 weeks supply for any appropriate indication AZTREONAM Inj 1 g For any indication approved by the hospital service, with review at 6 weeks. BENZATHINE PENICILLIN Inj 1.2 mega u per 2 ml For prophylaxis of endocarditis BENZYLPENICILLIN SODIUM (PENICILLIN G) Inj 1 mega u For any indication approved by the hospital service, with review at 8 weeks. CEFAMANDOLE NAFATE Inj 500 mg Inj 1 g For any indication approved by the hospital service, with review at 8 weeks. CEFAZOLIN SODIUM Inj 500 mg Inj 1 g For any indication approved by the hospital service, with review at 8 weeks. CEFEPIME HYDROCHLORIDE Inj 1 g, 15 ml Inj 2 g, 77 ml For any indication approved by the hospital service, with review at 6 weeks.

CYCLOSPORIN Cap 25 mg Cap 50 mg Cap 100 mg Oral liq 100 mg per ml For aplastic anaemia

Gengraf Neoral Gengraf Neoral Gengraf Neoral Gengraf Neoral

DEXTROSE Inj 5%, 10 ml Where required for antibiotic treatment funded under DCS or HEC ENOXAPARIN SODIUM Inj 20 mg per 0.2 ml Clexane Inj 40 mg per 0.4 ml Clexane Inj 60 mg per 0.6 ml Clexane Inj 80 mg per 0.8 ml Clexane Inj 100 mg per ml Clexane Inj 120 mg per 0.8 ml Clexane Inj 150 mg per ml Clexane For the treatment of venous thromboembolism (VTE) for a maximum of 14 days or until a stabilised therapeutic INR is established. For a maximum treatment period from the time of diagnosis to 8 weeks post partum for a conﬁrmed thromboembolic event during pregnancy. For prophylaxis of thromboembolism for patients considered high risk after consultation with a specialist from diagnosis of pregnancy to 8 weeks post partum. For a maximum treatment period from diagnosis of pregnancy to 8 weeks post partum for women normally maintained on long-term oral anticoagulation who are at very high risk of thromboembolism. For the treatment for a maximum of 7 days pre and post operatively for patients on oral anticoagulants requiring surgical intervention in a public hospital or until an appropriate therapeutic INR level is reached. For a maximum of 14 days treatment in high-risk patients post pelvic, colo-rectal and major orthopaedic surgery. For a maximum of 7 days treatment for patients with an acute coronary syndrome (ACS) awaiting further hospital intervention. For a maximum of 14 days treatment post cardioversion in non anticoagulated patients with atrial ﬁbrillation or until appropriate therapeutic INR level is reached. For treatment of malignancy - associated venous thromboembolism. ERTAPENEM SODIUM Inj 1 g For any indication approved by the hospital service, with review at 6 weeks. FILGRASTIM Inj 300 µg per 0.5 ml preﬁlled syringe Neupogen Inj 300 µg per 1 ml vial Neupogen Inj 480 µg per 0.5 ml preﬁlled syringe Neupogen Indeﬁnite supply for any appropriate indication for the management of patients with cancer.

DALTEPARIN SODIUM Inj 2,500 IU per 0.2 ml Fragmin Inj 5,000 IU per 0.2 ml Fragmin Inj 7,500 IU per 0.75 ml Fragmin Inj 10,000 IU per 0.4 ml Fragmin Inj 10,000 IU per 1 ml Fragmin Inj 12,500 IU per 0.5 ml Fragmin Inj 15,000 IU per 0.6 ml Fragmin Inj 18,000 IU per 0.72 ml Fragmin For the treatment of venous thromboembolism (VTE) for a maximum of 14 days or until a stabilised therapeutic INR is established. For a maximum treatment period from the time of diagnosis to 8 weeks post partum for a conﬁrmed thromboembolic event during pregnancy. For prophylaxis of thromboembolism for patients considered high risk after consultation with a specialist from diagnosis of pregnancy to 8 weeks post partum. For a maximum treatment period from diagnosis of pregnancy to 8 weeks post partum for women normally maintained on long-term oral anticoagulation who are at very high risk of thromboembolism. For the treatment for a maximum of 7 days pre and post operatively for patients on oral anticoagulants requiring surgical intervention in a public hospital or until an appropriate therapeutic INR level is reached. For a maximum of 14 days treatment in high-risk patients post pelvic, colo-rectal and major orthopaedic surgery. For a maximum of 7 days treatment for patients with an acute coronary syndrome (ACS) awaiting further hospital intervention. For a maximum of 14 days treatment post cardioversion in non anticoagulated patients with atrial ﬁbrillation or until appropriate therapeutic INR level is reached. For treatment of malignancy - associated venous thromboembolism. DEMECLOCYCLINE Cap 150 mg Ledermycin Indeﬁnite supply for SIADH (syndrome of inappropriate anti diuretic hormone) (Section 29)

Discretionary Community Supply Pharmaceuticals

FLUCLOXACILLIN SODIUM Inj 250 mg Inj 500 mg Inj 1 g For any indication approved by the hospital service, with review at 8 weeks. FLUCONAZOLE Inj 100 mg per 50 ml For any indication approved by the hospital service, with review at 6 weeks. FORTIFIED EYE DROPS Up to 4 weeks supply of proprietary eyedrops fortiﬁed with any appropriate anti-infective agent for the treatment of severe corneal or eye surface infections FOSCARNET Inj 24 mg per ml IV soln Indeﬁnite supply for any appropriate indication GANCICLOVIR Inj 500 mg Cymevene For prophylaxis and treatment of CMV-associated disease in immunocompromised patients and following organ transplant. GENTAMICIN SULPHATE Inj 40 mg per ml, 2 ml Indeﬁnite supply for any indication approved by the hospital service. HEPARINISED SALINE Inj 10 iu per ml, 5 ml Inj 100 iu per ml, 5 ml For the maintenance of IV lines HYDRALAZINE Tab 25 mg S29 For patients with congestive heart failure: 1) who have not responded to treatment with ACE inhibitors and/or ARBs; or 2) in whom treatment with ACE inhibitors and/or ARBs is not tolerated due to renal impairment HYOSCINE (SCOPOLAMINE) Patches 1.5 mg Scopoderm TTS Up to 6 months supply for symptom control in terminally ill patients IMIPENEM WITH CILASTATIN Inj 500 mg with cilastin 500 mg For any indication approved by the hospital service, with review at 6 weeks. INDOMETHACIN Cap 25 mg S29 Cap 50 mg S29 For any indication approved by the hospital service ITRACONAZOLE Oral liq 10 mg per ml Up to 3 months supply for use in liver transplant patients IVERMECTIN Tab 6 mg Indeﬁnite supply for the treatment of ﬁlaricides, cutaneous larva migrans (creeping eruption) and Strongyloidiasis (Section 29) LENOGRASTIM Inj 13.4 million iu vial Granocyte Inj 33.6 million iu vial Granocyte Indeﬁnite supply for any appropriate indication for the management of patients with cancer. LIGNOCAINE Viscous solution 2% For patients with head, neck and oesophageal cancer for up to 9 weeks following radiation therapy. L-ORNITHINE L-ASPARTATE (LOLA) S29 Sach 5 mg For patients with chronic hepatic encephalopathy who have not responded to treatment with lactulose MEROPENEM Inj 500 mg Inj 1 g For any indication approved by the hospital service, with review at 6 weeks. METHOXSALEN Cap 10 mg Oxsoralen Tab 10 mg Methoxypsaralen Indeﬁnite supply for PUVA – psoralen plus ultraviolet a (UVA) therapy for severe, disabling psoriasis prephototherapy. METOLAZONE S29 Tab 5 mg For patients with congestive heart failure: 1) who have not responded to treatment with ACE inhibitors and/or ARBs; or 2) in whom treatment with ACE inhibitors and/or ARBs is not tolerated due to renal impairment

Discretionary Community Supply Pharmaceuticals

MINOXIDIL Tab 2.5 mg Loniten Tab 5 mg Loniten Tab 10 mg Loniten Indeﬁnite supply for the treatment of severe hypertension that is resistant to other anti-hypertensives or where alternatives are not tolerated (Section 29) MOLGRAMOSTIM Inj 300 µg Leucomax Indeﬁnite supply for any appropriate indication for the management of patients with cancer. NETILMICIN Inj 150 mg per 1.5 ml Up to 2 weeks supply for any appropriate indication (extension for up to 6 weeks supply for endocarditis should be applied for under Hospital EC) NIMODIPINE Tab 30 mg Up to 21 days supply post sub-arachnoid haemorrhage ONDANSETRON HYDROCHLORIDE Tab 4 mg Zofran Tab 8 mg Zofran Tab dispersible 4 mg Zofran Zydis Tab dispersible 8 mg Zofran Zydis For treatment of patients with hyperemesis gravidarum for the term of the pregnancy following failure of other antiemetic regimens. PEGFILGRASTIM Inj 6 mg per 0.6 ml preﬁlled syringe Indeﬁnite supply for any appropriate indication for the management of patients with cancer. PENTAMIDINE Inj 300 mg Indeﬁnite supply for any appropriate indication PHENINDIONE Tab 10 mg Tab 25 mg Tab 50 mg Indeﬁnite supply for warfarin resistance anti-coagulation therapy (Section 29) PIPERACILLIN SODIUM Inj 2 g Inj 4 g For any indication approved by the hospital service, with review at 6 weeks. PIPERACILLIN WITH TAZOBACTAM Inj 4 g with tazobactam 500 mg For any indication approved by the hospital service, with review at 6 weeks. POLYHEXAMETHYLENE BIGUANIDE Eye drops 0.02% For a period of 3 months for treatment of acanthamoeba keratitis. PRAZIQUANTEL Cysticide Tab 500 mg S29 For the treatment of worm infestations (Section 29) PRIMAQUINE Tab 2.5 mg Tab 5 mg Tab 7.5 mg Indeﬁnite supply for any appropriate indication (Section 29) PYRIMETHAMINE Tab 25 mg S29 For the treatment of toxoplasmosis in patients with HIV for a period of 3 months; For pregnant patients for the term of the pregnancy; For infants with congenital toxoplasmosis until 12 months of age. SODIUM CHLORIDE Tab 600 mg Slow Sodium Indeﬁnite supply for salt wasting nephropathy (Section 29) Inj 0.9% Where required for injection of antibiotic treatment funded under DCS or HEC SPECIAL FOOD SUPPLEMENT Liquid, 237 ml Impact Advanced Recovery Vanilla and Chocolate Three packs of 237 mls per days for 5 to 7 days prior to major gastrointestinal or head or neck surgery.

SULPHADIAZINE Tab 500 mg S29 For the treatment of toxoplasmosis in patients with HIV for a period of 3 months; For pregnant patients for the term of the pregnancy; For infants with congenital toxoplasmosis until 12 months of age. TEICOPLANIN Inj 400 mg For any indication approved by the hospital service, with review at 6 weeks.

Discretionary Community Supply Pharmaceuticals

TICARCILLIN DISODIUM WITH CLAVULANIC ACID Inj 3 g with clavulanic acid 0.1 g For any indication approved by the hospital service, with review at 6 weeks. TINZAPARIN SODIUM Inj 3,500 anti-Xa IU/0.35 ml Innohep Inj 4,500 anti-Xa IU/0.45 ml Innohep Inj 10,000 anti-Xa IU/0.5 ml Innohep Inj 14,000 anti-Xa IU/0.7 ml Innohep Inj 18,000 anti-Xa IU/0.9 ml Innohep Inj 20,000 anti-Xa IU/ml, 2 ml Innohep For the treatment of venous thromboembolism (VTE) for a maximum of 14 days or until a stabilised therapeutic INR is established. For a maximum treatment period from the time of diagnosis to 8 weeks post partum for a conﬁrmed thromboembolic event during pregnancy. For prophylaxis of thromboembolism for patients considered high risk after consultation with a specialist from diagnosis of pregnancy to 8 weeks post partum. For a maximum treatment period from diagnosis of pregnancy to 8 weeks post partum for women normally maintained on long-term oral anticoagulation who are at very high risk of thromboembolism. For the treatment for a maximum of 7 days pre and post operatively for patients on oral anticoagulants requiring surgical intervention in a public hospital or until an appropriate therapeutic INR level is reached. For a maximum of 14 days treatment in high-risk patients post pelvic, colo-rectal and major orthopaedic surgery. For a maximum of 7 days treatment for patients with an acute coronary syndrome (ACS) awaiting further hospital intervention. For a maximum of 14 days treatment post cardioversion in non anticoagulated patients with atrial ﬁbrillation or until appropriate therapeutic INR level is reached. For treatment of malignancy - associated venous thromboembolism. TOBRAMYCIN Inj 40 mg per ml, 2 ml Indeﬁnite supply for any indication approved by the hospital service. TRIMETHOPRIM Tab 100 mg Indeﬁnite supply for any appropriate indication (Section 29) VALGANCICLOVIR Tab 450 mg Up to 14 weeks supply for cytomegalovirus (CMV) retinitis in immunocompromised patients and prophylaxis of CMV following solid organ transplant VANCOMYCIN HYDROCHLORIDE Inj 50 mg per ml, 10 ml For any indication approved by the hospital service, with review at 6 weeks. WATER Puriﬁed for inj Where required for injection of antibiotic treatment funded under DCS or HEC

INDEX Generic Chemicals and Brands

Amitriptyline ....................................17 Amizide ...........................................17 Amlodipine ......................................17 Amoxycillin ......................................17 Amoxycillin clavulanate Contracted ..................................17 DCS ............................................58 Amphotericin B Contracted ..................................17 DCS ............................................58 Anastrozole .....................................18 Androderm ......................................54 Anexate ..........................................31 Antabuse ........................................27 Antinaus ..........................................48 Antithymocyte globulin (equine) ..................................... 18 Apo-Allopurinol ...............................16 Apo-Amlodipine ..............................17 Apo-Amoxi ......................................17 Apo-Captopril .................................21 Apo-Clopidogrel ..............................24 Apo-Doxazosin ...............................28 Apo-Gliclazide ................................32 Apo-Megestrol ................................39 Apo-Moclobemide ...........................42 Apo-Nadolol ....................................43 Apo-Oxybutynin ..............................45 Apo-Pindolol ...................................47 Apo-Prazo .......................................48 Apo-Prednisone ..............................48 Apo-Risperidone .............................50 Apo-Terbinaﬁne ..............................54 Apo-Zopiclone ................................57 Apomine .........................................18 Apomorphine hydrochloride ...........18 Aprepitant .......................................18 Apresoline .......................................34 Aqueous cream ..............................18 Arava ..............................................38 Aripiprazole .....................................18 Aristocort ........................................56 Aromasin ........................................30 Arrow-Azithromycin ........................18 Arrow-Bendroﬂuazide .....................19 Arrow-Citalopram ............................24 Arrow-Clopidogrel ...........................24 Arrow-Diazepam .............................27 Arrow-Enalapril ...............................28 Arrow-Etidronate .............................29 Arrow-Lamotrigine ..........................37 Arrow-Lisinopril ...............................39 Arrow-Nifedipine XR .......................44 Arrow-Norﬂoxacin ...........................44 Arrow-Ranitidine .............................49 Arrow-Roxithromycin ......................51 Arrow-Simva ...................................52 Arrow-Sumatriptan ..........................54 Arrow-Testosterone ........................54 Arrow-Topiramate ...........................55 Arrow-Tramadol ..............................55 Arsenic trioxide ...............................18 Asacol .............................................40 Asamax ...........................................40 Aspen Adrenaline ...........................16 Aspen Ciproﬂoxacin ........................23 Asthalin ...........................................51 Atacand ..........................................21 Atazanavir sulphate ........................18 Atenolol ...........................................18 Atenolol Tablet USP ........................18 ATGAM ...........................................18 Ativan ..............................................39 Atomoxetine hydrochloride .............18 Atracurium besylate ........................18 Atropine sulphate ............................18 Atropt ..............................................18 Avanza ............................................42 Azithromycin ...................................18 Azol .................................................26 Aztreonam ......................................58 -BBaclofen ..........................................19 Baraclude .......................................28 Basiliximab .....................................19 Beclazone 100 ................................19 Beclazone 250 ................................19 Beclazone 50 ..................................19 Beclomethasone dipropionate ............................... 19 Bendroﬂuazide ................................19 Benzathine benzylpenicillin ............19 Benzathine penicillin .......................58 Benztrop .........................................19 Benztropine mesylate .....................19 Benzylpenicillin sodium ..................19 Benzylpenicillin sodium (penicillin G) ............................................... 58 Beractant ........................................19 Beta Scalp ......................................19 Betadine .........................................48 Betadine Skin Prep .........................48

-AA-Scabies .......................................46 Abacavir sulphate with lamivudine ................................. 16 Abciximab .......................................16 Abilify ..............................................18 Acarbose ........................................16 Accu-Chek Performa ................19, 20 Accupril ...........................................49 Accuretic 10 ....................................49 Accuretic 20 ....................................49 Acetazolamide ................................16 Acetylcysteine .................................16 Aciclovir ..........................................16 Acidex .............................................52 Acitretin ...........................................16 Actigall ............................................56 Activated charcoal ..........................16 Adalimumab ....................................16 Adeﬁn XL ........................................44 Adefovir dipivoxil .............................16 Adrenaline ......................................16 Advantan ........................................41 Advate ............................................50 Aerrane ...........................................37 AFT-Leﬂunomide ............................38 Aggrastat ........................................55 Alanase ...........................................19 Albendazole ....................................58 Albenza ...........................................58 Aldara .............................................35 Alendronate sodium ........................16 Alendronate sodium with cholecalciferol ............................ 16 Alfacalcidol .....................................16 Allersoothe ......................................48 Allopurinol .......................................16 Alprostadil .......................................16 Amantadine hydrochloride ..............16 AmBisome ......................................17 Ambrisentan ...................................17 Amikacin sulphate Contracted ..................................17 DCS ............................................58 Amiloride ........................................17 Amiloride with hydrochlorothiazide ................... 17 Aminophylline .................................17 Amirol .............................................17 Amisulpride .....................................17 Amitrip ............................................17

INDEX Generic Chemicals and Brands

Betagan ..........................................38 Betahistine dihydrochloride ............19 Betaloc CR .....................................41 Betamethasone valerate .................19 Bezaﬁbrate .....................................19 Bezalip Retard ................................19 Bicalox ............................................19 Bicalutamide ...................................19 Bicillin LA ........................................19 Biodone ..........................................40 Biodone Extra Forte ........................40 Biodone Forte .................................40 Bisacodyl ........................................19 Blood glucose diagnostic test meter ......................................... 19 Blood glucose diagnostic test strip ............................................ 20 Bosentan ........................................20 Botox ..............................................24 Brimonidine tartrate ........................20 Budesonide .....................................20 Bumetanide ....................................20 Bupafen ..........................................20 Bupivacaine hydrochloride .............20 Bupivacaine hydrochloride with adrenaline .................................. 20 Bupivacaine hydrochloride with fentanyl ...................................... 20 Bupropion hydrochloride .................20 Burinex ...........................................20 Buscopan ........................................35 Buspirone hydrochloride .................20 Butacort Aqueous ...........................20 -CCaffeine citrate ...............................21 Cal-d-Forte .....................................23 Calcipotriol ......................................21 Calcitonin ........................................21 Calcitriol ..........................................21 Calcium carbonate ..........................21 Calcium folinate ..............................21 Calcium Folinate Ebewe .................21 Calcium gluconate ..........................21 Calcium polystyrene sulphonate ................................. 21 Calcium Resonium .........................21 Calsource .......................................21 Camptosar ......................................36 Cancidas .........................................22 Candesartan ...................................21 Capecitabine ...................................21 Capsaicin ........................................21 Captopril .........................................21 Carboplatin .....................................22 Carboplatin Ebewe .........................22 Carbosorb-X ...................................16 Cardinol LA .....................................49 Cardizem CD ..................................27 CareSens ........................................20 CareSens II .....................................19 CareSens POP ...............................19 Carvedilol .......................................22 Caspofungin ...................................22 Catapres .........................................24 Catapres-TTS-1 ..............................24 Catapres-TTS-2 ..............................24 Catapres-TTS-3 ..............................24 Cefaclor monohydrate ....................22 Cefalexin Sandoz ............................22 Cefamandole nafate .......................58 Cefazolin sodium Contracted ..................................22 DCS ............................................58 Cefepime hydrochloride Contracted ..................................22 DCS ............................................58 Cefotaxime .....................................22 Cefotaxime Sandoz ........................22 Cefotaxime sodium .........................58 Cefoxitin sodium Contracted ..................................22 DCS ............................................58 Ceftazidime Contracted ..................................22 DCS ............................................58 Ceftriaxone sodium Contracted ..................................22 DCS ............................................58 Cefuroxime axetil Contracted ..................................22 DCS ............................................58 Cefuroxime sodium Contracted ..................................22 DCS ............................................58 Celiprolol .........................................22 CellCept ..........................................43 Celol ...............................................22 Cephalexin monohydrate ................22 Cetirizine hydrochloride ..................23 Cetirizine-AFT ................................23 Chloramphenicol .............................23 Chlorhexidine Contracted ..................................23 DCS ............................................58 Chlorhexidine gluconate .................23 Chlorhexidine in alcohol .................23 Chlorhexidine with cetrimide ...........23 Chlorothiazide .................................23 Chlorsig ..........................................23 Chlorthalidone ................................23 Cholecalciferol ................................23 Cilazapril .........................................23 Cilazapril with hydrochlorothiazide ................... 23 Cilicaine ..........................................48 Cilicaine VK ....................................47 Ciproﬂoxacin Contracted ..................................23 DCS ............................................58 Cisplatin ..........................................24 Cisplatin Ebewe ..............................24 Citalopram hydrobromide ...............24 Citanest ..........................................48 Cladribine .......................................24 Clarithromycin .................................24 Clexane Contracted ..................................28 DCS ............................................59 Clindamycin ....................................24 Clobetasol propionate .....................24 Clomazol .........................................24 Clomiphene citrate ..........................24 Clonazepam ...................................24 Clonidine .........................................24 Clonidine hydrochloride ..................24 Clopidogrel Contracted ..................................24 DCS ............................................58 Clopine ...........................................25 Clopixol ...........................................57 Clostridum botulinum ......................24 Clotrimazole ....................................24 Clozapine ........................................25 Clozaril ...........................................25 Co-trimoxazole ...............................25 Cocaine ..........................................25 Codeine phosphate ........................25 Colaspase (L-asparaginase) ..........25 Colchicine .......................................25 Colgout ...........................................25 Colifoam .........................................34 Colistin sulphomethate ...................25 Colistin-Link ....................................25 Colofac ...........................................39 Coloxyl ............................................47 Combivent ......................................51 Comtan ...........................................28 Concerta .........................................41

INDEX Generic Chemicals and Brands

Condyline ........................................47 Cosopt ............................................28 Crotamiton ......................................25 Crystacide ......................................34 Curam .............................................17 Curosurf ..........................................47 Cyclizine hydrochloride ...................25 Cyclizine lactate ..............................25 Cycloblastin ....................................25 Cyclophosphamide .........................25 Cyclosporin Contracted ..................................25 DCS ............................................59 Cyklokapron ....................................55 Cymevene Contracted ..................................32 DCS ............................................60 Cyproterone acetate .......................25 Cysticide .........................................61 Cytarabine ......................................26 -DD-Penamine ....................................46 D-Zol ...............................................26 Dacarbazine ...................................26 Daivonex .........................................21 Daktarin ..........................................42 Dalacin C ........................................24 Dalteparin sodium Contracted ..................................26 DCS ............................................59 Danazol ..........................................26 Danthron with polaxamer ................26 Dantrium .........................................26 Dantrium IV ....................................26 Dantrolene sodium .........................26 Dasatinib .........................................26 Daunorubicin ..................................26 De-Worm ........................................39 Demeclocycline ..............................59 Depo-Medrol ...................................41 Depo-Medrol with Lidocaine ...........41 Depo-Provera .................................39 Depo-Testosterone .........................54 Deprim ............................................25 Dermol ............................................24 Desferrioxamine mesylate ..............26 Desﬂurane ......................................26 Desmopressin .................................26 Desmopressin-PH&T ......................26 Dexamethasone .............................27 Dexamethasone sodium phosphate .................................. 27 Dexamphetamine sulphate .............27 Dextran 70 with sodium chloride ...................................... 27 Dextrose Contracted ..................................27 DCS ............................................59 DHC Continus .................................27 Diamox ...........................................16 Diatol ..............................................55 Diazepam .......................................27 Diclax ..............................................27 Diclofenac sodium ..........................27 Diﬂucan POS ..................................30 Dihydrocodeine tartrate ..................27 Dilatrend .........................................22 Diltiazem hydrochloride ..................27 Dilzem .............................................27 Dinoprostone ..................................27 Diprivan ..........................................49 Dipyridamole ...................................27 Disulﬁram ........................................27 Diurin 40 .........................................32 Dixarit .............................................24 DM Ject ..........................................36 Docetaxel ........................................27 Docetaxel Ebewe ............................27 Docusate sodium ............................28 Docusate sodium with sennosides ................................ 28 Dopamine hydrochloride .................28 Dopress ..........................................28 Dorzolamide hydrochloride with timolol maleate .......................... 28 Dothiepin hydrochloride ..................28 Doxazosin mesylate .......................28 Doxine ............................................28 Doxorubicin .....................................28 Doxorubicin Ebewe .........................28 Doxycycline hydrochloride ..............28 DP-Anastrozole ..............................18 Dr Reddy’s Omeprazole .................45 Dr Reddy’s Pantoprazole ................46 Dr Reddy’s Risperidone ..................50 Dulcolax ..........................................19 Duolin .............................................51 Duovisc ...........................................53 Duphalac ........................................37 Duride .............................................37 Dysport ...........................................24 -EE-Mycin ...........................................29 Efexor XR .......................................56 Efudix ..............................................31 Eligard ............................................38 Elocon .............................................42 Emend Tri-Pack ..............................18 EMLA ..............................................39 Emtricitabine ...................................28 Emtriva ...........................................28 Emulsifying ointment ......................28 Enalapril .........................................28 Enbrel .............................................29 Endoxan .........................................25 Enfuvirtide ......................................28 Enoxaparin sodium Contracted ..................................28 DCS ............................................59 Entacapone ....................................28 Entecavir .........................................28 Ephedrine sulphate ........................29 Epirubicin ........................................29 Epirubicin Ebewe ............................29 Eprex ..............................................29 Eptiﬁbatide ......................................29 Ergometrine maleate ......................29 Ertapenem sodium Contracted ..................................29 DCS ............................................59 Erythrocin IV ...................................29 Erythromycin ethyl succinate ..........29 Erythromycin lactobionate ..............29 Erythropoietin alpha .......................29 Erythropoietin beta .........................29 Etanercept ......................................29 Ethambutol hydrochloride ...............29 Etidronate disodium ........................29 Etoposide ........................................29 Exemestane ....................................30 -FFelo 10 ER ......................................30 Felo 5 ER ........................................30 Felodipine .......................................30 Fenpaed .........................................35 Fentanyl citrate ...............................30 Ferodan ..........................................30 Ferro-F-Tabs ...................................30 Ferro-tab .........................................30 Ferrous fumarate ............................30 Ferrous fumarate with folic acid ............................................ 30 Ferrous sulphate .............................30 Ferrum H ........................................36 Fibalip .............................................19 Filgrastim Contracted ..................................30 DCS ............................................59

INDEX Generic Chemicals and Brands

Finasteride ......................................30 Fintral ..............................................30 Flagyl ..............................................42 Flagyl-S ..........................................42 Flamazine .......................................51 Flecainide acetate ..........................30 Fleet Phosphate Enema .................52 Flixotide ..........................................31 Flixotide Accuhaler .........................31 Florinef ...........................................30 Fluanxol ..........................................31 Flucloxacillin sodium Contracted ..................................30 DCS ............................................60 Flucloxin .........................................30 Fluconazole Contracted ..................................30 DCS ............................................60 Fludara ...........................................30 Fludara Oral ....................................30 Fludarabine phosphate ...................30 Fludrocortisone acetate ..................30 Flumazenil ......................................31 Fluocortolone caproate with ﬂuocortolone pivalate and cinchocaine ................................ 31 Fluorometholone .............................31 Fluorouracil Ebewe .........................31 Fluorouracil sodium ........................31 Fluox ...............................................31 Fluoxetine hydrochloride .................31 Flupenthixol decanoate ..................31 Fluphenazine decanoate ................31 Flutamide ........................................31 Flutamin ..........................................31 Fluticasone .....................................31 Fluticasone with salmeterol ............31 FML ................................................31 Foban .............................................32 Folic acid ........................................31 Fortiﬁed eye drops ..........................60 Fortum ............................................22 Fosamax .........................................16 Fosamax Plus .................................16 Foscarnet ........................................60 Fragmin Contracted ..................................26 DCS ............................................59 FreeStyle Lite ...........................19, 20 Fucidin ............................................32 Fucithalmic .....................................32 Furosemide .....................................32 Fusidic acid .....................................32 Fuzeon ............................................28 -GGabapentin .....................................32 Gadobendate dimeglumine ............32 Gadobutrol ......................................32 Gadodiamide ..................................32 Gadovist .........................................32 Ganciclovir Contracted ..................................32 DCS ............................................60 Gastrograﬁn ....................................40 Gastrosoothe ..................................35 Gelatin plasma replacer ..................32 Gelofusine ......................................32 Gemcitabine Ebewe .......................32 Gemcitabine hydrochloride .............32 Gengraf ...........................................59 Genoptic .........................................32 Genox .............................................54 Gentamicin sulphate Contracted ..................................32 DCS ............................................60 Gliclazide ........................................32 Glipizide ..........................................32 Glivec ..............................................35 Glucobay ........................................16 Glucose ..........................................33 Glucose with sodium, potassium, magnesium, chloride and acetate ....................................... 33 Glucose with sodium, potassium, magnesium, chloride, acetate and gluconate ............................ 33 Glycerol ..........................................33 Glyceryl trinitrate ............................33 Glycine ............................................33 Glypressin .......................................54 Goserelin acetate ...........................33 Granocyte .......................................60 -HHabitrol ...........................................44 Haemaccel ......................................32 Haldol .............................................33 Haldol Concentrate .........................33 Haloperidol .....................................33 Haloperidol decanoate ...................33 Healon ............................................53 Healon GV ......................................53 healthE Fatty Cream .......................44 Heparin sodium ..............................33 Heparin with sodium chloride .........34 Heparinised saline Contracted ..................................34 DCS ............................................60 Hepsera ..........................................16 Herceptin ........................................55 Holoxan ..........................................35 Humalog Mix 25 ..............................35 Humalog Mix 50 ..............................35 Humira ............................................16 HumiraPen ......................................16 Hybloc .............................................37 Hydralazine Contracted ..................................34 DCS ............................................60 Hydrea ............................................34 Hydrocortisone ...............................34 Hydrocortisone acetate ..................34 Hydrocortisone butyrate .................34 Hydrocortisone with miconazole ................................ 34 Hydrocortisone with natamycin and neomycin ............................ 34 Hydrogen peroxide .........................34 Hydroxocobalamin ..........................34 Hydroxychloroquine sulphate .........34 Hydroxyethyl starch 130/0.4 ...........34 Hydroxyethyl starch 200/0.5 ...........34 Hydroxyurea ...................................34 Hygroton .........................................23 Hyoscine (scopolamine) Contracted ..................................34 DCS ............................................60 Hyoscine hydrobromide ..................34 Hyoscine n-butylbromide ................35 Hypnovel .........................................42 Hypromellose ..................................35 -IIbiamox ...........................................17 Ibuprofen ........................................35 Idarubicin hydrochloride .................35 Ifosfamide .......................................35 Ilomedin ..........................................35 Iloprost ............................................35 Imatinib mesylate ............................35 Imipenem with cilastatin Contracted ..................................35 DCS ............................................60 Imipramine hydrochloride ...............35 Imiquimod .......................................35 Impact Advanced Recovery ............53 Impact Advanced Recovery Vanilla and Chocolate ........................... 61

INDEX Generic Chemicals and Brands

Indapamide .....................................35 Indomethacin ..................................60 Inﬂiximab ........................................35 Inhibace ..........................................23 Inhibace Plus ..................................23 Innohep ..........................................62 Innovacon hCG One Step Pregnancy Test .......................... 48 Insulin glargine ...............................35 Insulin lispro with insulin lispro protamine ................................... 35 Insulin pen needles .........................35 Insulin syringes, disposable with attached needle ......................... 36 Integrilin ..........................................29 Invanz .............................................29 Iodine with alcohol ..........................36 Iodixanol .........................................36 Iohexol ............................................36 Ioscan .............................................53 Ipratropium bromide .......................36 Ipratropium Steri-Neb .....................36 Irinotecan ........................................36 Irinotecan-Rex ................................36 Iron polymaltose .............................36 Iron sucrose ....................................37 Isentress .........................................49 Ismo-20 ...........................................37 Isoﬂurane ........................................37 Isoniazid .........................................37 Isopropyl alcohol .............................37 Isoptin .............................................56 Isosorbide mononitrate ...................37 Isotretinoin ......................................37 Itch-Soothe .....................................25 Itraconazole Contracted ..................................37 DCS ............................................60 Ivermectin Contracted ..................................37 DCS ............................................60 -KKaletra ............................................39 Kenacomb ......................................56 Kenacort-A ......................................56 Kenacort-A40 ..................................56 Ketoconazole ..................................37 Ketone blood beta-ketone electrodes .................................. 37 Kivexa .............................................16 Klacid ..............................................24 Klamycin .........................................24 Klean Prep ......................................47 Kogenate FS ...................................50 Konakion MM ..................................47 Konsyl-D .........................................43 -LL-ornithine l-aspartate (lola) S29 ........................................... 60 Labetalol .........................................37 Lactulose ........................................37 Lamictal ..........................................37 Lamotrigine .....................................37 Lansoprazole ..................................38 Lantus .............................................35 Lantus SoloStar ..............................35 Lax-Tabs .........................................19 Laxofast 120 ...................................28 Laxofast 50 .....................................28 Laxsol .............................................28 Ledermycin .....................................59 Leﬂunomide ....................................38 Lenograstim ....................................60 Letara .............................................38 Letrozole .........................................38 Leucomax .......................................61 Leunase ..........................................25 Leuprorelin ......................................38 Leustatin .........................................24 Levobunolol ....................................38 Levodopa with benserazide ............38 Levodopa with carbidopa ................38 Levophed ........................................44 Lignocaine Contracted ..................................38 DCS ............................................60 Lignocaine hydrochloride ................38 Lignocaine hydrochloride with adrenaline .................................. 39 Lignocaine with chlorhexidine .........39 Lignocaine with prilocaine ..............39 Lioresal Intrathecal .........................19 Liquiﬁlm Forte .................................47 Liquiﬁlm Tears .................................47 Lisinopril .........................................39 Locoid .............................................34 Locoid Crelo ...................................34 Locoid Lipocream ...........................34 Logem .............................................37 Loniten ............................................61 Lopinavir with ritonavir ....................39 Loraclear Hayfever Relief ...............39 Lorapaed ........................................39 Loratadine .......................................39 Lorazepam ......................................39 Lovir ................................................16 Loxamine ........................................46 Lucrin Depot ...................................38 Lucrin Depot PDS ...........................38 Lycinate ..........................................33 -Mm-Eslon ..........................................43 m-Fluconazole ................................30 m-Mometasone ...............................42 Mabthera ........................................51 Macrogol 3350 ................................39 Madopar 125 ..................................38 Madopar 250 ..................................38 Madopar 62.5 .................................38 Madopar Dispersible .......................38 Madopar HBS .................................38 Magnesium sulphate ......................39 Magnevist .......................................40 Mannitol ..........................................39 Marcain ...........................................20 Marcain Heavy ................................20 Marcain Isobaric .............................20 Marcain with Adrenaline .................20 Marine Blue Lotion SPF 30+ ..........54 Martindale Acetylcysteine ...............16 Maxalt Melt .....................................51 Maxidex ..........................................27 Maxipime ........................................22 Mebendazole ..................................39 Mebeverine hydrochloride ..............39 Medrol .............................................41 Medroxyprogesterone acetate ....................................... 39 Megestrol acetate ...........................39 Meglumine diatrizoate with sodium amidotrizoate ................ 40 Meglumine gadopentetate ..............40 Meropenem Contracted ..................................40 DCS ............................................60 Merrem ...........................................40 Mesalazine .....................................40 Mesna .............................................40 Metamide ........................................41 Metformin hydrochloride .................40 Methadone hydrochloride ...............40 Methatabs .......................................40 Methoblastin ...................................40 Methopt ...........................................35 Methotrexate ...................................40 Methotrexate Ebewe .......................40 Methoxsalen ...................................60 Methoxypsaralen ............................60

INDEX Generic Chemicals and Brands

Methyl hydroxybenzoate .................40 Methylcellulose ...............................40 Methyldopa .....................................40 Methylphenidate hydrochloride ............................. 41 Methylphenidate hydrochloride extended-release ....................... 41 Methylprednisolone ........................41 Methylprednisolone aceponate .................................. 41 Methylprednisolone acetate ............41 Methylprednisolone acetate with lignocaine .................................. 41 Methylprednisolone sodium succinate ................................... 41 Metoclopramide hydrochloride ............................. 41 Metolazone S29 .............................60 Metoprolol - AFT CR .......................41 Metoprolol succinate .......................41 Metoprolol tartrate ..........................41 Metronidazole .................................42 Miacalcic .........................................21 Miconazole nitrate ..........................42 Micreme H ......................................34 Microlax ..........................................52 Midazolam ......................................42 Minidiab ..........................................32 Minirin .............................................26 Minoxidil ..........................................61 Mirtazapine .....................................42 Mitozantrone ...................................42 Mitozantrone Ebewe .......................42 Mivacron .........................................42 Mivacurium .....................................42 Moclobemide ..................................42 Modecate ........................................31 Mogine ............................................37 Molgramostim .................................61 Mometasone furoate .......................42 Morphine hydrochloride ..................42 Morphine sulphate ..........................43 Morphine tartrate ............................43 Movicol ...........................................39 Mucilaginous laxatives ....................43 Multihance ......................................32 Myambutol ......................................29 Mycobutin .......................................50 Mycophenolate mofetil ....................43 -NNadolol ...........................................43 Naloxone hydrochloride ..................43 Naltrexone hydrochloride ................43 Napamide .......................................35 Naproxen ........................................43 Naproxen sodium ............................43 Naropin ...........................................51 Natulan ...........................................48 Nausicalm .......................................25 Navelbine ........................................56 Navoban .........................................56 Neoral Contracted ..................................25 DCS ............................................59 NeoRecormon ................................29 Neostigmine methylsulphate ..........43 Neosynephrine HCL .......................47 Neotigason .....................................16 Netilmicin ........................................61 Neulastim ........................................46 Neupogen Contracted ..................................30 DCS ............................................59 Nevirapine ......................................43 Nicotine ...........................................44 Nifedipine ........................................44 Nilstat ..............................................44 Nimodipine ......................................61 Nitroderm TTS 10 ...........................33 Nitroderm TTS 5 .............................33 Nitrolingual Pumpspray ..................33 Nitronal ...........................................33 Noﬂam 250 .....................................43 Noﬂam 500 .....................................43 Noradrenaline acid tartrate .............44 Norethisterone ................................44 Norﬂoxacin ......................................44 Normison ........................................54 Norpress .........................................44 Nortriptyline hydrochloride ..............44 Norvasc ..........................................17 Norvir ..............................................51 Novasource Renal ..........................53 Nupentin .........................................32 Nyefax Retard .................................44 Nystatin ...........................................44 -OOctreotide .......................................44 Oil in water emulsion ......................44 Olanzapine .....................................44 Omeprazole ....................................45 Omnipaque .....................................36 Omniscan .......................................32 On Call Advanced .....................19, 20 Ondansetron hydrochloride Contracted ..................................45 DCS ............................................61 One-Alpha ......................................16 Onkotrone .......................................42 Optium 5 second test ......................20 Optium Blood Ketone Test Strips ......................................... 37 Optium Xceed .................................19 Oracort ...........................................56 Oratane ...........................................37 Ospamox ........................................17 Oxaliplatin .......................................45 Oxaliplatin Ebewe ...........................45 Oxsoralen .......................................60 Oxybutynin ......................................45 Oxycodone hydrochloride ...............45 OxyContin .......................................45 OxyNorm ........................................45 Oxytocin ..........................................45 Oxytocin with ergometrine maleate ...................................... 45 -PPacifen ............................................19 Paciﬁc Buspirone ............................20 Paclitaxel ........................................45 Paclitaxel Ebewe ............................45 Pamidronate disodium ....................45 Pamisol ...........................................45 Panadol ..........................................46 Pancuronium bromide ....................46 Pantocid ..........................................46 Pantoprazole ...................................46 Papaverine hydrochloride ...............46 Paracare .........................................46 Paracare Double Strength ..............46 Paracare Junior ..............................46 Paracetamol ...................................46 Parafﬁn ...........................................46 Paroxetine hydrochloride ................46 Paxam ............................................24 Pegﬁlgrastim Contracted ..................................46 DCS ............................................61 Penicillamine ..................................46 Pentamidine ....................................61 Pentasa ..........................................40 Peptamen OS 1.0 ...........................53 Peptisoothe .....................................49 Pergolide ........................................46 Perhexiline maleate ........................46 Permax ...........................................46 Permethrin ......................................46

INDEX Generic Chemicals and Brands

Pethidine hydrochloride ..................46 Pexsig .............................................46 Phenate ..........................................24 Phenindione ....................................61 Phenobarbitone ..............................46 Phenoxymethylpenicillin (penicillin V) ............................... 47 Phentolamine mesylate ..................47 Phenylephrine hydrochloride ..........47 Phytomenadione .............................47 Pimafucort ......................................34 Pindolol ...........................................47 Pinetarsol ........................................54 Pinorax ...........................................26 Pioglitazone ....................................47 Piperacillin sodium ..........................61 Piperacillin sodium with tazobactam sodium ................... 47 Piperacillin with tazobactam ...........61 Piram-D ..........................................47 Piroxicam ........................................47 Pizaccord ........................................47 Pizotifen ..........................................47 Plaquenil .........................................34 Plavix ..............................................24 Podophyllotoxin ..............................47 Poloxamer .......................................47 Polyethylene glycol with sodium sulphate ..................................... 47 Polyhexamethylene biguanide ................................... 61 Polyvinyl alcohol .............................47 Poractant alfa ..................................47 Potassium chloride .........................47 Potassium chloride with glucose ...................................... 47 Potassium chloride with glucose and sodium chloride .................. 48 Potassium chloride with sodium chloride ...................................... 48 Povidone iodine ..............................48 Praziquantel ....................................61 Prazosin hydrochloride ...................48 Prednisolone sodium phosphate .................................. 48 Prednisone .....................................48 Pregnancy test – hCG Urine ..........48 Prilocaine hydrochloride .................48 Primaquine .....................................61 Primaxin .........................................35 Primolut N .......................................44 Procaine penicillin ...........................48 Procarbazine hydrochloride ............48 Prochlorperazine ............................48 Prodopa ..........................................40 Prograf ............................................54 Promethazine hydrochloride ...........48 Promethazine Winthrop Elixir .........48 Propofol ..........................................49 Propranolol .....................................49 Propylene glycol .............................49 Prostin E2 .......................................27 Prostin VR ......................................16 Provera ...........................................39 Provive 1% .....................................49 Pyrimethamine ...............................61 Pytazen SR .....................................27 -QQ 200 ..............................................49 Q 300 ..............................................49 Quetapel .........................................49 Quetiapine ......................................49 Quinapril .........................................49 Quinapril with hydrochlorothiazide ................... 49 Quinine sulphate .............................49 -RRA-Morph .......................................42 Raltegravir potassium .....................49 Ranbaxy-Cefaclor ...........................22 Ranitidine hydrochloride .................49 Rapamune ......................................52 Rapilysin .........................................50 Recombinant factor VIII ..................50 Redipred .........................................48 Regitine ..........................................47 Remicade .......................................35 Remifentanil hydrochloride .............50 ReoPro ...........................................16 Resource Arginaid ..........................53 Resource Beneprotein ....................53 Resource Diabetic ..........................53 Reteplase .......................................50 Retrovir ...........................................57 ReVia ..............................................43 Reyataz ..........................................18 Ridal ...............................................50 Rifabutin .........................................50 Riodine ...........................................48 Risperdal ........................................50 Risperdal Consta ............................50 Risperdal Quicklet ..........................50 Risperidone ....................................50 Risperon .........................................50 Ritalin ..............................................41 Ritalin LA ........................................41 Ritalin SR ........................................41 Ritonavir .........................................51 Rituximab ........................................51 Rivotril .............................................24 Rizatriptan benzoate .......................51 Rocaltrol .........................................21 Ropin ..............................................51 Ropinirole hydrochloride .................51 Ropivacaine hydrochloride .............51 Ropivacaine hydrochloride with fentanyl ...................................... 51 Roxithromycin .................................51 Rubifen ...........................................41 Rubifen SR .....................................41 -SSalamol ...........................................51 Salapin ............................................51 Salazopyrin .....................................53 Salazopyrin EN ...............................53 Salbutamol ......................................51 Salbutamol with ipratropium bromide ...................................... 51 Salicylic acid ...................................51 Salmeterol ......................................51 Sandimmun ....................................25 Sandomigran ..................................47 Sandostatin .....................................44 Sandostatin LAR .............................44 SC Proﬁ-Fine ..................................35 Scopoderm TTS Contracted ..................................34 DCS ............................................60 Sebizole ..........................................37 Serenace ........................................33 Seretide ..........................................31 Seretide Accuhaler .........................31 Serevent .........................................51 Serevent Accuhaler ........................51 Serophene ......................................24 Seroquel .........................................49 Sevoﬂurane .....................................51 Sevredol .........................................43 Silver sulphadiazine ........................51 Simulect ..........................................19 Simvastatin .....................................52 Sinemet ..........................................38 Sinemet CR ....................................38 Sirolimus .........................................52 Siterone ..........................................25 Slow Sodium ...................................61 Slow-Lopresor ................................41 Sodium acid phosphate ..................52

INDEX Generic Chemicals and Brands

Sodium alginate ..............................52 Sodium bicarbonate ........................52 Sodium chloride Contracted ..................................52 DCS ............................................61 Sodium chloride with glucose .........52 Sodium citrate with sodium lauryl sulphoacetate ............................ 52 Sodium citro-tartrate .......................52 Sodium diotrizoate ..........................53 Sodium hyaluronate ........................53 Solian ..............................................17 Solifenacin succinate ......................53 Solox ...............................................38 Solu-Medrol ....................................41 Sonaﬂam ........................................43 Sorbolene with glycerin ..................53 Sotalol .............................................53 Spacer device .................................53 Span-K ............................................47 Special food supplement Contracted ..................................53 DCS ............................................61 Spiriva .............................................55 Spironolactone ................................53 Spirotone ........................................53 Sporanox ........................................37 Sprycel ...........................................26 StarQuin 10% .................................34 Starquin 200 6% .............................34 Stesolid ...........................................27 Strattera ..........................................18 Streptase ........................................53 Streptokinase ..................................53 Stromectol ......................................37 Sulphadiazine .................................61 Sulphasalazine ...............................53 Sulphur ...........................................53 Sumatriptan ....................................54 Sunscreens, proprietary .................54 Suprane ..........................................26 Survanta .........................................19 Sustagen Hospital Formula ............53 Suxamethonium chloride ................54 Symmetrel ......................................16 Synacthen .......................................55 Synacthen Depot ............................55 Synermox .......................................17 Syntocinon ......................................45 Syntometrine ..................................45 Syrup (pharmaceutical grade) ........................................ 54 -TTacrolimus ......................................54 Tambocor ........................................30 Tambocor CR ..................................30 Tamoxifen citrate .............................54 Tamoxifen Sandoz ..........................54 Tar with triethanolamine lauryl sulphate and ﬂuorescein ............ 54 Tazocin EF ......................................47 Teicoplanin ......................................61 Temazepam ....................................54 Temodal ..........................................54 Temozolomide ................................54 Tenofovir disoproxil fumarate ..........54 Tenoxicam ......................................54 Terbinaﬁne ......................................54 Terlipressin .....................................54 Testosterone ...................................54 Testosterone cypionate ...................54 Testosterone undecanoate .............54 Tetracosactrin .................................55 Ticarcillin disodium with clavulanic acid ........................... 62 Timolol maleate ..............................55 Timoptol XE ....................................55 Tinzaparin sodium ..........................62 Tiotropium bromide .........................55 Tiroﬁban hydrochloride ...................55 TMP ................................................56 Tobramycin Contracted ..................................55 DCS ............................................62 Tofranil ............................................35 Tolbutamide ....................................55 Topamax .........................................55 Topiramate ......................................55 Tracleer ...........................................20 Tracrium ..........................................18 Tramadol hydrochloride ..................55 Tramal .............................................55 Tramal 100 ......................................55 Tramal 50 ........................................55 Tramal Retard .................................55 Tranexamic acid ..............................55 Trastuzumab ...................................55 Tretinoin ..........................................55 Triamcinolone acetonide .................56 Triamcinolone acetonide with gramicidin, neomycin and nystatin ...................................... 56 Triamizide .......................................56 Triamterene with hydrochlorothiazide ................... 56 Trichozole .......................................42 Trimethoprim Contracted ..................................56 DCS ............................................62 Tropisetron ......................................56 -UUltiva ...............................................50 Ultraproct ........................................31 Ural .................................................52 Urex Forte .......................................32 Uromitexan .....................................40 Ursodeoxycholic acid ......................56 -VValaciclovir ......................................56 Valganciclovir ..................................62 Valoid (AFT) ....................................25 Valtrex .............................................56 Vancomycin hydrochloride Contracted ..................................56 DCS ............................................62 Venlafaxine .....................................56 Venofer ...........................................37 Ventavis ..........................................35 Ventolin ...........................................51 Vepesid ...........................................29 Verapamil hydrochloride .................56 Vergo 16 .........................................19 Verpamil SR ...................................56 Vesanoid .........................................55 Vesicare ..........................................53 Vinblastine sulphate .......................56 Vincristine sulphate ........................56 Vinorelbine ......................................56 Viramune ........................................43 Viramune Suspension ....................43 Viread .............................................54 Visipaque ........................................36 Vistil ................................................47 Vistil Forte ......................................47 Vivonex Paediatric ..........................53 Vivonex TEN ...................................53 Volibris ............................................17 Voltaren ..........................................27 Voltaren Ophtha ..............................27 Volumatic ........................................53 Voluven ...........................................34 -WWater Contracted ..................................57 DCS ............................................62 Water with sodium, potassium,

INDEX Generic Chemicals and Brands

calcium and chloride .................. 57 Water with sodium, potassium, calcium, bicarbonate and chloride ...................................... 57 Water with sodium, potassium, calcium, bicarbonate, chloride and glucose ............................... 57 Water with sodium, potassium, magnesium, chloride, acetate and gluconate ............................ 57 -XXeloda ............................................21 Xylocaine ..................................38, 39 Xylocaine Jelly ................................38 Xyntha ............................................50 -ZZantac .............................................49 Zavedos ..........................................35 Zeldox .............................................57 Zentel ..............................................58 Zetop ..............................................23 Zidovudine (AZT) ............................57 Zinacef ............................................22 Zinc and castor oil ..........................57 Zinc sulphate ..................................57 Zincaps ...........................................57 Zinnat ..............................................22 Ziprasidone .....................................57 Zofran Contracted ..................................45 DCS ............................................61 Zofran Zydis Contracted ..................................45 DCS ............................................61 Zoladex ...........................................33 Zoledronic acid ...............................57 Zometa ...........................................57 Zopiclone ........................................57 Zostrix HP .......................................21 Zuclopenthixol decanoate ...............57 Zuclopenthixol hydrochloride ..........57 Zyban ..............................................20 Zyprexa ...........................................44 Zyprexa Zydis .................................44

NOTES

Pharmaceutical Management Agency Level 9, 40 Mercer Street, PO Box 10-254, Wellington 6143, New Zealand Phone: 64 4 460 4990 - Fax: 64 4 460 4995 - www.pharmac.govt.nz Freephone Information line (9am-5pm weekdays) 0800 66 00 50 ISSN 1172-3694 (Print) ISSN 1179-3708 (Online)

PHARMAC is the Government agency responsible for deciding which medicines are subsidised for New Zealanders. It manages spending on pharmaceuticals for the District Health Boards, and ensures that a comprehensive list of medicines (the Pharmaceutical Schedule) is subsidised for New Zealanders, and that the list of medicines continues to grow to meet the needs of patients.

Metadata

Title

Section H - effective 1 July 2010

Abstract

SVN Revision: 6999:7072 Date: 28/6/2010 User: geeringj on dell-ext509 AiTEX Hospital Pharmaceuticals July 2010 Editors Kaye Wilson & Scott Brydon email: schedule@pharmac.govt.nz Telephone +64 4 460 4990 Facsimile +64 4 460 4995 Level 9, 40 Mercer Street PO Box 10…

Page 1

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.